Product Name | Cat. No. | Formula | M.W. | Sequence | ? | ? | ? |
234 CM | SH5289 | C42H69N11O14S3 | 1048.26 | Lys-Tyr-Ile-Cys-Asn-Ser-Ser-Cys-Met | ? | ? | ? |
234 CW | SH5290 | C41H67N11O14S4 | 1066.30 | Lys-Tyr-Met-Cys-Asn-Ser-Ser-Cys-Met | ? | ? | ? |
26Rfa, Hypothalamic Peptide, frog | SH5291 | C127H197N37O36 | 2818.21 | Val-Gly-Thr-Ala-Leu-Gly-Ser-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Asn-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2 | ? | ? | ? |
26Rfa, Hypothalamic Peptide, human | SH5292 | C127H195N37O37 | 2832.20 | Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2 | ? | ? | ? |
26Rfa, Hypothalamic Peptide, rat | SH5293 | C126H195N37O37 | 2820.18 | Ala-Ser-Gly-Pro-Leu-Gly-Thr-Leu-Ala-Glu-Glu-Leu-Ser-Ser-Tyr-Ser-Arg-Arg-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2 | ? | ? | ? |
2A/2B Dengue Protease Substrate | SH5294 | C39H68N16O11 | 937.08 | Ac-Arg-Thr-Ser-Lys-Lys-Arg-pNA | ? | ? | ? |
2B-(A) | SH5295 | C81H137N28O28S | 1983.23 | Biotin-Arg-Arg-Ala-Ala-Glu-Glu-Leu-Asp-Ser-Arg-Ala-Gly-Ala-Pro-Gln-Leu | ? | ? | ? |
2B-(pS) | SH5296 | C81H137N28O31PS | 2062.22 | Biotin-Arg-Arg-Ala-Ala-Glu-Glu-Leu-Asp-Ser-Arg-Ala-Gly-pSer-Pro-Gln-Leu | ? | ? | ? |
2B-(S) | SH5297 | C81H138N28O29S | 2000.24 | Biotin-Arg-Arg-Ala-Ala-Glu-Glu-Leu-Asp-Ser-Arg-Ala-Gly-Ser-Pro-Gln-Leu | ? | ? | ? |
2B/3, Dengue Protease Substrate | SH5298 | C41H58N14O12 | 949.09 | Ac-Glu-Val-Lys-Lys-Gln-Arg-pNA | ? | ? | ? |
3/4A, Dengue Protease Substrate | SH5299 | C37H54N12O9 | 810.93 | Ac-Phe-Ala-Ala-Gly-Arg-Lys-pNA | ? | ? | ? |
4A/4B, 5A/5B Peptide | SH5300 | C49H73N11O22S3 | 1264.38 | Ac-Asp-Glu-Met-Glu-Glu-Cys-Ser-Met-Ser-Tyr-NH2 | ? | ? | ? |
4A/4B, Peptide (1) | SH5301 | C67H100N16O25S2 | 1593.76 | Asp-Glu-Met-Glu-Glu-Cys-Ser-Gln-His-Leu-Pro-Tyr-Ile | ? | ? | ? |
4B/5A Peptide | SH5302 | C59H91N17O22S2 | 1454.60 | Glu-Cys-Thr-Thr-Pro-Cys-Ser-Gly-Ser-Trp-Leu-Arg-Asp | ? | ? | ? |
5A/5B Peptide (1) | SH5303 | C46H72N10O18S2 | 1117.24 | Glu-Asp-Val-Val-Abu-Cys-Ser-Met-Ser-Tyr | ? | ? | ? |
5A/5B Peptide (3) | SH5304 | C34H50N8O13S1 | 810.90 | Ac-Glu-Glu-Val-Val-Ala-Cys-pNA | ? | ? | ? |
[beta-Ala70]-C3a (70-77) | SH5305 | C35H61N13O10 | 823.96 | beta-Ala-Ser-His-Leu-Gly-Leu-Ala-Arg | ? | ? | ? |
[beta-Ala8]-Neurokinin A (4-10) | SH5306 | C35H56N8O10S | 781.00 | Asp-Ser-Phe-Val-beta-Ala-Leu-Met-NH2 | ? | ? | ? |
[Ac-Cys4, DPhe7, Cys10] a-MSH (4-13), amide | SH5307 | C61H88N18O13S2 | 1345.61 | Ac-Cys-Glu-His-D-Phe-Arg-Trp-Cys-Lys-Pro-Val-NH2 | ? | ? | ? |
[Ala1]-PAR-4 (1-6) amide (mouse) | SH5308 | C34H48N8O7 | 680.81 | Ala-Tyr-Pro-Gly-Lys-Phe-NH2 | ? | ? | ? |
[Ala1]-PAR-4 (1-6) (mouse) | SH5309 | C34H47N7O8 | 681.80 | Ala-Tyr-Pro-Gly-Lys-Phe | ? | ? | ? |
[Ala2] Met-Enkephalin, amide | SH5310 | C28H38N6O6S | 586.72 | Tyr-Ala-Gly-Phe-Met-NH2 | ? | ? | ? |
[Ala3, 11, 18, Nle7] Endothelin-1, human | SH5311 | C109H161N25O29S2 | 2349.78 | Cys-Ser-Ala-Ser-Ser-Leu-Nle-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Cys-His-Leu-Ala-Ile-Ile-Trp | ? | ? | ? |
[Ala4] - MBP (1 - 11) | SH5312 | C49H81N21O17 | 1236.32 | Ac-Ala-Ser-Gln-Ala-Arg-Pro-Ser-Gln-Arg-His-Gly | ? | ? | ? |
[Ala5, beta-Ala8]-Neurokinin A (4-10) | SH5313 | C35H56N8O9S1 | 765.00 | Asp-Ala-Phe-Val-ß-Ala-Leu-Met-NH2 | ? | ? | ? |
[Ala8] - Humanin, [Ala8] - HN, Shna | SH5314 | C119H204N34O32S | 2655.23 | Met-Ala-Pro-Arg-Gly-Phe-Ser-Ala-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala | ? | ? | ? |
[Ala9] Autocamtide 2; Autocamtide-2-Related Inhibitory Peptide | SH5315 | C64H116N22O19 | 1497.70 | Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu | ? | ? | ? |
[Ala9, 10, Lys11, 12] Glycogen Synthase (1-12) | SH5316 | C56H103N17O16 | 1270.70 | Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys | ? | ? | ? |
[Ala11, 22, 28]-VIP (human, bovine, porcine, rat) | SH5317 | C139H231N43O39S | 3160.72 | His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Ala-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Ala-Leu-Asn-Ser-Ile-Leu-Ala-NH2 | ? | ? | ? |
[Ala11, D-Leu15]-Orexin B (human) | SH5318 | C120H206N44O35S | 2857.28 | Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | ? | ? | ? |
[Ala13] - Apelin – 13 | SH5319 | C63H107N23O16S | 1474.76 | Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala | ? | ? | ? |
[Ala18] Endothelin-1, human | SH5320 | C108H163N25O30S5 | 2451.94 | Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Ala-Ile-Ile-Trp | ? | ? | ? |
[Ala31, Aib32]-Neuropeptide Y (porcine) | SH5321 | C187H281N55O56 | 4194.63 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
[Ala81] - MBP (74 - 85) | SH5322 | C55H94N20O21 | 1371.48 | Gln-Lys-Ser-Gln-Arg-Ser-Gln-Ala-Glu-Asn-Pro-Val | ? | ? | ? |
[Ala144] - PLP (139 - 151) A144 - PLP(139 - 151) | SH5323 | C64H99N19O17 | 1406.62 | His-Ser-Leu-Gly-Lys-Ala-Leu-Gly-His-Pro-Asp-Lys-Phe | ? | ? | ? |
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) ((Ala286)-CaMK-II (281-302)) | SH5324 | C111H191N39O29S2 | 2600.12 | Met-His-Arg-Gln-Glu-Ala-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala | ? | ? | ? |
[APLILSR]pPSA | SH5325 | C80H131N21O22S | 1771.12 | Ala-Pro-Leu-Ile-Leu-Ser-Arg-Ile-Val-Gly-Gly-Trp-Glu-Cys-Glu-Lys | ? | ? | ? |
[Arg0] Met-Enkephalin | SH5326 | C33H47N9O8S | 729.86 | Arg-Tyr-Gly-Gly-Phe-Met | ? | ? | ? |
[Arg3]-Amyloid beta-Protein (1-40) | SH5327 | C195H300N56O56S | 4356.97 | Asp-Ala-Arg-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
[Arg3] Substance P | SH5328 | C63H98N20O13S | 1375.67 | Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
[Arg3, 14]CTX IV (3-14) | SH5329 | C74H119N25O14 | 1582.91 | Arg-Asn-Arg-Leu-Ile-Pro-Pro-Phe-Trp-Lys-Thr-Arg-NH2 | ? | ? | ? |
[Arg8]-a-Neo-Endorphin (1-8) | SH5330 | C46H73N15O10 | 996.19 | Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Arg | ? | ? | ? |
[Arg8]-Conopressin G | SH5331 | C44H71N17O10S2 | 1062.29 | Cys-Phe-Ile-Arg-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Arg8]-Vasopressin | SH5332 | C46H67N15O12S2 | 1086.25 | Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Arg8]-Vasopressin (4-9) | SH5333 | C25H44N12O8S | 672.76 | Gln-Asn-Cys-Pro-Arg-Gly-NH2 | ? | ? | ? |
[Arg8]-Vasopressin (free acid) | SH5334 | C46H64N14O13S2 | 1085.24 | Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Arg8]-Vasotocin | SH5335 | C43H67N15O12S2 | 1050.23 | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Arg8, des-Gly-NH29]-Vasopressin | SH5336 | C44H61N13O12S2 | 1028.18 | Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Arg14, 20, 21, Leu16]-PACAP (1-27)-Gly-Lys-Arg, amide, human, ovine, rat | SH5337 | C157H253N53O42 | 3555.10 | His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Arg-Gln-Leu-Ala-Val-Arg-Arg-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-NH2 | ? | ? | ? |
[Arg14, 20, 21, Leu16]-PACAP (1-27), amide, human, ovine, rat | SH5338 | C143H226N46O39 | 3213.70 | His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Arg-Gln-Leu-Ala-Val-Arg-Arg-Tyr-Leu-Ala-Ala-Val-Leu-NH2 | ? | ? | ? |
[Arg15, Asp16, 25, Pro18, 21, 23, Val22, Ile24]-Amyloid b-Protein (15-25) | SH5339 | C64H94N14O16 | 1315.55 | Arg-Asp-Leu-Pro-Phe-Phe-Pro-Val-Pro-Ile-Asp | ? | ? | ? |
[Arg91, Ala96] - MBP (87 - 99), human | SH5340 | C72H112N22O17 | 1557.83 | Val-His-Phe-Phe-Arg-Asn-Ile-Val-Thr-Ala-Arg-Thr-Pro | ? | ? | ? |
[Asn1, Val5]-Angiotensin II | SH5341 | C49H70N14O11 | 1031.19 | Asn-Arg-Val-Tyr-Val-His-Pro-Phe | ? | ? | ? |
[Asn5]-Delta-Sleep Inducing Peptide | SH5342 | C35H49N11O14 | 847.85 | Trp-Ala-Gly-Gly-Asn-Ala-Ser-Gly-Glu | ? | ? | ? |
[Asn10, Leu11, D-Trp12]-pTH-Related Protein (7-34) amide (human, rat) | SH5343 | C162H254N50O36 | 3478.11 | Leu-Leu-His-Asn-Leu-D-Trp-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 | ? | ? | ? |
[Asn370] tyrosinase (368–376) | SH5344 | C42H67N11O15S2 | 1030.19 | Tyr-Met-Asn-Gly-Thr-Met-Ser-Gln-Val | ? | ? | ? |
[Asn670, Leu671]-Amyloid b/A4 Protein Precursor770 (667-675) | SH5345 | C44H66N10O18 | 1023.07 | Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe | ? | ? | ? |
[Asn670, Leu671]-Amyloid b/A4 Protein Precursor770 (667-676) | SH5346 | C50H78N14O19 | 1179.26 | Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg | ? | ? | ? |
[Asn76] PTH (64-84), human | SH5347 | C94H163N27O35 | 2231.51 | Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | ? | ? | ? |
[Asp371] Tyrosinase(369-377), human | SH5348 | C42H66N10O16S2 | 1031.20 | Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val | ? | ? | ? |
[Asp5, 6, Me-Phe8] Substance P | SH5349 | C40H56N8O11S | 857.00 | Asp-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
[Cit5]-TRAP-5 | SH5350 | C30H49N7O8 | 635.77 | Ser-Phe-Leu-Leu-Cit | ? | ? | ? |
[Cys0]-GTP-Binding Protein Gsa (28-42); GTP-Binding Protein Fragment, Gs alpha | SH5351 | C85H143N30O24S1 | 2001.30 | Cys-Lys-Gln-Leu-Gln-Lys-Asp-Lys-Gln-Val-Tyr-Arg-Ala-Thr-His-Arg | ? | ? | ? |
[Cys18]-Atrial Natriuretic Factor (4-18) amide (rat) | SH5352 | C64H107N25O19S2 | 1594.90 | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Cys-NH2 (Disulfide bridge Cys7-Cys18) | ? | ? | ? |
[Cys2, Tyr3, Orn5, Pen7-amide]-Somatostatin 14 (7-14) | SH5353 | C50H69N11O11S2 | 1064.26 | D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 | ? | ? | ? |
[Cys3, 6, Tyr8, Pro10]-Substance P | SH5354 | C57H82N16O13S3 | 1295.60 | Arg-Pro-Cys-Pro-Gln-Cys-Phe-Tyr-Gly-Pro-Met-NH2 (Disulfide bridge: 3-6) | ? | ? | ? |
[Cys(Acm)2, 7]-a-CGRP (human) | SH5355 | C169H273N53O51S3 | 3933.59 | Ala-Cys(Acm)-Asp-Thr-Ala-Thr-Cys(Acm)-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | ? | ? | ? |
[Cys8, 13]-Dynorphin A (1-13) amide | SH5356 | C69H112N24O14S2 | 1565.94 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Cys-Arg-Pro-Lys-Leu-Cys-NH2 (Disulfide bridge Cys8-Cys13) | ? | ? | ? |
[Cys(Acm)20, 31]-EGF (20-31) | SH5357 | C63H98N16O23S3 | 1543.77 | Cys(Acm)-Met-His-Ile-Glu-Ser-Leu-Asp-Ser-Tyr-Thr-Cys(Acm) | ? | ? | ? |
[CysCys21] Atrial Natriuretic Factor (3-28), Rat | SH5358 | C119H189N43O36S2 | 2862.20 | Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr (Disulfide bridge Cys7-Cys23 ) | ? | ? | ? |
[D-Ala1] Peptide T, amide | SH5359 | C35H56N10O15 | 856.89 | D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 | ? | ? | ? |
[D-Ala2]-beta-Casomorphin (1-3) amide | SH5360 | C21H26N4O4 | 398.47 | Tyr-D-Ala-Phe-NH2 | ? | ? | ? |
[D-Ala2]- beta-Casomorphin (1-4) amide (bovine) | SH5361 | C26H33N5O5 | 495.58 | Tyr-D-Ala-Phe-Pro-NH2 | ? | ? | ? |
[D-Ala2]- beta-Casomorphin (1-5) amide (bovine) | SH5362 | C28H36N6O6 | 552.64 | Tyr-D-Ala-Phe-Pro-Gly-NH2 | ? | ? | ? |
[D-Ala2]- beta-Casomorphin (1-5), bovine | SH5363 | C28H35N5O7 | 553.60 | Tyr-D-Ala-Phe-Pro-Gly | ? | ? | ? |
[D-Ala2]-beta-Casomorphin (1-6), bovine | SH5364 | C33H42N6O8 | 650.70 | Tyr-D-Ala-Phe-Pro-Gly-Pro | ? | ? | ? |
[D-Ala2] Deltorphin I | SH5365 | C37H52N8O10 | 768.87 | Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2 | ? | ? | ? |
[D-Ala2] Deltorphin II | SH5366 | C38H54N8O10 | 782.90 | Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 | ? | ? | ? |
[D-Ala2] Dynorphin A (1-9), porcine | SH5367 | C53H86N18O11 | 1151.38 | Tyr-D-Ala-Gly-Phe-Leu-Arg-Arg-Ile-Arg | ? | ? | ? |
[D-Ala2]-GRF (1-29) amide (human) | SH5368 | C149H245N44O42S | 3356.95 | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | ? | ? | ? |
[D-Ala2] Leu-Enkephalin | SH5369 | C29H39N5O7 | 569.66 | Tyr-D-Ala-Gly-Phe-Leu | ? | ? | ? |
[D-Ala2] Leu-Enkephalin, amide | SH5370 | C29H40N6O6 | 568.68 | Tyr-D-Ala-Gly-Phe-Leu-NH2 | ? | ? | ? |
[D-Ala2] Met-Enkephalin | SH5371 | C28H37N5O7S | 587.70 | Tyr-D-Ala-Gly-Phe-Met | ? | ? | ? |
[D-Ala2] Met-Enkephalin, amide | SH5372 | C28H38N6O6S | 586.72 | Tyr-D-Ala-Gly-Phe-Met-NH2 | ? | ? | ? |
[D-Ala2, 4, Tyr5] -beta-Casomorphin (1-5), amide, bovine | SH5373 | C33H40N6O7 | 632.70 | Tyr-D-Ala-Phe-D-Ala-Tyr-NH2 | ? | ? | ? |
[D-Ala2, DArg6] Dynorphin A, (1-13), porcine | SH5374 | C76H128N24O15 | 1618.02 | Tyr-D-Ala-Gly-Phe-Leu-D-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | ? | ? | ? |
[D-Ala2, DLeu5] Enkephalin amide | SH5375 | C29H40N6O6 | 568.67 | Tyr-D-Ala-Gly-Phe-D-Leu-NH2 | ? | ? | ? |
[D-Ala2, DMet5] Enkephalin | SH5376 | C28H37N5O7S | 587.70 | Tyr-D-Ala-Gly-Phe-D-Met | ? | ? | ? |
[D-Ala2, DPro4, Tyr5] -beta-Casomorphin (1-5), amide | SH5377 | C35H42N6O7 | 658.80 | Tyr-D-Ala-Phe-D-Pro-Tyr-NH2 | ? | ? | ? |
[D-Ala2, Hyp4, Tyr5]- beta-Casomorphin (1-5) amide | SH5378 | C35H42N6O8 | 674.76 | Tyr-D-Ala-Phe-Hyp-Tyr-NH2 | ? | ? | ? |
[D-Ala2, Leu5, Arg6] Enkephalin | SH5379 | C35H51N9O8 | 725.85 | Tyr-D-Ala-Gly-Phe-Leu-Arg | ? | ? | ? |
[D-Ala2, Met5]- ß-Casomorphin (1-5), bovine | SH5380 | C31H41N5O7S | 627.78 | Tyr-D-Ala-Phe-Pro-Met | ? | ? | ? |
[D-Ala2, Met5]- beta-Casomorphin (1-5) , bovine , amide | SH5381 | C31H42N6O6S | 626.78 | Tyr-D-Ala-Phe-Pro-Met-NH2 | ? | ? | ? |
[D-Ala4]-Substance P (4-11) | SH5382 | C44H65N11O10S | 940.14 | D-Ala-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
[D-Arg0, Hyp2, 3, D-Phe7]-Bradykinin | SH5383 | C60H87N19O14 | 1298.48 | D-Arg-Arg-Hyp-Hyp-Gly-Phe-Ser-D-Phe-Phe-Arg | ? | ? | ? |
[D-Arg0, Hyp3, D-Phe7]-Bradykinin | SH5384 | C60H87N19O13 | 1282.48 | D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Phe-Arg | ? | ? | ? |
[D-Arg0, Hyp3, D-Phe7, Leu8]-Bradykinin | SH5385 | C57H89N19O13 | 1248.46 | D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Leu-Arg | ? | ? | ? |
[D-Arg1, D-Phe5, D-Trp7, 9, Leu11]-Substance P | SH5386 | C79H109N19O12 | 1516.87 | D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | ? | ? | ? |
[D-Arg1, D-Phe5, D-Trp7, 11]-Substance P | SH5387 | C75H101N19O12 | 1460.76 | D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-Gly-Leu-D-Trp-NH2 | ? | ? | ? |
[D-Arg1, D-Pro2, D-Phe7, D-His9]-Substance P | SH5388 | C67H102N20O13S | 1427.75 | D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Phe-Phe-D-His-Leu-Met-NH2 | ? | ? | ? |
[D-Arg1, D-Pro2, D-Trp7, 9, Leu11]-Substance P | SH5389 | C75H108N20O13 | 1497.82 | D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | ? | ? | ? |
[D-Arg1, D-Trp5, 7, 9, Leu11]-Substance P | SH5390 | C81H110N20O12 | 1555.91 | D-Arg-Pro-Lys-Pro-D-Trp-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | ? | ? | ? |
[D-Arg1, D-Trp7, 9, Leu11]-Substance P | SH5391 | C75H108N20O13 | 1497.82 | D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | ? | ? | ? |
[D-Arg2] Dermorphin (1-4), amide | SH5392 | C26H36N8O5 | 540.63 | Tyr-D-Arg-Phe-Gly-NH2 | ? | ? | ? |
[D-Arg2, Lys4]-Dermorphin (1-4), amide | SH5393 | C30H45N9O5 | 611.75 | Tyr-D-Arg-Phe-Lys-NH2 | ? | ? | ? |
[D-Arg2, Sar4]-Dermorphin (1-4) | SH5394 | C27H37N7O6 | 555.64 | Tyr-D-Arg-Phe-Sar | ? | ? | ? |
[D-Arg2]- Kyotorphin | SH5395 | C15H23N5O4 | 337.38 | Tyr-D-Arg | ? | ? | ? |
[D-Arg25]-Neuropeptide Y, human, rat; [D-Arg25]-NPY, human, rat | SH5396 | C189H285N55O57S | 4271.80 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-D-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
[D-Arg6] - Dynorphin A (1 -13), porcine | SH5397 | C75H126N24O15 | 1603.98 | Tyr-Gly-Gly-Phe-Leu-D-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | ? | ? | ? |
[D-Arg6, Asn10]-MCH (6-16) amide (human, mouse, rat) | SH5398 | C60H100N22O14S3 | 1449.80 | Ac-D-Arg-Cys-Met-Leu-Asn-Arg-Val-Tyr-Arg-Pro-Cys-NH2 (Disulfide bridge Cys2-Cys11) | ? | ? | ? |
[D-Arg8] - Dynorphin A (1 -13), porcine | SH5399 | C75H127N27O15 | 1647.01 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-D-Arg-Arg-Pro-Lys-Leu-Lys | ? | ? | ? |
[D-Asp1]-Amyloid- beta-Protein (1-42) | SH5400 | C203H311N55O60S | 4514.14 | D-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala | ? | ? | ? |
[D-Cys6, Asn7, D-Ala11, Cys14]-Bombesin (6-14) | SH5401 | C44H64N14O10S2 | 1013.22 | D-Cys-Asn-Trp-Ala-Val-D-Ala-His-Leu-Cys-NH2 (Disulfide bridge Cys1-Cys9) | ? | ? | ? |
[D-Glu5, D-Trp7, 9, 10]-Substance P (5-11) | SH5402 | C57H66N12O10S | 1111.30 | D-Glu-Gln-D-Trp-Phe-D-Trp-D-Trp-Met-NH2 | ? | ? | ? |
[D-His26]-Neuropeptide Y, human, rat; [D-His26]-NPY, human, rat | SH5403 | C189H285N55O57S1 | 4271.70 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-D-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
[D-Leu2]-Melanocyte-Stimulating Hormone-Release Inhibiting Factor | SH5404 | C13H24N4O3 | 284.36 | Pro-D-Leu-Gly-NH2 | ? | ? | ? |
[D-Lys16]-ACTH(1-24) | SH5405 | C136H210N40O31S | 2933.50 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-d-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | ? | ? | ? |
[D-Lys3] - GHRP – 6 | SH5406 | C49H63N13O6 | 930.13 | His-D-Trp-D-Lys-Trp-D-Phe-Lys-NH2 | ? | ? | ? |
[D-Met2, Pro5] Enkephalin, amide | SH5407 | C30H40N6O6S | 612.75 | Tyr-D-Met-Gly-Phe-Pro-NH2 | ? | ? | ? |
[D-Phe2]-VIP (human, bovine, porcine, rat) | SH5408 | C153H242N44O41S | 3385.97 | His-D-Phe-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | ? | ? | ? |
[D-Phe2, 6, Pro3]-LHRH | SH5409 | C59H80N14O13 | 1193.37 | Pyr-D-Phe-Pro-Ser-Tyr-D-Phe-Leu-Arg-Pro-Gly-NH2 | ? | ? | ? |
[D-Phe6, Leu-NHEt13, des-Met14]-Bombesin (6-14) | SH5410 | C49H69N13O9 | 984.12 | D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHEt | ? | ? | ? |
[D-Phe7]-Bradykinin | SH5411 | C54H75N15O11 | 1110.29 | Arg-Pro-Pro-Gly-Phe-Ser-D-Phe-Phe-Arg | ? | ? | ? |
[D-Phe7]-Somatostatin-14 | SH5412 | C76H104N18O19S2 | 1637.91 | Ala-Gly-Cys-Lys-Asn-Phe-D-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge Cys3-Cys14) | ? | ? | ? |
[D-Phe7, D-Trp10]-Somatostatin 14 (7-14) | SH5413 | C49H64N10O12S2 | 1049.30 | D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr (Disulfide bridge: Cys2-Cys7) | ? | ? | ? |
[D-Phe11]-Neurotensin | SH5414 | C78H121N21O19 | 1657.00 | pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-D-Phe-Ile-Leu | ? | ? | ? |
[D-Phe12]-Bombesin | SH5415 | C74H112N22O18S | 1629.93 | Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-D-Phe-Leu-Met-NH2 | ? | ? | ? |
[D-Phe12, Leu14]-Bombesin | SH5416 | C75H114N22O18 | 1611.90 | Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-D-Phe-Leu-Leu-NH2 | ? | ? | ? |
[D-Phe12, Nle21, 38]-CRF (12-41) (human, rat) | SH5417 | C158H265N49O43 | 3539.18 | D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 | ? | ? | ? |
[D-Phe7] a-MSH, amide | SH5418 | C77H109N21O19S | 1664.92 | Ac-Ser-Tyr-Ser-Met-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | ? | ? | ? |
[D-Pro10]-Dynorphin A (1-11), porcine | SH5419 | C63H103N21O13 | 1362.66 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-D-Pro-Lys | ? | ? | ? |
[D-Pro194]-IL-1 beta (193-195) (human) | SH5420 | C15H28N4O5 | 344.41 | Lys-D-Pro-Thr | ? | ? | ? |
[D-Pro2]-beta-Casomorphin (1-5) , bovine | SH5421 | C30H37N5O7 | 579.66 | Tyr-D-Pro-Phe-Pro-Gly | ? | ? | ? |
[D-Pro2]-beta-Casomorphin (1-5) , bovine, amide | SH5422 | C30H38N6O6 | 578.70 | Tyr-D-Pro-Phe-Pro-Gly-NH2 | ? | ? | ? |
[D-Pro2, D-Phe7, D-Trp9]-Substance P | SH5423 | C72H105N19O13S | 1476.82 | Arg-D-Pro-Lys-Pro-Gln-Gln-D-Phe-Phe-D-Trp-Leu-Met-NH2 | ? | ? | ? |
[D-Pro2, D-Trp6, 8, Nle10]-Neurokinin B | SH5424 | C67H87N15O14 | 1326.53 | Asp-D-Pro-His-Asp-Phe-D-Trp-Val-D-Trp-Leu-Nle-NH2 | ? | ? | ? |
[D-Pro2, D-Trp7, 9]-Substance P | SH5425 | C74H106N20O13S | 1515.86 | Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Met-NH2 | ? | ? | ? |
[D-Pro4, D-Trp7, 9, 10]-Substance P (4-11) | SH5426 | C62H74N14O10S | 1207.43 | D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-D-Trp-Met-NH2 | ? | ? | ? |
[D-Pro4, D-Trp7, 9, 10, Val8]-Substance P (4-11) | SH5427 | C58H74N14O10S | 1159.39 | D-Pro-Gln-Gln-D-Trp-Val-D-Trp-D-Trp-Met-NH2 | ? | ? | ? |
[D-Pro4, D-Trp7, 9, Nle11]-Substance P (4-11) | SH5428 | C58H77N13O10 | 1116.34 | D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Nle-NH2 | ? | ? | ? |
[D-Ser1]-ACTH (1-24), human | SH5429 | C136H210N40O31S | 2933.50 | D-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | ? | ? | ? |
[D-Ser14] - Humanin (HN) | SH5430 | C119H204N34O32S2 | 2687.28 | Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-D-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-arg-Arg-Ala | ? | ? | ? |
[D-Ser2] Leu-Enkephalin-Thr | SH5431 | C33H46N6O10 | 686.77 | Tyr-D-Ser-Gly-Phe-Leu-Thr | ? | ? | ? |
[D-Trp11]-Neurotensin | SH5432 | C80H122N22O19, | 1696.00 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-D-Trp-Ile-Leu | ? | ? | ? |
[D-Trp12, Tyr34]-pTH (7-34) amide (bovine) | SH5433 | C165H251N49O40S2 | 3625.25 | Phe-Met-His-Asn-Leu-D-Trp-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2 | ? | ? | ? |
[DThr2] Leu-Enkephalin-Thr | SH5434 | C34H48N6O10 | 700.79 | Tyr-D-Thr-Gly-Phe-Leu-Thr | ? | ? | ? |
[D-Trp2] Met-Enkephalin, amide | SH5435 | C36H43N7O6S | 701.85 | Tyr-D-Trp-Gly-Phe-Met-NH2 | ? | ? | ? |
[D-Trp2, 7, 9]-Substance P | SH5436 | C80H109N21O13S | 1604.96 | Arg-D-Trp-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Met-NH2 | ? | ? | ? |
[D-Trp32]-Neuropeptide Y (human) | SH5437 | C196H288N56O56S1 | 4356.90 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-D-Trp-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
[D-Trp32]-Neuropeptide Y (porcine) | SH5438 | C196H288N56O56S1 | 4356.90 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-D-Trp-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
[D-Trp34]-Neuropeptide Y, human; [D-Trp34]-NPY, human | SH5439 | C195H287N55O56S1 | 4329.80 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-D-Trp-Arg-Tyr-NH2 | ? | ? | ? |
[D-Trp8]-Somatostatin-14 | SH5440 | C76H104N18O19S2 | 1637.91 | Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge Cys3-Cys14) | ? | ? | ? |
[D-Trp8, D-Cys14]-Somatostatin-14 | SH5441 | C76H104N18O19S2 | 1637.91 | Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-D-Cys (Disulfide bridge Cys3-Cys14) | ? | ? | ? |
[D-Tyr11]-Neurotensin | SH5442 | C78H121N21O20 | 1673.00 | Glp-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-DTyr-Ile-Leu | ? | ? | ? |
[D-Tyr27, 36, D-Thr32]-Neuropeptide Y, human | SH5443 | C189H285N55O57S1 | 4271.80 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-D-Tyr-Ile-Asn-Leu-Ile-D-Thr-Arg-Gln-Arg-D-Tyr-NH2 | ? | ? | ? |
[D-Tyr27, 36, D-Thr32]-Neuropeptide Y (27-36), rat; [D-Tyr27, 36, D-Thr32]-NPY (27-36), rat | SH5444 | C61H99N19O15 | 1338.60 | D-Tyr-Ile-Asn-Leu-Ile-D-Thr-Arg-Gln-Arg-D-Tyr-NH2 | ? | ? | ? |
[D-Tyr6, beta-Ala11, beta-Phe13, Nle14]-Bombesin | SH5445 | C81H115N23O18 | 1698.98 | Pyr-Gln-Arg-Leu-Gly-D-Tyr-Gln-Trp-Ala-Val-Beta-Ala-His-beta-Phe-Nle-NH2 | ? | ? | ? |
[D-Ser13]-Somatostatin-14 | SH5446 | C76H104N18O19S2 | 1637.91 | Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-D-Ser-Cys (Disulfide bridge Cys3-Cys14) | ? | ? | ? |
[D-Val22] Big Endothelin-1 (16-38), human | SH5447 | C119H180N32O33 | 2586.96 | His-Leu-Asp-Ile-Ile-Trp-D-val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg-Ser | ? | ? | ? |
[D-Val22, Phe33] Big Endothelin-1 (16-38), human | SH5448 | C122H178N32O33 | 2620.97 | His-Leu-Asp-Ile-Ile-Trp-D-Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Phe-Gly-Ser-Pro-Arg-Ser | ? | ? | ? |
[Des-Acetyl]-a-MSH | SH5449 | C75H107N21O18S | 1622.88 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val- NH2 | ? | ? | ? |
[Des-Ala1, des-Gly2, His4, 5, D-Trp8]-Somatostatin-14 | SH5450 | C73H92N18O16S2 | 1541.79 | Cys-His-His-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge Cys1-Cys12) | ? | ? | ? |
[Des-Arg30, Des-Pro31]-Dendroaspis Natriuretic Peptide | SH5451 | C169H263N51O54S2 | 3937.42 | Glu-Val-Lys-Tyr-Asp-Pro-Cys-Phe-Gly-His-Lys-Ile-Asp-Arg-Ile-Asn-His-Val-Ser-Asn-Leu-Gly-Cys-Pro-Ser-Leu-Arg-Asp-Pro-Asn-Ala-Pro-Ser-Thr-Ser-Ala (Disulfide bridge Cys7-Cys23) | ? | ? | ? |
[Des-Asp10]Decorsin, Leech | SH5452 | C175H272N54O59S6 | 4268.78 | Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu | ? | ? | ? |
[Des-Asp187]-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | SH5453 | C42H67N9O12 | 890.06 | Ile-Thr-Gln-Val-Pro-Phe-Ser-Val | ? | ? | ? |
[Des-Asp187, Met186]-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | SH5454 | C43H69N9O11S | 920.15 | Ile-Met-Gln-Val-Pro-Phe-Ser-Val | ? | ? | ? |
[Des-Gln16]-PACAP (6-27), amide, human, ovine, rat | SH5455 | C116H185N31O29S1 | 2510.00 | Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2 | ? | ? | ? |
[Des-Gly10, Dleu6, ProNHEt9], LH-RH, Leuprolide | SH5456 | C59H84N16O12 | 1209.40 | Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | ? | ? | ? |
[Des-Gly77, His78] Myelin, Basic Protein (68-84), bovine | SH5457 | C73H115N23O26 | 1730.87 | Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ala-Gln-Arg-Pro-Gln-Asp-Glu-Asn | ? | ? | ? |
[Des-His1, Glu9] - Glucagon (1- 29), amide | SH5458 | C148H221N41O47S | 3358.72 | Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-NH2 | ? | ? | ? |
[Des-Leu9]-Kinetensin | SH5459 | C50H74N16O10 | 1059.25 | Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe | ? | ? | ? |
[Des-Leu26, Cys(Acm)20, 31]-EGF (20-31) | SH5460 | C57H87N15O22S3 | 1430.61 | Cys(Acm)-Met-His-Ile-Glu-Ser-Asp-Ser-Tyr-Thr-Cys(Acm) | ? | ? | ? |
[Des-octanoyl]-Ghrelin, human | SH5461 | C141H235N47O41 | 3244.74 | Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg | ? | ? | ? |
[Des-octanoyl] - Ghrelin, rat | SH5462 | C139H231N45O41 | 3188.67 | Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg | ? | ? | ? |
[Des-Pro2]Bradykinin | SH5463 | C45H66N14O10 | 963.12 | Arg-Pro-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
[Des-Ser1] Cerebellin | SH5464 | C66H108N22O21 | 1545.73 | Gly-Ser-Ala-Lys-Val-Ala-Phe-Ser-Ala-Ile-Arg-Ser-Thr-Asn-His | ? | ? | ? |
[Des-Thr5]-Glucagon | SH5465 | C149H218N42O47S | 3381.72 | His-Ser-Gln-Gly-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | ? | ? | ? |
[Des-Thr7]-Glucagon | SH5466 | C149H218N42O47S | 3381.72 | His-Ser-Gln-Gly-Thr-Phe-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | ? | ? | ? |
[Des-Tyr1]-beta-Endorphin, human | SH5467 | C149H242N38O44S | 3301.88 | Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | ? | ? | ? |
[Des-Tyr1]- g-Endorphin | SH5468 | C74H122N18O25S | 1695.97 | Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu | ? | ? | ? |
[Des-Tyr1] Dynorphin A (1-8) | SH5469 | C37H63N13O8 | 818.00 | Gly-Gly-Phe-Leu-Arg-Arg-Ile | ? | ? | ? |
[Des-Tyr1] Leu-Enkephalin | SH5470 | C19H28N4O5 | 392.46 | Gly-Gly-Phe-Leu | ? | ? | ? |
[Des-Tyr1] Met-Enkephalin | SH5471 | C18H26N4O5S | 410.50 | Gly-Gly-Phe-Met | ? | ? | ? |
[Fmoc-Glu70, Ala71, 72, Lys74]-C3a (70-77) | SH5472 | C53H80N12O13 | 1091.83 | Fmoc-Glu-Ala-Ala-Leu-Lys-Leu-Ala-Arg | ? | ? | ? |
[Gln11] -beta- Amyloid (1 - 16) | SH5473 | C84H120N28O27 | 1954.06 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys | ? | ? | ? |
[Gln11] -beta- Amyloid (1 - 28) | SH5474 | C145H210N42O45 | 3261.54 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | ? | ? | ? |
[Gln11] -beta- Amyloid (1 - 40) | SH5475 | C194H296N54O57S | 4328.91 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
[Gln144] - PLP (139 - 151), Q144 - PLP(139 - 151) | SH5476 | C66H102N20O18 | 1463.67 | His-Ser-Leu-Gly-Lys-Gln-Leu-Gly-His-Pro-Asp-Lys-Phe | ? | ? | ? |
[Gln18]-Platelet Factor 4 (15-22) (human) | SH5477 | C38H69N15O13 | 944.06 | Thr-Thr-Ser-Gln-Val-Arg-Pro-Arg | ? | ? | ? |
[Gln22] -beta- Amyloid (1 - 40) | SH5478 | C194H296N54O57S | 4328.91 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
[Gln22] - 25359 - Amyloid (6 -40) | SH5479 | C167H258N46O48S | 3710.26 | His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
[Gln4] Neurotensin | SH5480 | C78H122N22O19, | 1671.90 | Pyr-Leu-Tyr-Gln-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu | ? | ? | ? |
[Gln8] LH-RH, chicken | SH5481 | C54H71N15O14 | 1154.28 | Pyr-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly-NH2 | ? | ? | ? |
[Gln9]-Amyloid beta-Protein (1-40) | SH5482 | C197H300N54O59S | 4400.98 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gln-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
[Glu1] Fibrinopeptide B, human | SH5483 | C66H95N19O26 | 1570.60 | Glu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg | ? | ? | ? |
[Glu10] - ACTH (1 - 17) | SH5484 | C98H149N29O25S | 2165.50 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Glu-Lys-Pro-Val-Gly-Lys-Lys-Arg | ? | ? | ? |
[Glu2]-TRH | SH5485 | C15H22N4O6 | 354.38 | Pyr-Glu-Pro-NH2 | ? | ? | ? |
[Glu3, 4, 7, 10, 14]-Conantokin G | SH5486 | C83H137N25O35 | 2045.16 | Gly-Glu-Glu-Glu-Leu-Gln-Glu-Asn-Gln-Glu-Leu-Ile-Arg-Glu-Lys-Ser-Asn-NH2 | ? | ? | ? |
[Gly1, Ser3, 22, Gln4, 34, Thr6, Ala19, Tyr21, Ala23, 31, Aib32]-Pancreatic Polypeptide (human) | SH5487 | C183H281N57O54S2 | 4207.73 | Gly-Pro-Ser-Gln-Pro-Thr-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
[Gly11] Substance P | SH5488 | C60H92N18O13 | 1273.52 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Gly-NH2 | ? | ? | ? |
[Gly22] -beta- Amyloid (1 - 40) | SH5489 | C191H291N53O56S | 4257.83 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
[Gly22]-Amyloid b-Protein (1-42) | SH5490 | C200H307N55O58S | 4442.07 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala | ? | ? | ? |
[Gly28, Cys30]-Amyloid b-Protein (1-30) | SH5491 | C146H209N43O47S | 3350.61 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Gly-Gly-Cys-NH2 | ? | ? | ? |
[Gly30, Cys31]- beta-Amyloid (13-31) | SH5492 | C91H137N27O27S | 2073.33 | His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Gly-Cys | ? | ? | ? |
[His1, Lys6] - GHRP, GHRP- 6 | SH5493 | C46H56N12O6 | 873.04 | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 | ? | ? | ? |
[His11]Substance P | SH5494 | C64H96N20O13 | 1353.60 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-His-NH2 | ? | ? | ? |
[Ile12, Val15] MUC5AC Analog 3 | SH5495 | C67H112N16O25 | 1541.73 | Gly-Thr-Thr-Pro-Ser-Pro-Val-Pro-Thr-Thr-Ser-Ile-Thr-Ser-Val-Pro | ? | ? | ? |
[Ile161]MAGE - A2 (157 - 166) | SH5496 | C59H91N11O15 | 1194.45 | Tyr-Leu-Gln-Leu-Ile-Phe-Gly-Ile-Glu-Val | ? | ? | ? |
[Ile34]-beta- Amyloid (25 - 34) | SH5497 | C40H72N12O13 | 929.09 | Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Ile | ? | ? | ? |
[Ile7] Angiotensin III | SH5498 | C43H68N12O9 | 897.10 | Arg-Val-Tyr-Ile-His-Pro-Ile | ? | ? | ? |
[Ile76]-TNF-a (70-80) (human) | SH5499 | C55H91N15O16 | 1218.43 | Pro-Ser-Thr-His-Val-Leu-Ile-Thr-His-Thr-Ile | ? | ? | ? |
[Ile8]-Oxytocin | SH5500 | C43H66N12O12S2 | 1007.20 | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Ile-Gly-NH2 (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Ile-Ser] - Bradykinin (T - Kinin) | SH5501 | C59H89N17O14 | 1260.47 | Ile-Ser-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
[Leu116]-Prepro-Neuromedin U (104-136) (human) | SH5502 | C177H276N46O45 | 3768.45 | Phe-Leu-Phe-His-Tyr-Ser-Lys-Thr-Gln-Lys-Leu-Gly-Leu-Ser-Asn-Val-Val-Ser-Ser-Val-Val-His-Pro-Leu-Leu-Gln-Leu-Val-Pro-His-Leu-His-Glu | ? | ? | ? |
[Leu13] Motilin, human, porcine | SH5503 | C121H190N34O35 | 2681.07 | Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | ? | ? | ? |
[Leu144] - PLP (139 - 151), L144 - PLP(139 - 151) | SH5504 | C67H105N19O17 | 1448.70 | His-Ser-Leu-Gly-Lys-Leu-Leu-Gly-His-Pro-Asp-Lys-Phe | ? | ? | ? |
[Leu144, Arg147]-Myelin Proteolipid Protein(139-151) | SH5505 | C67H110N20O17 | 1467.75 | Ser-His-Leu-Gly-Lys-Leu-Leu-Gly-Arg-Pro-Asp-Lys-Phe | ? | ? | ? |
[Leu144, Arg147] - PLP (139 - 151), [L144, R147 - PLP(139 - 151)] | SH5506 | C67H110N20O17 | 1467.75 | His-Ser-Leu-Gly-Lys-Leu-Leu-Gly-Arg-Pro-Asp-Lys-Phe | ? | ? | ? |
[Leu15]-Gastrin I (human) | SH5507 | C98H126N20O31 | 2080.19 | Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Leu-Asp-Phe-NH2 | ? | ? | ? |
[Leu31, Pro34]-Neuropeptide Y (human, rat) | SH5508 | C190H286N54O56 | 4222.70 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | ? | ? | ? |
[Leu31, Pro34]-Neuropeptide Y (13-36) (human, rat) | SH5509 | C134H206N40O35S | 2969.45 | Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | ? | ? | ? |
[Leu31, Pro34]-Neuropeptide Y (porcine) | SH5510 | C189H284N54O56S1 | 4240.80 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | ? | ? | ? |
[Leu31, Pro34]-Peptide YY (human) | SH5511 | C195H296N54O56 | 4292.90 | Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | ? | ? | ? |
[Leu8, D-Trp22, Tyr25]-Somatostatin-28 | SH5512 | C138H209N41O40S2 | 3146.58 | Ser-Ala-Asn-Ser-Asn-Pro-Ala-Leu-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Tyr-Thr-Ser-Cys (Disulfide bridge Cys17-Cys28) | ? | ? | ? |
[Leu8, Des-Arg9] – Bradykinin | SH5513 | C41H63N11O10 | 870.03 | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu | ? | ? | ? |
[Lys0] g-1-MSH, amide | SH5514 | C78H109N23O15S | 1640.95 | Lys-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2 | ? | ? | ? |
[Lys0] - ? - 1 - MSH (41 - 58), amide | SH5515 | C80H112N24O16S1 | 1641.10 | Lys-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-NH2 | ? | ? | ? |
[Lys0] - Bradykinin (Kallidin) | SH5516 | C56H85N17O12 | 1188.41 | Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
[Lys1015, 1024]-Thrombospondin-1 (1015-1024)(human, bovine, mouse) | SH5517 | C68H105N17O12S | 1384.77 | Lys-Arg-Phe-Tyr-Val-Val-Met-Trp-Lys-Lys | ? | ? | ? |
[Lys15]-Amyloid b-Protein(15-21) | SH5518 | C44H69N9O8 | 852.10 | Lys-Lys-Leu-Val-Phe-Phe-Ala | ? | ? | ? |
[Lys3] – Bombesin | SH5519 | C71H110N22O18S | 1591.88 | Pyr -Gln-Lys-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
[Lys3, Phe10, Tyr13] -Autocamtide - 2 - RelatedInhibitory Peptide (AIP) Analog | SH5520 | C74H121N23O20 | 1652.93 | Lys-Lys-Lys-Leu-Arg-Arg-Gln-Glu-Ala-Phe-Asp-Ala-Tyr | ? | ? | ? |
[Lys4] Sarafotoxin S6c | SH5521 | C105H153N27O36S5 | 2529.87 | Cys-Thr-Cys-Lys-Asp-Met-Thr-Asp-Glu-Glu-Cys-Leu-Asn-Phe-Cys-His-Gln-Asp-Val-Ile-Trp [Disulfide bridge Cys1-15, 3-11] | ? | ? | ? |
[Lys6] Leu-Enkephalin | SH5522 | C34H49N7O8 | 683.81 | Tyr-Gly-Gly-Phe-Leu-Lys | ? | ? | ? |
[Lys8]-Conopressin S | SH5523 | C41H73N15O10S2 | 1000.26 | Cys-Ile-Ile-Arg-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Lys8, Asn9] Neurotensin LANT-6 (8-13) | SH5524 | C36H58N8O9 | 746.91 | Lys-Asn-Pro-Tyr-Ile-Leu | ? | ? | ? |
[Lys8, Lys9]-Neurotensin (8-13) | SH5525 | C38H64N8O8 | 760.98 | Lys-Lys-Pro-Tyr-Ile-Leu | ? | ? | ? |
[Lys8] Vasopressin | SH5526 | C46H65N13O12S2 | 1056.24 | Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Lys8]-Vasotocin (free acid) | SH5527 | C43H66N12O13S2 | 1023.21 | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Lys-Gly (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Met2]-Deltorphin | SH5528 | C44H62N10O10S2 | 955.17 | Tyr-Met-Phe-His-Leu-Met-Asp-NH2 | ? | ? | ? |
[Met5, Arg6] Enkephalin-Arg | SH5529 | C39H59N13O9S | 886.05 | Tyr-Gly-Gly-Phe-Met-Arg-Arg | ? | ? | ? |
[Met5, Arg6] Enkephalin | SH5530 | C33H47N9O8S | 729.86 | Tyr-Gly-Gly-Phe-Met-Arg | ? | ? | ? |
[Met5, Arg6, Gly7, Leu8] Enkephalin | SH5531 | C41H61N11O10S | 900.08 | Tyr-Gly-Gly-Phe-Met-Arg-Gly-Leu | ? | ? | ? |
[Met5, Arg6, Phe7] Enkephalin | SH5532 | C42H56N10O9S | 877.04 | Tyr-Gly-Gly-Phe-Met-Arg-Phe | ? | ? | ? |
[Met5, Arg6, Phe7] Enkephalin, amide | SH5533 | C42H57N11O8S | 876.06 | Tyr-Gly-Gly-Phe-Met-Arg-Phe-NH2 | ? | ? | ? |
[Met5, Arg6, 7, Val8, Gly9] Enkephalin | SH5534 | C46H71N15O11S | 1042.24 | Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly | ? | ? | ? |
[Met5, Lys6] a-Neo-Endorphin (1-6) | SH5535 | C33H47N7O8S | 701.85 | Tyr-Gly-Gly-Phe-Met-Lys | ? | ? | ? |
[Met5, Lys6, 7] a-Neo-Endorphin (1-7) | SH5536 | C39H59N9O9S | 830.02 | Tyr-Gly-Gly-Phe-Met-Lys-Lys | ? | ? | ? |
[Met5, Lys6, Arg7] a-Neo-Endorphin (1-7) | SH5537 | C39H59N11O9S | 858.04 | Tyr-Gly-Gly-Phe-Met-Lys-Arg | ? | ? | ? |
[Nle10]-Neurokinin A (4-10) | SH5538 | C35H56N8O10 | 748.88 | Asp-Ser-Phe-Val-Gly-Leu-Nle-NH2 | ? | ? | ? |
[Nle11] Substance P | SH5539 | C64H100N18O13 | 1329.62 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Nle-NH2 | ? | ? | ? |
[Nle13]-Motillin | SH5540 | C121H190N34O35 | 2681.07 | Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Nle-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | ? | ? | ? |
[Nle13, Glu14] Motilin, human, porcine | SH5541 | C44H61N13O13S | 1012.13 | Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Nle-Glu-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | ? | ? | ? |
[Nle21, Tyr32] Corticotropin Releasing Factor, ovine | SH5542 | C209H343N57O64 | 4678.40 | Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-Tyr-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala- NH2 | ? | ? | ? |
[Nle27]-GRF (1-29) amide (human) | SH5543 | C150H247N44O42 | 3338.91 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Arg- NH2 | ? | ? | ? |
[Nle253]-HSV-1 UL 26 Open Reading Frame (238-257) | SH5544 | C102H152N26O29 | 2206.51 | Gly-Ile-Ala-Gly-His-Thr-Tyr-Leu-Gln-Ala-Ser-Glu-Lys-Phe-Lys-Nle-Trp-Gly-Ala-Glu | ? | ? | ? |
[Nle4] a-MSH, amide | SH5545 | C78H111N21O19 | 1646.88 | Ac-Ser-Tyr-Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | ? | ? | ? |
[Nle4, DPhe7] a-MSH, amide; Melanotan ? | SH5546 | C78H111N21O19 | 1646.90 | Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | ? | ? | ? |
[Nle8’18, Tyr34]-pTH (1-34) amide (bovine) | SH5547 | C185H293N55O50 | 4108.70 | Ala-Val-Ser-Glu-Ile-Gln-Phe-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr- NH2 | ? | ? | ? |
[Nle8’18, Tyr34]-pTH (3-34) amide (bovine) | SH5548 | C177H279N53O48 | 3917.49 | Ser-Glu-Ile-Gln-Phe-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr- NH2 | ? | ? | ? |
[Nle8’18, Tyr34]-pTH (7-34) amide (bovine) | SH5549 | C158H248N48O40 | 3460.01 | Phe-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2 | ? | ? | ? |
[Nle8’21, Tyr34]-pTH (1-34)amide (rat) | SH5550 | C182H296N56O48 | 4036.73 | Ala-Val-Ser-Glu-Ile-Gln-Leu-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Nle-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr- NH2 | ? | ? | ? |
[Phe1, Ser2]-TRAP-6 | SH5551 | C34H56N10O9 | 748.89 | Phe-Ser-Leu-Leu-Arg-Asn | ? | ? | ? |
[Phe1, Ser2, Tyr6]-PAR-1 (1-6) amide (human) | SH5552 | C39H60N10O8 | 796.98 | Phe-Ser-Leu-Leu-Arg-Tyr- NH2 | ? | ? | ? |
[Phe13, Tyr19]-MCH (human, mouse, rat) | SH5553 | C109H160N30O26S4 | 2434.93 | Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp-Gln-Tyr (Disulfide bridge: Cys7-Cys16) | ? | ? | ? |
[Phe1376] – Fibronectin Fragment (1371 - 1382) | SH5554 | C63H103N25O19 | 1514.68 | Arg-Gln-Asp-Arg-Val-Phe-His-Ser-Arg-Asn-Ser-Ile | ? | ? | ? |
[Phe17] - Apelin 17 | SH5555 | C96H156N34O20S | 2138.59 | Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | ? | ? | ? |
[Phe2]-TRH | SH5556 | C19H24N4O4 | 372.44 | Pyr-Phe-Pro- NH2 | ? | ? | ? |
[Phe2, Nle4]-ACTH (1-24) | SH5557 | C137H212N40O30 | 2899.47 | Ser-Phe-Ser-NLE-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | ? | ? | ? |
[Phe2, Orn8]-Oxytocin | SH5558 | C42H65N13O11S2 | 992.19 | Cys-Phe-Ile-Gln-Asn-Cys-Pro-Orn-Gly- NH2 (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Phe22] Big Endothelin-1 (19-37), human | SH5559 | C104H152N26O26 | 2182.53 | Ile-Ile-Trp-Phe-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg | ? | ? | ? |
[Phe4]-Dermorphin (1-4) amide | SH5560 | C30H35N5O5 | 545.64 | Tyr-D-Ala-Phe-Phe-NH2 | ? | ? | ? |
[Phe7] Dynorphin A (1-7), amide, porcine | SH5561 | C43H59N11O8 | 858.02 | Tyr-Gly-Gly-Phe-Leu-Arg-Phe-NH2 | ? | ? | ? |
[Phe7] Dynorphin A (1-7), porcine | SH5562 | C43H58N10O9 | 859.00 | Tyr-Gly-Gly-Phe-Leu-Arg-Phe | ? | ? | ? |
[Pro18, Asp21] beta - Amyloid (17-21), iAb5 | SH5563 | C33H43N5O8 | 637.74 | Leu-Pro-Phe-Phe-Asp | ? | ? | ? |
[Pro34]-Neuropeptide Y (porcine) | SH5564 | C190H286N54O56 | 4222.70 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Pro-Arg-Tyr- NH2 | ? | ? | ? |
[Pro34]-Neuropeptide Y, human, rat; [Pro34]-NPY, human, rat | SH5565 | C189H285N55O57S1 | 4271.80 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Pro-Arg-Tyr- NH2 | ? | ? | ? |
[Pro34]Peptide YY, PYY, human | SH5566 | C194H294N54O56 | 4278.83 | Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Pro-Arg-Tyr-NH2 | ? | ? | ? |
[Pro7]-Neurokinin B | SH5567 | C55H77N13O14S2 | 1208.43 | Asp-Met-His-Asp-Phe-Phe-Pro-Gly-Leu-Met- NH2 | ? | ? | ? |
[Pro9] Substance P | SH5568 | C66H102N18O13S1 | 1387.73 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met- NH2 | ? | ? | ? |
[pY185]MAP (177 - 189) kinase | SH5569 | C67H100N18O22 | 1509.65 | Asp-His-Thr-Gly-Phe-Leu-Thr-Glu-Tyr(PO3H2)-Val-Ala-Thr-Arg | ? | ? | ? |
[Pyr1] - Apelin - 13 | SH5570 | C69H108N22O16S | 1533.85 | pyr-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | ? | ? | ? |
[Pyr11]-Amyloid b-Protein (11-40) | SH5571 | C143H226N38O39S | 3133.71 | Pyr-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
[Pyr16]-VIP (16-28) (chicken) | SH5572 | C67H113N17O18S | 1476.83 | Pyr-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Val-Leu-Thr-NH2 | ? | ? | ? |
[Pyr16]-VIP (16-28) (human, bovine, porcine, rat) | SH5573 | C68H1141N18O18S | 1503.86 | Pyr-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn- NH2 | ? | ? | ? |
[Pyr3]-Amyloid beta-Protein (3-42) | SH5574 | C196H299N53O55S | 4309.97 | Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | ? | ? | ? |
[Pyr4] - MBP (4 - 14) | SH5575 | C60H100N20O17 | 1391.61 | Pyr-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu | ? | ? | ? |
[Pyr5]-Substance P (5-11) | SH5576 | C41H57N9O9S | 852.05 | Pyr-Gln-Phe-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
[Pyr6]-Substance P (6-11) | SH5577 | C36H49N7O7S | 723.91 | Pyr-Phe-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
[Pyr6, Pro9]-Substance P (6-11) | SH5578 | C39H53N7O7S | 763.98 | Pyr-Phe-Phe-Pro-Leu-Met-NH2 | ? | ? | ? |
[pSer5] - Kemptide, Biotinylated | SH5579 | C42H76N15O14PS | 1078.22 | Biotin-Leu-Arg-Arg-Ala-Ser(PO3H2)-Leu-Gly | ? | ? | ? |
[Sar1]-Angiotensin I/II (1-7) amide | SH5580 | C40H63N13O8 | 854.02 | Sar-Arg-Val-Tyr-Ile-His-Pro-NH2 | ? | ? | ? |
[Sar1] Angiotensin II | SH5581 | C49H71N13O11 | 1018.19 | Sar-Arg-Val-Tyr-Ile-His-Pro-Phe | ? | ? | ? |
[Sar1, Ala8]-Angiotensin II | SH5582 | C43H67N13O10 | 926.10 | Sar-Arg-Val-Tyr-Ile-His-Pro-Ala | ? | ? | ? |
[Sar1, Gly8]-Angiotensin II | SH5583 | C42H65N13O10 | 912.06 | Sar-Arg-Val-Tyr-Ile-His-Pro-Gly | ? | ? | ? |
[Sar1, Ile4, 8]-Angiotensin II | SH5584 | C43H75N13O9 | 918.15 | Sar-Arg-Val-Ile-Ile-His-Pro-Ile | ? | ? | ? |
[Sar1, Thr8]-Angiotensin II | SH5585 | C44H69N13O11 | 956.12 | Sar-Arg-Val-Tyr-Ile-His-Pro-Thr | ? | ? | ? |
[Sar1, Val5, Ala8]-Angiotensin II | SH5586 | C42H65N13O10 | 912.10 | Sar-Arg-Val-Tyr-Val-His-Pro-Ala | ? | ? | ? |
[Ser140]-Myelin Proteolipid Protein (139-151) (depalmitoylated), human, bovine, dog, mouse, rat | SH5587 | C72H104N20O17 | 1521.70 | His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe | ? | ? | ? |
[Ser2] - Neuromedin C | SH5588 | C67H87N15O14 | 1326.53 | Gly-Ser-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
[Ser25] - PKC (19 - 31) | SH5589 | C67H118N26O17 | 1559.85 | Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val | ? | ? | ? |
[Ser25] - PKC (19 - 31), biotinylated | SH5590 | C83H144N30O20S | 1914.30 | Lys(Biotin)-Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val | ? | ? | ? |
[Ser25] - PKC (19 - 36) Substrate | SH5591 | C93H159N35O25 | 2167.52 | Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn | ? | ? | ? |
[Ser4, Ile8]-Oxytocin | SH5592 | C41H63N11O12S2 | 966.15 | Cys-Tyr-Ile-Ser-Asn-Cys-Pro-Ile-Gly-NH2 (Disulfide bridge Cys1-Cys6) | ? | ? | ? |
[Ser8]-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) | SH5593 | C149H226N40O46 | 3313.70 | His-Ser-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | ? | ? | ? |
[Sar9] Substance P | SH5594 | C64H100N18O13S | 1361.61 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-NH2 | ? | ? | ? |
[Thr30]-Neuropeptide Y, human | SH5595 | C187H280N54O59S1 | 4259.70 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Thr-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
[Thr4, Gly7]-Oxytocin | SH5596 | C39H61N11O12S2 | 940.10 | Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2 (Disulfide bridge Cys1-Cys6 ) | ? | ? | ? |
[Thr46]-Osteocalcin (45-49) (human) | SH5597 | C25H37N5O7 | 519.60 | Phe-Thr-Gly-Pro-Val | ? | ? | ? |
[Thr6]-Bradykinin | SH5598 | C51H75N15O11 | 1074.26 | Arg-Pro-Pro-Gly-Phe-Thr-Pro-Phe-Arg | ? | ? | ? |
[Trp11]-Neurotensin | SH5599 | C80H122N22O19, | 1696.00 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Trp-Ile-Leu | ? | ? | ? |
[Trp11] Neurotensin (8-13) | SH5600 | C40H65N13O7 | 840.05 | Arg-Arg-Pro-Trp-Ile-Leu | ? | ? | ? |
[Trp3, Arg5]-Ghrelin (1-5) | SH5601 | C31H41N9O7 | 651.73 | Gly-Ser-Trp-Phe-Arg | ? | ? | ? |
[Trp63, 64] - C3a (63 - 77) | SH5602 | C86H134N26O18 | 1820.19 | Trp-Trp-Gly-Lys-Lys-Tyr-Arg-Ala-Ser-Lys-Leu-Gly-Leu-Ala-Arg | ? | ? | ? |
[Trp7, beta-Ala8]-Neurokinin A (4-10) | SH5603 | C41H57N9O10S | 868.03 | Asp-Ser-Phe-Trp-beta-Ala-Leu-Met-NH2 | ? | ? | ? |
[Tyr0] - alfa - CGRP, [Tyr0] - alfa -CGRP, rat | SH5604 | C171H271N51O54S2 | 3969.50 | Tyr-Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 (Disulfide bridge: Cys 2-Cys 7) | ? | ? | ? |
[Tyr0] - alfa - CGRP, human | SH5605 | C172H276N52O51S2 | 3952.56 | Tyr-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 (Disulfide bridge: Cys 2-Cys 7) | ? | ? | ? |
[Tyr0]-Apelin-13 (human, bovine, mouse, rat) | SH5606 | C78H120N24O18S | 1714.03 | Tyr-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | ? | ? | ? |
[Tyr0]-Atriopeptin II (rat) | SH5607 | C107H165N35O34S2 | 2549.90 | Tyr-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg (Disulfide bridge Cys4-Cys20 ) | ? | ? | ? |
[Tyr0]-BNP-32 (human) | SH5608 | C152H253N51O44S4 | 3627.28 | Tyr-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His (Disulfide bridge: Cys 11-Cys 27) | ? | ? | ? |
[Tyr0]-C-Peptide (dog) | SH5609 | C146H234N38O51 | 3337.72 | Tyr-Glu-Val-Glu-Asp-Leu-Gln-Val-Arg-Asp-Val-Glu-Leu-Ala-Gly-Ala-Pro-Gly-Glu-Gly-Gly-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ala-Leu-Gln | ? | ? | ? |
[Tyr0]-C-Peptide (human) | SH5610 | C138H220N36O50 | 3183.50 | Tyr-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln | ? | ? | ? |
[Tyr0]-C-Type Natriuretic Peptide (32-53) (human, porcine, rat) | SH5611 | C102H166N28O30S3 | 2360.82 | Tyr-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys (Disulfide bridge: Cys 7-Cys 23) | ? | ? | ? |
[Tyr0] Fibrinopeptide A, human | SH5612 | C72H106N20O28 | 1699.76 | Tyr-Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg | ? | ? | ? |
[Tyr0] Gastric Inhibitory Peptide (23-42), human; [Tyr22] Gastric Inhibitory Peptide (22-42), human | SH5613 | C119H182N34O31 | 2584.90 | Tyr-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | ? | ? | ? |
[Tyr0]-Hypercalcemia Malignancy Factor (1-40) | SH5614 | C216H343N67O60 | 4838.60 | Tyr-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser | ? | ? | ? |
[Tyr0] - Neurokinin A | SH5615 | C59H89N15O16S | 1296.52 | Tyr-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
[Tyr0] - Neurokinin B | SH5616 | C64H88N14O16S2 | 1373.63 | Tyr-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
[Tyr0]-pTH-Related Protein (1-34) (human, rat) | SH5617 | C189H296N58O50 | 4180.79 | Tyr-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala | ? | ? | ? |
[Tyr0]-Prepro-Atrial Natriuretic Factor (104-123) (human) | SH5618 | C103H180N32O30 | 2346.80 | Tyr-Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg-Ala-Leu-Leu-Thr-Ala-Pro-Arg | ? | ? | ? |
[Tyr0]-Stresscopin-Related Peptide (human) | SH5619 | C214H367N69O59 | 4850.74 | Tyr-His-Pro-Gly-Ser-Arg-Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2 | ? | ? | ? |
[Tyr0]-Stresscopin (human) | SH5620 | C204H335N57O55S2 | 4530.42 | Tyr-Thr-Lys-Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2 | ? | ? | ? |
[Tyr0]-Urocortin (rat) | SH5621 | C215H347N63O66 | 4870.55 | Tyr-Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 | ? | ? | ? |
[Tyr1] Adipokinetic Hormone, locust | SH5622 | C58H78N14O15 | 1211.50 | Tyr-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-NH2 | ? | ? | ? |
[Tyr1]-Delta-Sleep Inducing Peptide | SH5623 | C33H47N9O16 | 825.79 | Tyr-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu | ? | ? | ? |
[Tyr1] -pTH (1-34), human | SH5624 | C189H295N55O51S2 | 4193.87 | Tyr-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | ? | ? | ? |
[Tyr1]-pTH (1-34) (rat) | SH5625 | C186H295N55O49S2 | 4149.86 | Tyr-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | ? | ? | ? |
[Tyr1] Somatostatin | SH5626 | C82H108N18O20S2 | 1730.01 | Tyr-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge: Cys3-Cys14) | ? | ? | ? |
[Tyr1]-TRAP-7 | SH5627 | C455H67N11O10 | 922.10 | Tyr-Phe-Leu-Leu-Arg-Asn-Pro | ? | ? | ? |
[Tyr11]-Somatostatin-14 | SH5628 | C76H104N18O20S2 | 1653.91 | Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Thr-Ser-Cys (Disulfide bridge: Cys 3-Cys 14) | ? | ? | ? |
[Tyr11] Somatostatin | SH5629 | C76H102N18O20S2 | 1651.91 | Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Thr-Ser-Cys(Disulfide bridge: Cys3-Cys14) | ? | ? | ? |
[Tyr12]-Somatostatin-28 (1-14) | SH5630 | C65H107N23O20S | 1562.78 | Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Tyr-Arg-Lys | ? | ? | ? |
[Tyr15]-ACTH (7-15) | SH5631 | C55H76N14O11 | 1109.31 | Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Tyr | ? | ? | ? |
[Tyr15]-Fibrinopeptide B | SH5632 | C75H102N20O27 | 1715.78 | Pyr-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-Tyr | ? | ? | ? |
[Tyr15] Fibrinopeptide B, human | SH5633 | C75H102N20O27 | 1715.78 | Glp-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-Tyr | ? | ? | ? |
[Tyr22]-a-CGRP (22 - 37), rat | SH5634 | C82H120N20O25 | 1785.99 | Tyr-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | ? | ? | ? |
[Tyr27]-a-CGRP (27-37) (canine, mouse, rat) | SH5635 | C54H79N13O17 | 1182.31 | Tyr-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | ? | ? | ? |
[Tyr27]-pTH (27-48) (human) | SH5636 | C104H159N29O31 | 2311.60 | Tyr-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser | ? | ? | ? |
[Tyr34]-pTH (7-34) amide (bovine) | SH5637 | C156H244N48O40S2 | 3496.08 | Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2 | ? | ? | ? |
[Tyr36]-pTH-Related Protein (1-36) (human, rat) | SH5638 | C194H303N59O53 | 4309.91 | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr | ? | ? | ? |
[Tyr38, Phe42, 46]-Osteocalcin (38-49) (human) | SH5639 | C73H101N19O17 | 1516.70 | Tyr-Gln-Glu-Ala-Phe-Arg-Arg-Phe-Phe-Gly-Pro-Val | ? | ? | ? |
[Tyr4]-Bombesin | SH5640 | C74H108N24O19S1 | 1669.90 | Pyr-Gln-Arg-Tyr-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
[Trp4]-Kemptide | SH5641 | C40H66N14O9 | 887.05 | Leu-Arg-Arg-Trp-Ser-Leu-Gly | ? | ? | ? |
[Tyr4] - MBP (1 - 11) | SH5642 | C55H85N21O18 | 1328.42 | Ac-Ala-Ser-Gln-Tyr-Arg-Pro-Ser-Gln-Arg-His-Gly | ? | ? | ? |
[Tyr4, D-Phe12]-Bombesin | SH5643 | C77H110N22O19S | 1579.95 | Pyr-Gln-Arg-Tyr-Gly-Asn-Gln-Trp-Ala-Val-Gly-D-Phe-Leu-Met-NH2 | ? | ? | ? |
[Tyr43] PTH (43-68) (human) | SH5644 | C126H208N42O43 | 2999.32 | Tyr-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly | ? | ? | ? |
[Tyr5, D-Trp6, 8, 9, Arg-NH210]-Neurokinin A (4-10) | SH5645 | C57H68N14O10 | 1109.30 | Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Arg-NH2 | ? | ? | ? |
[Tyr52] PTH (52-84) (human) | SH5646 | C158H262N44O56 | 3674.08 | Tyr-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | ? | ? | ? |
[Tyr6, D-Phe7, D-His9]-Substance P (6-11) | SH5647 | C44H57N9O7S | 856.07 | Tyr-D-Phe-Phe-D-His-Leu-Met-NH2 | ? | ? | ? |
[Tyr63] PTH (63-84), human | SH5648 | C103H172N28O37 | 2394.68 | Tyr-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | ? | ? | ? |
[Tyr65, Phe67]-C5a (65-74) (human) | SH5649 | C55H85N15O16S | 1244.45 | Tyr-Ser-Phe-Lys-Asp-Met-Gln-Leu-Gly-Arg | ? | ? | ? |
[Tyr69, Ala71, 72, Lys74]-C3a (69-77) | SH5650 | C45H77N13O11 | 976.20 | Tyr-Ala-Ala-Ala-Leu-Lys-Leu-Ala-Arg | ? | ? | ? |
[Tyr8]-Atrial Natriuretic Peptide (5-27), rat; [Tyr8]-Atriopeptin II, rat | SH5651 | C98H156N34O33S2 | 2402.70 | Ser-Ser-Cys-Tyr-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg (Disulfide bridge Cys3-Cys19 ) | ? | ? | ? |
[Tyr8] Bradykinin | SH5652 | C50H73N15O12 | 1076.23 | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg | ? | ? | ? |
[Tyr8] Substance P | SH5653 | C63H98N18O14S | 1363.66 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Met-NH2 | ? | ? | ? |
[Tyr8, Nle11] Substance P | SH5654 | C64H100N18O14 | 1345.62 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Nle-NH2 | ? | ? | ? |
[Tyr9]-beta-MSH (porcine); (Tyr49)-beta-Lipotropin (41-58) (porcine) | SH5655 | C101H140N24O30S | 2202.43 | Asp-Glu-Gly-Pro-Tyr-Lys-Met-Glu-Tyr-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | ? | ? | ? |
[Val3]-beta-Casomorphin (1-4) amide (bovine) | SH5656 | C24H35N5O5 | 473.58 | Tyr-Pro-Val-Pro-NH2 | ? | ? | ? |
[Val35] -beta - Amyloid (1 - 42) | SH5657 | C203H311N55O60 | 4482.07 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Val-Val-Gly-Gly-Val-Val-I le-Ala | ? | ? | ? |
[Val4]-Angiotensin III | SH5658 | C45H64N12O9 | 917.10 | Arg-Val-Tyr-Val-His-Pro-Phe | ? | ? | ? |
[Val438]-Tyrosinase (432-444) (human) | SH5659 | C65H93N15O26 | 1500.55 | Ser-Tyr-Leu-Gln-Asp-Ser-Val-Pro-Asp-Ser-Phe-Gln-Asp | ? | ? | ? |
[Val5] Angiotensin I, human | SH5660 | C61H87N17O14 | 1282.50 | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | ? | ? | ? |
[Val5] Angiotensin II, human | SH5661 | C49H69N13O12 | 1032.18 | Asp-Arg-Val-Tyr-Val-His-Pro-Phe | ? | ? | ? |
[Val5, Asn9]-Angiotensin I | SH5662 | C59H86N16O15 | 1259.44 | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu | ? | ? | ? |
[Val671]-Amyloid b/A4 Protein Precursor770 (667-676) | SH5663 | C51H82N14O18 | 1179.31 | Ser-Glu-Val-Lys-Val-Asp-Ala-Glu-Phe-Arg | ? | ? | ? |
alfa-ANF(1-28), human | SH5664 | C127H203N45O39S3 | 3080.46 | Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr (Disulfide bridge Cys7-Cys23) | ? | ? | ? |
alfa-Bag Cell Peptide (1 - 7) | SH5665 | C44H67N13O9 | 922.11 | Ala-Pro-Arg-Leu-Arg-Phe-Tyr | ? | ? | ? |
alfa- Bag Cell Peptide (1 - 8) | SH5666 | C47H72N14O11 | 1009.19 | Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser | ? | ? | ? |
alfa-Bag Cell Peptide (1 - 9) | SH5667 | C53H83N15O12 | 1122.35 | Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser-Leu | ? | ? | ? |
alfa-Casein (90-95) | SH5668 | C103H175N35O27S | 2367.83 | Arg-Tyr-Leu-Gly-Tyr-Leu | ? | ? | ? |
alfa-Casomorphin (1-2) | SH5669 | C14H18N2O4 | 278.31 | Tyr-Pro | ? | ? | ? |
alfa-CGRP (19 - 37), human | SH5670 | C86H137N25O25 | 1921.20 | Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | ? | ? | ? |
alfa-CGRP (23-37) (human) | SH5671 | C74H117N21O20 | 1620.89 | Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | ? | ? | ? |
alfa-CGRP (29-37) (canine, mouse, rat) | SH5672 | C40H61N11O14 | 920.00 | Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | ? | ? | ? |
alfa-CGRP (30-37) (canine, mouse, rat) | SH5673 | C35H54N10O13 | 822.88 | Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | ? | ? | ? |
alfa-CGRP (31-37) (canine, mouse, rat) | SH5674 | C31H47N9O11 | 721.77 | Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | ? | ? | ? |
alfa-CGRP (32-37) (canine, mouse, porcine, rat) | SH5675 | C27H41N7O9 | 607.67 | Val-Gly-Ser-Glu-Ala-Phe-NH2 | ? | ? | ? |
alfa-CGRP (33-37) (canine, mouse, porcine, rat) | SH5676 | C22H32N6O8 | 508.54 | Gly-Ser-Glu-Ala-Phe-NH2 | ? | ? | ? |
alfa-Conotoxin EI | SH5677 | C83H123N27O27S5 | 2091.39 | Arg-Asp-Hyp-Cys-Cys-Tyr-His-Pro-Thr-Cys-Asn-Met-Ser-Asn-Pro-Gln-Ile-Cys- NH2 | ? | ? | ? |
alfa-Conotoxin GI | SH5678 | C55H76N20O18S4 | 1433.63 | Glu-Cys-Cys-Asn-Pro-Ala-Cys-Gly-Arg-His-Tyr-Ser-Cys-NH2 (Disulfide bridge: Cys2-Cys7, Cys3-Cys13) | ? | ? | ? |
alfa-Conotoxin GS | SH5679 | C139H232N52O47S7 | 3624.11 | Ala-Cys-Ser-Gly-Arg-Gly-Ser-Arg-Cys-Hyp-Hyp-Gln-Cys-Cys-Met-Gly-Leu-Arg-Cys-Gly-Arg-Gly-Asn-Pro-Gln-Lys-Cys-Ile-Gly-Ala-His-Gla-Asp-Val | ? | ? | ? |
alfa-Conotoxin IMI | SH5680 | C52H74N20O15S4 | 1347.58 | Gly-Cys-Cys-Ser-Asp-Pro-Arg-Cys-Ala-Trp-Arg-Cys- NH2 (Disulfide bridge: Cys2-Cys8, Cys3-Cys12) | ? | ? | ? |
alfa-Conotoxin MI | SH5681 | C58H92N22O17S4 | 1497.74 | Gly-Arg-Cys-Cys-His-Pro-Ala-Cys-Gly-Lys-Asn-Tyr-Ser-Cys-NH2 | ? | ? | ? |
alfa-Conotoxin SI | SH5682 | C55H84N16O16S4 | 1353.60 | Ile-Cys-Cys-Asn-Pro-Ala-Cys-Gly-Pro-Lys-Tyr-Ser-Cys- NH2 (Disulfide bridges Cys2-Cys7, Cys3-Cys13 ) | ? | ? | ? |
alfa-Conotoxin SIA | SH5683 | C60H82N18O17S4 | 1455.70 | Tyr-Cys-Cys-His-Pro-Ala-Cys-Gly-Lys-Asn-Phe-Asp-Cys-NH2 (Disulfide bridge: Cys2 -Cys7, Cys3 - Cys13) | ? | ? | ? |
alfa-Defensin-1, human | SH5684 | C167H256N48O50S6 | 3928.58 | Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys (Disulfide bridge: Cys 5- Cys 34, Cys 12- Cys 27, Cys 17- Cys 35) | ? | ? | ? |
alfa-Endorphin | SH5685 | C77H120N18O26S | 1745.98 | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr | ? | ? | ? |
alfa-Gliadin (57–73) | SH5686 | C93H136N22O27 | 1994.25 | Gln-Leu-Gln-Pro-Phe-Pro-Gln-Pro-Glu-Leu-Pro-Tyr-Pro-Gln-Pro-Gln-Ser | ? | ? | ? |
alfa-Helical CRF (12-41) | SH5687 | C152H251N43O47S2 | 3497.08 | Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2 | ? | ? | ? |
alfa-Helical CRF (9-41) | SH5688 | C166H274N46O53S2 | 3826.44 | Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2 | ? | ? | ? |
alfa-Mating Factor (1-6) | SH5689 | C45H59N11O8 | 882.04 | Trp-His-Trp-Leu-Gln-Leu | ? | ? | ? |
alfa-Melanocyte Stimulating Hormone (11-13)(MSHa) | SH5690 | C16H31N5O3 | 341.46 | Lys-Pro-Val-NH2 | ? | ? | ? |
alfa-Melanocyte Stimulating Hormone [Acetyl-D-Lys11, D-Val13] (11-13) (MSHa) | SH5691 | C18H33N5O4 | 383.49 | Ac-D-Lys-Pro-D-Val-NH2 | ? | ? | ? |
alfa-Melanocyte Stimulating Hormone [Met5, Pro6, D-Phe7, D-Trp9, Phe10] (5-13) (MSHa) | SH5692 | C61H87N15O9S | 1206.53 | Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH2 | ? | ? | ? |
alfa-Melanocyte Stimulating Hormone, acetylated-[D-Val13] (11-13) (MSHa) | SH5693 | C18H33N5O4 | 383.49 | Ac-Lys-Pro-D-Val-NH2 | ? | ? | ? |
alfa-MSH | SH5694 | C77H109N21O19S | 1664.90 | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | ? | ? | ? |
alfa-MSH, Free Acid | SH5695 | C77H108N20O20S | 1665.91 | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val | ? | ? | ? |
alfa-Neo-Endorphin (1-7) | SH5696 | C40H61N11O9 | 840.00 | Tyr-Gly-Gly-Phe-Leu-Arg-Lys | ? | ? | ? |
alfa-Neo-Endorphin Analog | SH5697 | C66H102N20O13 | 1383.68 | Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Arg-Pro-Lys-NH2 | ? | ? | ? |
alfa-Neo-Endorphin, porcine | SH5698 | C60H89N15O13 | 1228.47 | Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-Lys | ? | ? | ? |
alfa-Neoendorphin (1-8) | SH5699 | C49H70N12O11 | 1003.17 | Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr | ? | ? | ? |
alfa-Substance IB | SH5700 | C33H51N9O7 | 685.82 | Arg-Gly-Pro-Phe-Pro-Ile | ? | ? | ? |
beta I probe | SH5701 | C81H116N26O24 | 1873.99 | Ser-Arg-Glu-Trp-Glu-Asp-Gly-Phe-Gly-Gly-Arg-Trp-Leu-Ser-Arg | ? | ? | ? |
beta II probe | SH5702 | C94H150N26O31S | 2172.46 | Ser-Ser-Leu-Asp-Leu-Ser-Gln-Phe-Pro-Met-Thr-Ala-Ser-Phe-Leu-Arg-Glu-Ser-Arg | ? | ? | ? |
beta III probe | SH5703 | C87H143N27O28S3 | 2111.45 | Ser-Ser-Glu-Ala-Cys-Val-Gly-Arg-Trp-Met-Leu-Cys-Glu-Gln-Leu-Gly-Val-Ser-Arg | ? | ? | ? |
beta-Amyloid (1-11) | SH5704 | C56H76N16O22 | 1325.32 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu | ? | ? | ? |
beta-Amyloid (1-14) , mouse, rat | SH5705 | C69H95N21O24 | 1602.65 | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His | ? | ? | ? |
beta-Amyloid (1-15) | SH5706 | C78H107N25O27 | 1826.87 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln | ? | ? | ? |
beta- Amyloid (1-16) | SH5707 | C84H119N27O28 | 1955.05 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys | ? | ? | ? |
beta-Amyloid(1-16), mouse, rat | SH5708 | C80H116N26O26 | 1857.98 | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-NH2 | ? | ? | ? |
beta-Amyloid (1-28) | SH5709 | C145H209N41O46 | 3262.53 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | ? | ? | ? |
beta- Amyloid (1-33) | SH5710 | C164H242N46O51 | 3674.03 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly | ? | ? | ? |
beta- Amyloid (1-34) | SH5711 | C170H253N47O52 | 3787.20 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu | ? | ? | ? |
beta- Amyloid (1-37) | SH5712 | C182H274N50O55S | 4074.58 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly | ? | ? | ? |
beta- Amyloid (1-38) | SH5713 | C184H277N51O56S | 4131.63 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly | ? | ? | ? |
beta-Amyloid (1-39) | SH5714 | C81H128N32O19S2 | 1918.30 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val | ? | ? | ? |
beta-Amyloid (1-40), rat | SH5715 | C190H291N51O57S1 | 4233.81 | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
beta-Amyloid (1-40), Ultra Pure, TFA | SH5716 | C194H295N53O58S1 | 4329.90 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
beta-Amyloid (1-42), human | SH5717 | C203H311N55O60S1 | 514.14 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala | ? | ? | ? |
beta-Amyloid (1-49) | SH5718 | C239H376N62O69S | 5254.10 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile-Val-Ile-Thr-Leu | ? | ? | ? |
beta-Amyloid (1-49) | SH5719 | C71H99N17O16 | 1446.68 | Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | ? | ? | ? |
beta-Amyloid (10-35) | SH5720 | C133H204N34O37S | 2903.38 | Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | ? | ? | ? |
beta- Amyloid (11-22) | SH5721 | C70H102N18O18 | 1483.70 | Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu | ? | ? | ? |
beta-Amyloid (11- 40) | SH5722 | C143H228N38O40S | 3151.71 | Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
beta-Amyloid (12-20) | SH5723 | C57H83N15O11 | 1154.39 | Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | ? | ? | ? |
beta-Amyloid (12-28) | SH5724 | C89H135N25O25 | 1955.22 | Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | ? | ? | ? |
beta-Amyloid (12-28) – Cys | SH5725 | C92H140N26O26S | 2058.36 | Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Cys | ? | ? | ? |
beta-Amyloid (13-27) | SH5726 | C84H126N24O24 | 1856.09 | His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | ? | ? | ? |
beta-Amyloid (15-21) | SH5727 | C43H65N9O9 | 852.05 | Gln-Lys-Leu-Val-Phe-Phe-Ala | ? | ? | ? |
beta-Amyloid (16-20) | SH5728 | C35H52N6O6 | 652.84 | Lys-Leu-Val-Phe-Phe | ? | ? | ? |
beta- Amyloid (16-23) | SH5729 | C47H69N9O13 | 968.13 | Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp | ? | ? | ? |
beta-Amyloid (16-26) | SH5730 | C57H86N12O17 | 1211.39 | Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser | ? | ? | ? |
beta-Amyloid (17-21) | SH5731 | C32H45N5O6 | 595.75 | Leu-Val-Phe-Phe-Ala | ? | ? | ? |
beta-Amyloid (17-40) | SH5732 | C110H178N26O31S | 2392.86 | Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
beta-Amyloid (17-42) | SH5733 | C119H194N28O33S | 2577.10 | Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala | ? | ? | ? |
beta-Amyloid (18-28) | SH5734 | C55H81N13O18 | 1212.34 | Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | ? | ? | ? |
beta- Amyloid (2-40) | SH5735 | C190H290N52O55S | 4214.81 | Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
beta-Amyloid (22-35) | SH5736 | C59H102N16O21S | 1403.63 | Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | ? | ? | ? |
beta-Amyloid (25-35) | SH5737 | C45H81N13O14S1 | 1060.30 | Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | ? | ? | ? |
beta - Amyloid (30 - 16) | SH5738 | C86H126N24O21S2 | 1896.22 | Cys-Thr-Phe-Val-Arg-Thr-His-Ile-Phe-Cys-Lys-Glu-His-Gln-Phe | ? | ? | ? |
beta-Amyloid (31-35) | SH5739 | C25H47N5O6S | 545.75 | Ile-Ile-Gly-Leu-Met | ? | ? | ? |
beta-Amyloid (32-35) | SH5740 | C19H36N4O5S | 432.59 | Ile-Gly-Leu-Met | ? | ? | ? |
beta-Amyloid (35-25) | SH5741 | C45H81N13O14S | 1060.29 | Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly | ? | ? | ? |
beta- Amyloid (37- 43) | SH5742 | C27H49N7O9 | 615.73 | Gly-Gly-Val-Val-Ile-Ala-Thr | ? | ? | ? |
beta- Amyloid (4-10) | SH5743 | C39H52N12O12 | 880.92 | Phe-Arg-His-Asp-Ser-Gly-Tyr | ? | ? | ? |
beta-Amyloid(40-1) | SH5744 | C194H295N53O58S | 4329.90 | Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp | ? | ? | ? |
beta-Amyloid (7-22) | SH5745 | C88H124N22O26 | 1906.10 | Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu | ? | ? | ? |
beta- Amyloid (8-38) | SH5746 | C147H227N39O43S | 3260.75 | Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly | ? | ? | ? |
beta-Amyloid P Component (27 -38), amide | SH5747 | C68H106N19O17S | 1493.78 | Glu-Lys-Pro-Leu-Gln-Asn-Phe-Thr-Leu-Cys-Phe-Arg-NH2 | ? | ? | ? |
beta-Amyloid Peptide (1-42), rat | SH5748 | C199H307N53O59S1 | 4418.05 | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | ? | ? | ? |
beta-Amyloid Protein Precursor (657 - 676) | SH5749 | C95H152N30O31 | 2210.45 | His-His-Gly-Val-Val-Glu-Val-Asp-Ala-Ala-Val-Thr-Pro-Glu-Glu-Arg-His-Leu-Ser-Lys | ? | ? | ? |
beta- Amyloid Protein Precursor 770 (135 - 155) | SH5750 | C116H173N35O31S2 | 2618.01 | Phe-Leu-His-Gln-Glu-Arg-Met-Asp-Val-Cys-Glu-Thr-His-Leu-His-Trp-His-Thr-Val-Ala-Lys | ? | ? | ? |
beta-Amyloid/A4 Protein Precusor (APP) (319-335) | SH5751 | C86H151N31O26S2 | 2099.48 | Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Val-Met | ? | ? | ? |
beta-Amyloid/A4 Protein Precursor (APP) (328 - 332) | SH5752 | C25H47N11O9S | 677.79 | Arg-Glu-Arg-Met-Ser | ? | ? | ? |
beta-Amyloid/A4 Protein Precursor 770 (394 - 410) | SH5753 | C92H152N32O26S2 | 2186.56 | Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Trp-Met | ? | ? | ? |
beta-Amyloid/A4 Protein Precursor (APP) (96-110), analog | SH5754 | C81H128N32O19S2 | 1918.25 | Ac-Asn-Trp-Cys-Lys-Arg-Gly-Arg-Lys-Gln-Cys-Lys-Thr-His-Pro-His-NH2 (Disulfide bridges Cys98-Cys105 ) | ? | ? | ? |
beta-Bag Cell Peptide | SH5755 | C33H53N13O6 | 727.87 | Arg-Leu-Arg-Phe-His | ? | ? | ? |
beta-Casein (90-96) | SH5756 | C103H175N35O27S | 2367.83 | Arg-Tyr-Leu-Gly-Tyr-Leu-Glu | ? | ? | ? |
beta-Casomorphin, bovine | SH5757 | C41H55N7O9 | 789.94 | Tyr-Pro-Phe-Pro-Gly-Pro-Ile | ? | ? | ? |
beta-Casomorphin, human | SH5758 | C44H61N7O11 | 864.02 | Tyr-Pro-Phe-Val-Glu-Pro-Ile | ? | ? | ? |
beta-Casomorphin (1-3) | SH5759 | C23H27N3O5 | 425.49 | Tyr-Pro-Phe | ? | ? | ? |
beta-Casomorphin (1-3) amide | SH5760 | C23H28N4O4 | 424.50 | Tyr-Pro-Phe-NH2 | ? | ? | ? |
beta-Casomorphin (1-4) (bovine) | SH5761 | C28H34N4O6 | 522.61 | Tyr-Pro-Phe-Pro | ? | ? | ? |
beta-Casomorphin (1-4) amide (bovine) | SH5762 | C28H35N5O5 | 521.62 | Tyr-Pro-Phe-Pro-NH2 | ? | ? | ? |
beta-Casomorphin (1-5) (bovine) | SH5763 | C30H37N5O7 | 579.66 | Tyr-Pro-Phe-Pro-Gly | ? | ? | ? |
beta-Casomorphin (1-5) amide (bovine) | SH5764 | C30H38N6O6 | 578.67 | Tyr-Pro-Phe-Pro-Gly-NH2 | ? | ? | ? |
beta-Casomorphin (1-6) (bovine) | SH5765 | C35H44N6O8 | 676.78 | Tyr-Pro-Phe-Pro-Gly-Pro | ? | ? | ? |
beta-Defensin-3, human | SH5766 | C216H371N75O59S6 | 5155.22 | Gly-Ile-Ile-Asn-Thr-Leu-Gln-Lys-Tyr-Tyr-Cys-Arg-Val-Arg-Gly-Gly-Arg-Cys-Ala-Val-Leu-Ser-Cys-Leu-Pro-Lys-Glu-Glu-Gln-Ile-Gly-Lys-Cys-Ser-Thr-Arg-Gly-Arg-Lys-Cys-Cys-Arg-Arg-Lys-Lys (Disulfide bridge: Cys11-Cys40, Cys18-Cys33, Cys23-Cys41) | ? | ? | ? |
beta-Defensin-4, human | SH5767 | C108H295N63O52S6 | 4366.13 | Glu-Leu-Asp-Arg-Ile-Cys-Gly-Tyr-Gly-Thr-Ala-Arg-Cys-Arg-Lys-Lys-Cys-Arg-Ser-Gln-Glu-Tyr-Arg-Ile-Gly-Arg-Cys-Pro-Asn-Thr-Tyr-Ala-Cys-Cys-Leu-Arg-Lys(Disulfide bridge: Cys6-Cys33; Cys13-Cys27; Cys17-Cys34) | ? | ? | ? |
beta-Endorphin, camel | SH5768 | C155H250N42O44S1 | 3438.04 | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln | ? | ? | ? |
beta-Endorphin, equine | SH5769 | C154H248N42O44S | 3424.01 | Tyr-Gly-Gly-Phe-Met-Ser-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln | ? | ? | ? |
beta-Endorphin, human | SH5770 | C158H251N39O46S1 | 3465.06 | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | ? | ? | ? |
beta-Endorphin, porcine | SH5771 | C154H248N42O44S | 3424.01 | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Val-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln | ? | ? | ? |
beta-Endorphin, rat | SH5772 | C157H254N42O44S1 | 3466.09 | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Val-His-Lys-Lys-Gly-Gln | ? | ? | ? |
beta-Endorphin (1-26), human | SH5773 | C130H208N32O38S | 2859.36 | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala | ? | ? | ? |
beta-Endorphin (1-27), camel, bovine, ovine | SH5774 | C136H215N35O39S | 2996.51 | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His | ? | ? | ? |
beta-Endorphin (1-27), human | SH5775 | C139H217N33O40S | 3022.54 | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr | ? | ? | ? |
beta-Endorphin (1-5) + (16-31), human | SH5776 | C112H173N27O29S | 2393.86 | Tyr-Gly-Gly-Phe-Met-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | ? | ? | ? |
beta-Endorphin (18-31) (human) | SH5777 | C75H122N20O20 | 1623.93 | Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | ? | ? | ? |
beta-Endorphin (27-31) (human) | SH5778 | C28H45N7O9 | 623.71 | Tyr-Lys-Lys-Gly-Glu | ? | ? | ? |
beta-Endorphin (30-31) (human) | SH5779 | C7H12N2O5 | 204.18 | Gly-Glu | ? | ? | ? |
beta-Endorphin (6-31), human | SH5780 | C131H218N34O40 | 2909.40 | Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | ? | ? | ? |
beta-Interleukin I (163-171), human | SH5781 | C39H64N12O19 | 1005.01 | Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys | ? | ? | ? |
beta-Interleukin II (44-56) | SH5782 | C68H113N19O19 | 1500.77 | Ile-Leu-Asn-Gly-Ile-Asn-Asn-Tyr-Lys-Asn-Pro-Lys-Leu | ? | ? | ? |
beta-Lipotropin (1-10), porcine | SH5783 | C42H66N10O15 | 951.05 | Glu-Leu-Ala-Gly-Ala-Pro-Pro-Glu-Pro-Ala | ? | ? | ? |
beta-Lipotropin (61-64) | SH5784 | C22H26N4O6 | 442.48 | Tyr-Gly-Gly-Phe | ? | ? | ? |
beta-Lipotropin (61-69) | SH5785 | C45H66N10O15S | 1019.15 | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys | ? | ? | ? |
beta-Lipotropin (88-91) | SH5786 | C19H36N6O7 | 460.53 | Lys-Lys-Gly-Glu | ? | ? | ? |
beta-MSH, human | SH5787 | C118H174N34O35S | 2660.90 | Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | ? | ? | ? |
beta-MSH, monkey | SH5788 | C98H138N28O29S | 2204.41 | Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | ? | ? | ? |
beta- MSH, porcine | SH5789 | C98H138N26O29S1 | 2176.40 | Asp-Glu-Gly-Pro-Tyr-Lys-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | ? | ? | ? |
beta-Neo-Endorphin | SH5790 | C54H77N13O12 | 1100.30 | Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro | ? | ? | ? |
beta-Neuroprotectin | SH5791 | C37H60N8O10 | 776.93 | D-Ala-Asp-Leu-Ile-Ala-Tyr-Leu-NH2 | ? | ? | ? |
? - Bag Cell Peptide | SH5792 | C31H51N11O8 | 705.82 | Arg-Leu-Arg-Phe-Asp | ? | ? | ? |
?-MSH (3-8) | SH5793 | C39H52N12O7S | 832.98 | Met-Gly-His-Phe-Arg-Trp | ? | ? | ? |
?-Neuropeptide, rabbit | SH5794 | C99H158N34O29S | 2320.64 | Asp-Ala-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
?-TAC4 (30 - 61) - NH2 | SH5795 | C155H242N40O49S | 3481.96 | Thr-Glu-Ala-Glu-Thr-Trp-Glu-Gly-Ala-Gly-Pro-Ser-Ile-Gln-Leu-Gln-Leu-Gln-Glu-Val-Lys-Thr-Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
?-TAC4 (32 - 50) | SH5796 | C92H146N24O31 | 2084.33 | Ala-Glu-Thr-Trp-Glu-Gly-Ala-Gly-Pro-Ser-Ile-Gln-Leu-Gln-Leu-Gln-Glu-Val-Lys | ? | ? | ? |
?2 - MSH (41 - 58), amide | SH5797 | C74H100N22O15S | 1569.82 | Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-NH2 | ? | ? | ? |
?3-MSH | SH5798 | C126H188N44O37S | 2943.20 | Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-Arg-Arg-Asn-Gly-Ser-Ser-Ser-Ser-Gly-Val-Gly-Gly-Ala-Ala-Gln | ? | ? | ? |
?–Endorphin | SH5799 | C83H131N19O27S | 1859.14 | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu | ? | ? | ? |
?-MSH | SH5800 | C74H99N21O16S | 1570.81 | Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly | ? | ? | ? |
?1-MSH, amide | SH5801 | C72H97N21O14S | 1512.80 | Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2 | ? | ? | ? |
?- TxIX12 | SH5802 | C49H67N13O20S4 | 2812.30 | Glu-Cys-Cys-Glu-Asp-Gly-Trp-Cys-Cys-Thr-Ala-Ala | ? | ? | ? |
A-18-F-NH2; Morphine Modulating Neuropeptide | SH5803 | C89H130N24O24 | 1920.70 | Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2 | ? | ? | ? |
A-779 | SH5804 | C39H60N12O11 | 872.99 | Asp-Arg-Val-Tyr-Ile-His-D-Ala | ? | ? | ? |
A-a-A-Y-G-G-F-L | SH5805 | C37H52N8O10 | 768.87 | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu | ? | ? | ? |
A-F-A | SH5806 | C15H21N3O4 | 307.35 | Ala-Phe-Ala | ? | ? | ? |
A-G-D-V | SH5807 | C14H24N4O7 | 360.37 | H-Ala-Gly-Asp-Val | ? | ? | ? |
A-H-A | SH5808 | C12H19N5O4 | 297.32 | Ala-His-Ala | ? | ? | ? |
A-K-R-R-R-L-S-S-L-R-A | SH5809 | C54H104N24O14 | 1313.58 | Ala-Lys-Arg-Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala | ? | ? | ? |
A-L-A | SH5810 | C12H23N3O4 | 273.33 | Ala-Leu-Ala | ? | ? | ? |
A-L-a-L | SH5811 | C18H34N4O5 | 386.50 | Ala-Leu-Ala-Leu | ? | ? | ? |
A-VI-5 | SH5812 | C22H40N6O10 | 548.60 | Val-Glu-Ser-Ser-Lys | ? | ? | ? |
abII probe | SH5813 | C63H101N19O19S | 1460.69 | Ser-Ala-Pro-Arg-Ala-Thr-Ile-Ser-His-Tyr-Leu-Met-Gly-Gly | ? | ? | ? |
abIII probe | SH5814 | C87H115N23O24S | 1899.09 | Ser-Ser-Trp-Asp-Met-His-Gln-Phe-Phe-Trp-Glu-Gly-Val-Ser-Arg | ? | ? | ? |
Abl Cytosolic Substrate | SH5815 | C64H101N15O16 | 1336.61 | Glu-Ala-Ile-Tyr-Ala-Ala-Pro-Phe-Ala-Lys-Lys-Lys | ? | ? | ? |
Abltide | SH5816 | C60H93N15O15 | 1264.50 | Lys-Lys-Gly-Glu-Ala-Ile-Tyr-Ala-Ala-Pro-Phe-Ala-NH2 | ? | ? | ? |
Ac-[Asn30, Tyr32]-Calcitonin (8-32) (salmon I) | SH5817 | C127H205N37O40 | 2890.27 | Ac-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Asn-Thr-Tyr-NH2 | ? | ? | ? |
Ac-[Cys(Acm)33, 42]-EGF (33-42) amide (mouse) | SH5818 | C51H82N16O17S2 | 1255.45 | Ac-Cys(Acm)-Val-Ile-Gly-Tyr-Ser-Gly-Asp-Arg-Cys(Acm)-NH2 | ? | ? | ? |
Ac-[D-Lys2, Sar3]-Melanotropin-Potentiating Factor | SH5819 | C22H40N6O8 | 516.60 | Ac-Lys-D-Lys-Sar-Glu | ? | ? | ? |
Ac-[DTrp16] Endothelin-1 (16-21), human | SH5820 | C46H62N8O10 | 887.03 | Ac-D-Trp-Leu-Asp-Ile-Ile-Trp | ? | ? | ? |
Ac-[Lys0, Nle3]-g2-MSH amide | SH5821 | C83H116N24O17 | 1722.00 | Ac-Lys-Tyr-Val-Nle-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-NH2 | ? | ? | ? |
Ac-[Leu28, 31]-Neuropeptide Y (24-36) | SH5822 | C81H131N27O19 | 1787.10 | Ac-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
Ac- [Nle4, DPhe7] a-MSH (4-10), amide | SH5823 | C47H64N14O10 | 985.12 | Ac-Nle-Glu-His-D-Phe-Arg-Trp-Gly-NH2 | ? | ? | ? |
Ac-[Pro18, Asp21] beta- Amyloid (17 - 21), amide, iAb5p Pro18 Asp21 | SH5824 | C35H46N6O8 | 678.79 | Ac-Leu-Pro-Phe-Phe-Asp-NH2 | ? | ? | ? |
Ac-[Tyr1, D-Arg2]-GRF (1-29) amide (human) | SH5825 | C154H255N47O43S | 3485.10 | Ac-Tyr-D-Arg-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | ? | ? | ? |
Ac-[Tyr1, D-Phe2]-GRF (1-29) amide (human) | SH5826 | C157H252N44O43S | 3476.09 | Ac-Tyr-D-Phe-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | ? | ? | ? |
Ac-a-CGRP (19-37) (human) | SH5827 | C88H139N25O26 | 1963.24 | Ac-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | ? | ? | ? |
Ac- a-Endorphin | SH5828 | C79H122N18O27S | 1788.02 | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr | ? | ? | ? |
Ac-beta- Endorphin, bovine, camel, ovine | SH5829 | C157H252N42O45S1 | 3480.10 | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln | ? | ? | ? |
Ac - 5A/5B Peptide | SH5830 | C47H73N11O18S3 | 1176.34 | Ac-Glu-Asp-Val-Val-Cys-Cys-Ser-Met-Ser-Tyr-NH2 | ? | ? | ? |
Ac-ACTH (1-14), 10-1-12A | SH5831 | C79H111N21O21S | 1722.96 | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly | ? | ? | ? |
Ac-ACTH (1-17) | SH5832 | C97H147N29O24S | 2135.50 | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg | ? | ? | ? |
Ac-Adhesin (1025-1044) amide | SH5833 | C97H160N26O32 | 2202.51 | Ac-Gln-Leu-Lys-Thr-Ala-Asp-Leu-Pro-Ala-Gly-Arg-Asp-Glu-Thr-Thr-Ser-Phe-Val-Leu-Val-NH2 | ? | ? | ? |
Ac-Amylin (8-37), human | SH5834 | C140H218N42O46 | 3225.55 | Ac-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | ? | ? | ? |
Ac-Amylin (8-37), rat | SH5835 | C142H229N43O44 | 3242.67 | Ac-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | ? | ? | ? |
Ac-Amyloid beta-Protein (15-20) amide | SH5836 | C42H63N9O8 | 822.03 | Ac-Gln-Lys-Leu-Val-Phe-Phe-NH2 | ? | ? | ? |
Ac-Angiotensinogen (1-14), human | SH5837 | C85H124N24O20 | 1802.10 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn | ? | ? | ? |
Ac-Angiotensinogen (1-14), porcine | SH5838 | C87H125N21O21 | 1801.10 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser | ? | ? | ? |
Ac-Calpastatin (184-210) (human) | SH5839 | C142H230N36O44S | 3177.68 | Ac-Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala-NH2 | ? | ? | ? |
Ac-Choline Receptor alfa1(129-145) | SH5840 | C90H136N22O28S2 | 2038.34 | Glu-Ile-Ile-Val-Thr-His-Phe-Pro-Phe-Asp-Glu-Gln-Asn-Cys-Ser-Met-Lys | ? | ? | ? |
Ac-D-E | SH5841 | C11H16N2O8 | 304.30 | Ac-Asp-Glu | ? | ? | ? |
Ac-Endothelin-1 (16-21), human | SH5842 | C41H59N9O10 | 837.98 | Ac-His-Leu-Asp-Ile-Ile-Trp | ? | ? | ? |
Ac-GPK-pNA | SH5843 | C21H30N6O6 | 462.50 | Ac-Gly-Pro-Lys-pNA | ? | ? | ? |
Ac-GPK(Ac)-pNA | SH5844 | C23H32N6O7 | 504.50 | Ac-Gly-Pro-Lys(Ac)-pNA | ? | ? | ? |
Ac-GRP (20-26) (human, porcine, canine) | SH5845 | C410H57N13O8 | 859.99 | Ac-His-Trp-Ala-Val-Gly-His-Leu-NH2 | ? | ? | ? |
Ac-Hirudin (55-65) (desulfated) | SH5846 | C66H92N12O25 | 1453.53 | Ac-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln | ? | ? | ? |
Ac-IEAR-pNA | SH5847 | C28H43N9O9 | 649.70 | Ac-Ile-Glu-Ala-Arg-pNA | ? | ? | ? |
Ac-IETD-pNA | SH5848 | C27H38N6O12 | 638.60 | Ac-Ile-Glu-Thr-Asp-pNA | ? | ? | ? |
Ac-LEHD-pNA | SH5849 | C29H38N8O11 | 674.70 | Ac-Leu-Glu-His-Asp-pNA | ? | ? | ? |
Ac-Neurotrophin Receptor (368-381) amide (human) | SH5850 | C69H124N22O19 | 1565.89 | Ac-Ala-Thr-Leu-Asp-Ala-Leu-Leu-Ala-Ala-Leu-Arg-Arg-Leu-Gln-nh2 | ? | ? | ? |
Ac-P-G-A | SH5851 | C12H19N3O5 | 285.30 | Ac-Pro-Gly-Ala | ? | ? | ? |
Ac-Pepstatin | SH5852 | C21H37N5O7 | 471.56 | Ac-Val-Val-Sta-Ala-Sta | ? | ? | ? |
Ac-Phe-Gly-pNA | SH5853 | C19H20N4O5 | 384.40 | Ac-Phe-Gly-Pna | ? | ? | ? |
Ac-beta-Endorphin (human) | SH5854 | C160H253N39O47S | 3507.10 | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | ? | ? | ? |
Ac-d-Endorphin (bovine, camel, mouse, ovine) | SH5855 | C138H217N35O40S | 3038.54 | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His | ? | ? | ? |
Ac-g-Endorphin | SH5856 | C85H133N19O28S | 1901.18 | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu | ? | ? | ? |
Ac-Glutamine | SH5857 | C7H12N2O4 | 188.18 | Ac-Gln | ? | ? | ? |
Ac-MBP (4-14) Peptide | SH5858 | C62H105N21O18 | 1432.70 | Ac-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu | ? | ? | ? |
Ac-PACAP-38 (human, mouse, ovine, porcine, rat) | SH5859 | C205H333N63O54S | 4576.36 | Ac-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 | ? | ? | ? |
Ac-RYYRIK-NH2 | SH5860 | C44H70N14O9 | 939.14 | Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2 | ? | ? | ? |
Ac-S-D-K-P | SH5861 | C20H33N5O9 | 487.51 | Ac-Ser-Asp-Lys-Pro | ? | ? | ? |
Ac-VEID-pNA | SH5862 | C28H40N6O11 | 636.60 | Ac-Val-Glu-Ile-Asp-pNA | ? | ? | ? |
Ac-YVAD-pNA | SH5863 | C29H36N6O10 | 628.60 | Ac-Tyr-Val-Ala-Asp-pNA | ? | ? | ? |
Acetalin 1, Opioid Receptor Antagonist 1 | SH5864 | C44H66N14O7S2 | 967.23 | Ac-Arg-Phe-Met-Trp-Met-Arg-NH2 | ? | ? | ? |
Acetalin 3, Opioid Receptor Antagonist 3 | SH5865 | C42H61N114O8S2 | 912.15 | Ac-Arg-Phe-Met-Trp-Met-Thr-NH2 | ? | ? | ? |
Achatin-1 | SH5866 | C18H23N4O7 | 407.40 | Gly-D-Phe-Ala-Asp | ? | ? | ? |
Activated Protein C (390-404) (human) | SH5867 | C91H130N22O23 | 1900.18 | Tyr-Gly-Val-Tyr-Thr-Lys-Val-Ser-Arg-Tyr-Leu-Asp-Trp-Ile-His | ? | ? | ? |
Activity-Dependent Neurotrophic Factor-14 | SH5868 | C58H103N17O17 | 1310.57 | Val-Leu-Gly-Gly-Gly-Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala | ? | ? | ? |
Activity – Dependent Neurotrophic Factor, ADNF | SH5869 | C41H74N12O12 | 927.12 | Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala | ? | ? | ? |
Acyl Carrier Protein (65-74) (acid) | SH5870 | C47H74N12O16 | 1063.18 | Val-Gln-Ala-Ala-Ile-Asp-Tyr-Ile-Asn-Gly | ? | ? | ? |
Acyl Carrier Protein (65-74) (amide) | SH5871 | C47H75N13O15 | 1062.20 | Val-Gln-Ala-Ala-Ile-Asp-Tyr-Ile-Asn-Gly-NH2 | ? | ? | ? |
ACTH (1-4) | SH5872 | C20H30N4O8S | 486.60 | Ser-Tyr-Ser-Met | ? | ? | ? |
ACTH (1-10), human | SH5873 | C59H78N16O16S1 | 1299.40 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly | ? | ? | ? |
ACTH (1-13), human | SH5874 | C75H106N20O19S1 | 1623.90 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val | ? | ? | ? |
ACTH (1-14) | SH5875 | C77H169N21O20S | 1680.90 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly | ? | ? | ? |
ACTH (1-16), human | SH5876 | C89H133N25O22S | 1937.27 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys | ? | ? | ? |
ACTH (1-17), human | SH5877 | C95H145N29O23S | 2093.50 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg | ? | ? | ? |
ACTH (1-24), human | SH5878 | C136H210N40O31S | 2933.50 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | ? | ? | ? |
ACTH (1-39) (guinea pig) | SH5879 | C206H308N56O58S | 4529.16 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Ala-Asn-Gly-Ala-Glu-Glu-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | ? | ? | ? |
ACTH(1-39), human | SH5880 | C207H308N56O58S | 4541.10 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | ? | ? | ? |
ACTH (1-39), rat | SH5881 | C210H315N57O57S | 4582.30 | Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | ? | ? | ? |
ACTH (11-24) | SH5882 | C77H134N24O16 | 1652.08 | Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | ? | ? | ? |
ACTH (12-39), rat | SH5883 | C145H227N39O41 | 3172.66 | Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | ? | ? | ? |
ACTH (18-39), human | SH5884 | C112H165N27O36 | 2465.70 | Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | ? | ? | ? |
ACTH (18-39) (human) (Adrenocorticotropic Hormone) (Biotin) | SH5885 | C122H179N29O38 | 2692.02 | BiotinArg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | ? | ? | ? |
ACTH (22-39) | SH5886 | C90H125N19O32 | 1985.11 | Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | ? | ? | ? |
ACTH (3-24), human | SH5887 | C124H196N38O27S | 2683.25 | Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | ? | ? | ? |
ACTH (34-39) | SH5888 | C37H50N6O9 | 722.85 | Ala-Phe-Pro-Leu-Glu-Phe | ? | ? | ? |
ACTH (4-10), human | SH5889 | C44H59N13O10S1 | 962.10 | Met-Glu-His-Phe-Arg-Trp-Gly | ? | ? | ? |
ACTH (4-11) | SH5890 | C50H71N15O11S | 1090.28 | Met-Glu-His-Phe-Arg-Trp-Gly-Lys | ? | ? | ? |
ACTH (4-9) | SH5891 | C42H56N12O9S | 905.05 | Met-Glu-His-Phe-Arg-Trp | ? | ? | ? |
ACTH(4-9), Tyr | SH5892 | C53H68N14O12S | 1125.28 | Tyr-Met-Glu-His-Phe-Arg-Trp-Gly | ? | ? | ? |
ACTH(5-10) | SH5893 | C39H50N12O9 | 830.91 | Glu-His-Phe-Arg-Trp-Gly | ? | ? | ? |
ACTH (6-24), human | SH5894 | C111H175N35O21 | 2335.90 | His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | ? | ? | ? |
ACTH (7- 38), human | SH5895 | C167H257N47O46 | 3659.20 | Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu | ? | ? | ? |
Adipokinetic Hormone | SH5896 | C44H60N10O12 | 921.00 | Pyr-Leu-Thr-Phe-Thr-Ser-Trp-Gly-NH2 | ? | ? | ? |
Adipokinetic Hormone, AKH, locust | SH5897 | C54H74N14O15 | 1159.30 | Pyr-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-NH2 | ? | ? | ? |
Adipokinetic Hormone, G (AKH-G) | SH5898 | C43H57N11O12 | 920.02 | pyr-Val-Asn-Phe-Ser-Thr-Gly-Trp-NH2 | ? | ? | ? |
Adipokinetic Hormone II Locusta Migratoria | SH5899 | C43H57N11O11 | 904.02 | Pyr-Leu-Asn-Phe-Ser-Ala-Gly-Trp-NH2 | ? | ? | ? |
Adipokinetic Hormone (Apis mellifera ligustica, Bombyx mori, Heliothis zea, Manduca sexta) | SH5900 | C44H60N10O12 | 921.00 | Glp-Leu-Thr-Phe-Thr-Ser-Ser-Trp-Gly-NH2 | ? | ? | ? |
Adipokinetic Hormone II from Schistocera gregaria | SH5901 | C44H60N11O12 | 934.00 | Pyr-Leu-Asn-Phe-Ser-Thr-Gly-Trp-NH2 | ? | ? | ? |
Adipophilin | SH5902 | C35H63N9O14 | 833.94 | Ser-Val-Ala-Ser-Thr-Ile-Thr-Gly-Val | ? | ? | ? |
ADP-Ribosylation Factor 1, ARF1 (2 - 17) | SH5903 | C85H131N21O21 | 1783.12 | Gly-Asn-Ile-Phe-Ala-Asn-Leu-Phe-Lys-Gly-Leu-Phe-Gly-Lys-Lys-Glu | ? | ? | ? |
ADP - Ribosylation Factor 6, ARF6 (2 - 13) | SH5904 | C60H102N16O17 | 1319.58 | Gly-Lys-Val-Leu-Ser-Lys-Ile-Phe-Gly-Asn-Lys-Glu | ? | ? | ? |
ADR1 - derived peptide | SH5905 | C65H114N22O18 | 1491.77 | Leu-Lys-Lys-Leu-Thr-Arg-Arg-Ala-Ser-Phe-Ser-Gly-Gln | ? | ? | ? |
Adrenomedullin (1-12), human | SH5906 | C64H100N22O19S1 | 1513.70 | Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg | ? | ? | ? |
Adrenomedullin (1-50), rat | SH5907 | C248H381N77O75S5 | 5729.50 | Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2(Disulfide bridge Cys14-Cys19 ) | ? | ? | ? |
Adrenomedullin (1-52), human | SH5908 | C264H406N80O77S3 | 6028.90 | Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2(Disulfide bridge Cys16-Cys21) | ? | ? | ? |
Adrenomedullin (1- 52), porcine | SH5909 | C262H403N79O76S3 | 5971.80 | Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 (Disulfide bridge Cys16-Cys21) | ? | ? | ? |
Adrenomedullin (11-50) (rat) | SH5910 | C194H304N58O59S4 | 4521.20 | Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2(Disulfide bridge Cys4-Cys9 ) | ? | ? | ? |
Adrenomedullin (13-52), human | SH5911 | C200H308N58O59S2 | 4533.17 | Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp- Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 (Disulfide bridge:Cys16-Cys21) | ? | ? | ? |
Adrenomedullin (16-31) (human, pig) | SH5912 | C82H129N25O21S2 | 1865.21 | Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-NH2 (Disulfide bridge:Cys1-Cys6) | ? | ? | ? |
Adrenomedullin (22-52), human | SH5913 | C159H252N46O48 | 3576.06 | Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ? | ? | ? |
Adrenomedullin (26-52) (human) | SH5914 | C139H216N40O42 | 3119.49 | Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ? | ? | ? |
Adrenorphin | SH5915 | C44H69N15O9S1 | 984.20 | Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-NH2 | ? | ? | ? |
Adrenorphin, Free Acid | SH5916 | C44H68N14O10S | 985.18 | Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val | ? | ? | ? |
AF-1 | SH5917 | C45H69N13O10 | 3576.06 | Lys-Asn-Glu-Phe-Ile-Arg-Phe-NH2 | ? | ? | ? |
AF-2, nematode | SH5918 | C47H70N14O10 | 991.17 | Lys-His-Glu-Tyr-Leu-Arg-Phe-NH2 | ? | ? | ? |
AGRP (25-51) | SH5919 | C130H221N37O35S1 | 2894.50 | Leu-Ala-Pro-Met-Glu-Gly-Ile-Arg-Arg-Pro-Asp-Gln-Ala-Leu-Leu-Pro-Glu-Leu-Pro-Gly-Leu-Gly-Leu-Arg-Ala-Pro-Leu | ? | ? | ? |
AGRP (54-82) | SH5920 | C137H225N39O54 | 3282.50 | Thr-Thr-Ala-Glu-Gln-Ala-Glu-Glu-Asp-Leu-Leu-Gln-Glu-Ala-Gln-Ala-Leu-Ala-Glu-Val-Leu-Asp-Leu-Gln-Asp-Arg-Glu-Pro-Arg | ? | ? | ? |
AGRP (87-132), human | SH5921 | C219H339N65O63S11 | 5243.17 | Ac-Cys-Val-Arg-Leu-His-Glu-Ser-Cys-Leu-Gly-Gln-Gln-Val-Pro-Cys-Cys-Asp-Pro-Cys-Ala-Thr-Cys-Tyr-Cys-Arg-Phe-Phe-Asn-Ala-Phe-Cys-Tyr-Cys-Arg-Lys-Leu-Gly-Thr-Ala-Met-Asn-Pro-Cys-Ser-Arg-Thr | ? | ? | ? |
Akt Specific Substrate Peptide, Akt/PKB | SH5922 | C36H59N13O9 | 817.95 | Arg-Pro-Arg-Ala-Ala-Thr-Phe | ? | ? | ? |
AKT/PKB/Rac - Protein Kinase Substrate | SH5923 | C74H114N28O20 | 1715.91 | Ala-Arg-Lys-Arg-Glu-Arg-Thr-Tyr-Ser-Phe-Gly-His-His-Ala | ? | ? | ? |
Aldosterone Secretion Inhibiting Factor (1-35) (bovine) | SH5924 | C164H278N58O45S4 | 3910.64 | Ala-Leu-Arg-Gly-Pro-Lys-Met-Met-Arg-Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr (Disulfide bridge:Cys13-Cys29) | ? | ? | ? |
Allatostatin I | SH5925 | C61H94N18O16 | 1335.54 | Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-NH2 | ? | ? | ? |
Allatostatin I (free acid) | SH5926 | C61H94N18O16 | 1335.50 | Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu | ? | ? | ? |
Allatostatin II | SH5927 | C49H74N14O13 | 1067.20 | Gly-Asp-Gly-Arg-Leu-Tyr-Ala-Phe-Gly-Leu-NH2 | ? | ? | ? |
Allatostatin III | SH5928 | C42H62N10O12 | 899.02 | Gly-Gly-Ser-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 | ? | ? | ? |
Allatostatin IV | SH5929 | C45H68N12O12 | 969.10 | Asp-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 | ? | ? | ? |
Allatostatin VI | SH5930 | C65H90N18O16 | 1379.50 | Tyr-Pro-Gln-Glu-His-Arg-Phe-Ser-Phe-Gly-Leu-NH2 | ? | ? | ? |
Allatostatin VII | SH5931 | C46H69N13O13S | 1044.20 | Asp-Gly-Arg-Met-Tyr-Ser-Phe-Gly-Leu-NH2 | ? | ? | ? |
Allatotropin, Mas – AT | SH5932 | C65H103N19O17S2 | 1486.80 | Gly-Phe-Lys-Asn-Val-Glu-Met-Met-Thr-Ala-Arg-Gly-Phe-NH2 (Disulfide bridge:Cys2-Cys7) | ? | ? | ? |
Alloferon 1 | SH5933 | C52H76N22O16 | 1265.30 | His-Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly | ? | ? | ? |
Alloferon 2 | SH5934 | C46H69N19O15 | 1128.20 | Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly | ? | ? | ? |
Alternate Syntide | SH5935 | C63H112N18O19 | 1425.70 | Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ser-Ser-Leu-Pro-Gly-Leu-NH2 | ? | ? | ? |
Alytesin | SH5936 | C68H106N22O17S | 1535.80 | Pyr-Gly-Arg-Leu-Gly-Thr-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
Amylin, human | SH5937 | C165H261N51O55S2 | 3903.40 | Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | ? | ? | ? |
Amylin, rat | SH5938 | C167H270N52O53S2 | 3918.47 | Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2(Disulfide bridge:Cys2-Cys7) | ? | ? | ? |
Amylin (1-13) (human) | SH5939 | C54H95N19O19S2 | 1378.60 | Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala(Disulfide bridge:Cys2-Cys7) | ? | ? | ? |
Amylin (20-29) (human) | SH5940 | C43H68N12O16 | 1009.09 | Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser | ? | ? | ? |
Amylin (8-37), human | SH5941 | C138H215N41O46 | 3184.50 | Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr | ? | ? | ? |
Amylin (8-37), rat | SH5942 | C140H227N43O43 | 3200.63 | Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | ? | ? | ? |
Amylin (IAPP) (Feline) | SH5943 | C165H270N52O54S2 | 3910.45 | Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Ile-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Ala-Ile-Leu-Ser-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2(Disulfide bridge:Cys2-Cys7) | ? | ? | ? |
Amyloid Bri Protein (1-23) | SH5944 | C116H175N31O35S2 | 2628.00 | Glu-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser(Disulfide bridge:Cys5-Cys22) | ? | ? | ? |
Amyloid Bri Protein (1-34) | SH5945 | C173H273N49O52S2 | 3935.55 | Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn(Disulfide bridge: Cys5-Cys22) | ? | ? | ? |
Amyloid Bri Protein (1-34) (reduced) | SH5946 | C173H275N49O52S2 | 3937.55 | Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn | ? | ? | ? |
Amyloid Bri Protein Precursor277 (89-106) | SH5947 | C87H141N21O30S | 1993.27 | Cys-Gly-Ile-Lys-Tyr-Ile-Lys-Asp-Asp-Val-Ile-Leu-Asn-Glu-Pro-Ser-Ala-Asp | ? | ? | ? |
Amyloid Dan Protein (1-34) | SH5948 | C185H268N48O51S2 | 4044.63 | Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-TyrDisulfide bond | ? | ? | ? |
Amyloid Dan Protein (1-34) (reduced) | SH5949 | C185H270N48O51S2 | 4046.63 | Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-Tyr | ? | ? | ? |
Amyloid beta-Protein (1-43) | SH5950 | C207H318N56O62S | 4615.24 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala-Thr | ? | ? | ? |
Amyloid beta-Protein (20-29) | SH5951 | C43H66N12O17 | 1023.08 | Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly | ? | ? | ? |
Amyloid beta-Protein (25-35) amide | SH5952 | C45H82N14O13S | 1059.31 | Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2 | ? | ? | ? |
Amyloid beta-Protein (29-40) | SH5953 | C49H88N12O13S | 1085.38 | Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
Amyloid beta-Protein (33-42) | SH5954 | C41H74N10O11S | 915.17 | Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | ? | ? | ? |
Amyloid beta-Protein (42-1) | SH5955 | C203H311N55O60S | 4514.14 | Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp | ? | ? | ? |
Amyloid beta-Protein (6-20) | SH5956 | C86H119N23O23 | 1843.05 | His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | ? | ? | ? |
Amyloid beta/A4 Protein Precursor770 (667-676) | SH5957 | C51H82N14O18S | 1211.37 | Ser-Glu-Val-Lys-Met-Asp-Ala-Glu-Phe-Arg | ? | ? | ? |
Amyloid beta/A4 Protein Precursor770 (740-770) | SH5958 | C162H243N45O52S2 | 3717.14 | Ala-Ala-Val-Thr-Pro-Glu-Glu-Arg-His-Leu-Ser-Lys-Met-Gln-Gln-Asn-Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn | ? | ? | ? |
Amyloid P Component (33-38) amide | SH5959 | C37H56N10O7S | 784.98 | Phe-Thr-Leu-Cys-Phe-Arg-NH2 | ? | ? | ? |
Anantin (linear sequence) | SH5960 | C90H111N21O24 | 1871.00 | Gly-Phe-Ile-Gly-Trp-Gly-Asn-Asp-Ile-Phe-Gly-His-Tyr-Ser-Gly-Asp-Phe (Peptide beta bond between Gly1-Asp8 ) | ? | ? | ? |
Angiogenin (108-122) | SH5961 | C78H125N25O23 | 1781.02 | Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg | ? | ? | ? |
Angiogenin (108-123) | SH5962 | C83H132N26O24 | 1878.14 | Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-Pro | ? | ? | ? |
Angiotensin, Canine, Rat | SH5963 | C41H62N12O11 | 899.03 | Asp-Arg-Val-Tyr-Ile-His-Pro | ? | ? | ? |
Angiotensin (1-5) | SH5964 | C30H48N8O9 | 664.77 | Asp-Arg-Val-Tyr-Ile | ? | ? | ? |
Angiotensin (1-9) | SH5965 | C56H78N16O13 | 1183.35 | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His | ? | ? | ? |
Angiotensin A | SH5966 | C56H78N16O13 | 1183.34 | Ala-Arg-Val-Tyr-Ile-His-Pro-Phe | ? | ? | ? |
Angiotensin Converting Enzyme Inhibitor | SH5967 | C53H77N14O12 | 1102.29 | Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro | ? | ? | ? |
Angiotensin I [Des-Asp1-](Human) | SH5968 | C58H84N16O11 | 1181.42 | Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu | ? | ? | ? |
Angiotensin I, human | SH5969 | C62H89N17O14 | 1296.50 | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu | ? | ? | ? |
Angiotensin I/II (1-6) | SH5970 | C36H55N11O10 | 801.91 | Asp-Arg-Val-Tyr-Ile-His | ? | ? | ? |
Angiotensin I/II (3-7) | SH5971 | C31H45N7O7 | 627.75 | Val-Tyr-Ile-His-Pro | ? | ? | ? |
Angiotensin I/II (5-8) | SH5972 | C26H36N6O5 | 512.61 | Ile-His-Pro-Phe | ? | ? | ? |
Angiotensin I-Converting Enzyme Substrate | SH5973 | C24H27N3O5 | 437.49 | Bz-Phe-Ala-Pro | ? | ? | ? |
Angiotensin II Antipeptide | SH5974 | C42H62N10O12 | 899.02 | Glu-Gly-Val-Tyr-Val-His-Pro-Val | ? | ? | ? |
Angiotensin II human | SH5975 | C50H71N13O12 | 1046.19 | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | ? | ? | ? |
Angiotensin II (1-4), human | SH5976 | C24H37N7O8 | 551.60 | Asp-Arg-Val-Tyr | ? | ? | ? |
Angiotensin II (3-8), human | SH5977 | C40H54N8O8 | 774.93 | Val-Tyr-Ile-His-Pro-Phe | ? | ? | ? |
Angiotensin II (4-8), human | SH5978 | C35H45N7O7 | 675.79 | H-Tyr-Ile-His-Pro-Phe | ? | ? | ? |
Angiotensin II [Sar1 Ile8] | SH5979 | C46H74N13O10 | 968.10 | Sar-Arg-Val-Tyr-Ile-His-Pro-Ile | ? | ? | ? |
Angiotensin II Receptor, AT2, Amino Terminal Fragment | SH5980 | C79H125N23O28S | 1877.08 | Met-Lys-Asp-Asn-Phe-Ser-Phe-Ala-Ala-Thr-Ser-Arg-Asn-Ile-Thr-Ser-Ser | ? | ? | ? |
Angiotensin II Substrate | SH5981 | C50H72N13O15P | 1126.20 | Asp-Arg-Val-Tyr(PO3H2)-Ile-His-Pro-Phe | ? | ? | ? |
Angiotensin II type 1 receptor (181 - 187), AT1, ATE. | SH5982 | C40H52N10O13 | 880.92 | Ala-Phe-His-Tyr-Glu-Ser-Gln | ? | ? | ? |
Angiotensin III, human | SH5983 | C46H66N12O9 | 931.10 | H-Arg-Val-Tyr-Ile-His-Pro-Phe | ? | ? | ? |
Angiotensinogen (1- 13) | SH5984 | C79H116N22O17 | 1645.90 | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His | ? | ? | ? |
Angiotensinogen (1-14), human | SH5985 | C83H122N24O19 | 1760.05 | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn | ? | ? | ? |
Angiotensinogen (1-14), Porcine | SH5986 | C85H123N21O20 | 1759.10 | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser | ? | ? | ? |
Angiotensinogen (1-14) , Rat | SH5987 | C89H123N21O21 | 1823.10 | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-Tyr-Ser | ? | ? | ? |
Annexin 1 (ANXA - 1; Ac 2 - 12) | SH5988 | C63H94N14O17S | 1351.60 | Ac-Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp | ? | ? | ? |
Anorexigenic Peptide | SH5989 | C13H17N5O5 | 323.40 | Pyr-His-Gly | ? | ? | ? |
ANP (1-11), rat | SH5990 | C49H83N20O15S1 | 1224.40 | Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg | ? | ? | ? |
ANP (1-30), frog | SH5991 | C131H215N49O41S4 | 3260.73 | Ala-Pro-Arg-Ser-Met-Arg-Arg-Ser-Ser-Asp-Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Phe(Disulfide bridge:Cys11-Cys27) | ? | ? | ? |
Antagonist G | SH5992 | C49H62O6N12S | 951.20 | Arg-D-Trp-N-Me-Phe-D-Trp-Leu-Met-NH2 | ? | ? | ? |
Antho-Rf amide | SH5993 | C22H32N8O5 | 488.57 | Pyr-Gly-Arg-Phe-NH2 | ? | ? | ? |
Antho-Rwamide I | SH5994 | C31H46N10O7 | 670.79 | Pyr -Ser-Leu-Arg-Trp-NH2 | ? | ? | ? |
Antho-Rwamide II | SH5995 | C30H44N10O6 | 640.79 | Pyr -Gly-Leu-Arg-Trp-NH2 | ? | ? | ? |
Anti-Flt1 Peptide | SH5996 | C37H49N9O9 | 763.86 | Gly-Asn-Gln-Trp-Phe-Ile | ? | ? | ? |
Anti-Inflammatory Peptide 1 | SH5997 | C45H82N12O14S2 | 1079.36 | Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser | ? | ? | ? |
Anti-Inflammatory Peptide 2 | SH5998 | C46H77N13O15S | 1084.27 | His-Asp-Met-Asn-Lys-Val-Leu-Asp-Leu | ? | ? | ? |
Anti-Inflammatory Peptide 3 | SH5999 | C43H76N12O15S2 | 1065.28 | Met-Gln-Met-Asn-Lys-Val-Leu-Asp-Ser | ? | ? | ? |
Anti-Kentsin | SH6000 | C22H45N11O6 | 559.67 | Thr-Arg-Lys-Arg | ? | ? | ? |
Antiestrogen | SH6001 | C64H103N13O22S1P1 | 1469.65 | Cys-Asn-Val-Val-Pro-Leu-Tyr(PO3H2)-Asp-Leu-Leu-Leu-Glu | ? | ? | ? |
Antifreeze Polypeptide (AFP) (HPLC-6), Winter Flounder | SH6002 | C133H225N43O51 | 3242.53 | Asp-Thr-Ala-Ser-Asp-Ala-Ala-Ala-Ala-Ala-Ala-Leu-Thr-Ala-Ala-Asn-Ala-Lys-Ala-Ala-Ala-Glu-Leu-Thr-Ala-Ala-Asn-Ala-Ala-Ala-Ala-Ala-Ala-Ala-Thr-Ala-Arg | ? | ? | ? |
Antioxidant peptide A | SH6003 | C31H54N12O7S2 | 770.97 | Pro-His-Cys-Lys-Arg-Met | ? | ? | ? |
Antioxidant peptide B | SH6004 | C57H91N17O15 | 1254.47 | Thr-Arg-Asn-Tyr-Tyr-Val-Arg-Ala-Val-Leu | ? | ? | ? |
Anxiety Peptide | SH6005 | C81H138N24O29 | 1912.15 | Gln-Ala-Thr-Val-Gly-Asp-Val-Asn-Thr-Asp-Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys | ? | ? | ? |
Apamin | SH6006 | C79H131N31O24S4 | 2027.37 | Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2(Disulfide bridge:Cys1-Cys11, Cys3-Cys15) | ? | ? | ? |
Apelin-12 | SH6007 | C64H103N21O14S | 1422.73 | Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | ? | ? | ? |
Apelin-13, human, bovine | SH6008 | C69H111N23O16S | 1550.86 | Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH | ? | ? | ? |
Apelin-15 (63 - 75) | SH6009 | C67H119N29O16S | 1618.94 | Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met | ? | ? | ? |
Apelin-15 (63-77) | SH6010 | C81H135N31O18S | 1863.24 | Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | ? | ? | ? |
Apelin-36, human | SH6011 | C184H297N69O43S | 4195.92 | Leu-Val-Gln-Pro-Arg-Gly-Ser-Arg-Asn-Gly-Pro-Gly-Pro-Trp-Gln-Gly-Gly-Arg-Arg-Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | ? | ? | ? |
Aquaporin-2 (254-267), human | SH6012 | C69H116N24O22 | 1633.84 | Arg-Gln-Ser-Val-Glu-Leu-His-Ser-Pro-Gln-Ser-Leu-Pro-Arg | ? | ? | ? |
Aquaporin-2 (255-271), human | SH6013 | C77H129N25O26 | 1821.04 | Gln-Ser-Val-Glu-Leu-His-Ser-Pro-Gln-Ser-Leu-Pro-Arg-Gly-Ser-Lys-Ala | ? | ? | ? |
Aquaporin-2 (255-271), rat | SH6014 | C78H131N25O26 | 1835.07 | Gln-Ser-Val-Glu-Leu-His-Ser-Pro-Gln-Ser-Leu-Pro-Arg-Gly-Thr-Lys-Ala | ? | ? | ? |
AT1A, Angiotensin II receptor, (225 - 237) | SH6015 | C67H107N21O24 | 1590.73 | Ala-Tyr-Glu-Ile-Gln-Lys-Asn-Lys-Pro-Arg-Asn-Asp-Asp | ? | ? | ? |
Atrial Natriuretic Factor (1-24) (frog) | SH6016 | C103H165N37O34S3 | 2561.87 | Ser-Ser-Asp-Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Arg-Phe (Disulfide bond) | ? | ? | ? |
Atrial Natriuretic Peptide (1-28), rat | SH6017 | C128H205N45O39S2 | 3062.47 | Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge:Cys7-Cys23) | ? | ? | ? |
Atrial Natriuretic Factor (1-29) (chicken) | SH6018 | C124H211N47O40S5 | 3160.70 | Met-Met-Arg-Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Ile-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Met-Gly-Cys-Asn-Gly-Ser-Arg-Lys-Asn(Disulfide bridge Cys7-Cys23 ) | ? | ? | ? |
Atrial Natriuretic Peptide (126-149) (rat) | SH6019 | C104H168N38O33S2 | 2542.86 | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg(Disulfide bridge:Cys4-Cys20) | ? | ? | ? |
Atrial Natriuretic Peptide (126-150) (rat) | SH6020 | C113H177N39O35S2 | 2706.00 | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr (Disulfide bridge: Cys4-Cys20) | ? | ? | ? |
Atrial Natriuretic Factor (3-28) (human) | SH6021 | C117H187N43O36S3 | 2880.30 | Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge Cys5-Cys21 ) | ? | ? | ? |
Atrial Natriuretic Peptide (4-24), frog | SH6022 | C93H152N34O27S3 | 2273.64 | Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Arg-Phe(Disulfide bridge: Cys1-Cys17) | ? | ? | ? |
Atrial Natriuretic Factor (4-28) (human) | SH6023 | C112H175N39O35S3 | 2724.06 | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge Cys7-Cys23 ) | ? | ? | ? |
Atrial Natriuretic Peptide Substrate, [pS6] ANF 1 – 28 | SH6024 | C128H206N49O38S2P | 3143.50 | Ser-Leu-Arg-Arg-Ser-pSer-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge 7-23) | ? | ? | ? |
Atriopeptin I (rat) | SH6025 | C83H135N29O30S2 | 2083.31 | Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser(Disulfide bridge:Cys3-Cys19) | ? | ? | ? |
Atriopeptin II (rat, rabbit, mouse) | SH6026 | C98H156N34O32S2 | 2386.67 | Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg(Disulfide bridge:Cys3-Cys18) | ? | ? | ? |
Atriopeptin III (rat) | SH6027 | C107H165N35O34S2 | 2549.85 | Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge:Cys3-Cys19) | ? | ? | ? |
Autocamtide-2 [KKALRRQETVDAL] | SH6028 | C65H118N22O20 | 1527.80 | Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Thr-Val-Asp-Ala-Leu | ? | ? | ? |
Autocamtide-3 [KKALHRQETVDAL] | SH6029 | C65H113N21O20 | 1508.75 | Lys-Lys-Ala-Leu-His-Arg-Gln-Glu-Thr-Val-Asp-Ala-Leu | ? | ? | ? |
Bactenecin, bovine | SH6030 | C63H118N24O13S2 | 1483.90 | Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg(Disulfide bridge:Cys3-Cys11) | ? | ? | ? |
BAD (103 - 126), human | SH6031 | C131H200N40O38S | 2975.36 | Asn-Leu-Trp-Ala-Ala-Gln-Arg-Tyr-Gly-Arg-Glu-Leu-Arg-Arg-Met-Ser-Asp-Glu-Phe-Val-Asp-Ser-Phe-Lys | ? | ? | ? |
BAD (103 - 127), human | SH6032 | C137H212N42O39S | 3103.54 | Asn-Leu-Trp-Ala-Ala-Gln-Arg-Tyr-Gly-Arg-Glu-Leu-Arg-Arg-Met-Ser-Asp-Glu-Phe-Val-Asp-Ser-Phe-Lys-Lys | ? | ? | ? |
BAGE (2 - 10) | SH6033 | C44H74N12O10 | 931.15 | Ala-Ala-Arg-Ala-Val-Phe-Leu-Ala-Leu | ? | ? | ? |
Bak - BH3 | SH6034 | C72H125N25O24 | 1724.95 | Gly-Gln-Val-Gly-Arg-Gln-Leu-Ala-Ile-Ile-Gly-Asp-Asp-Ile-Asn-Arg | ? | ? | ? |
BAM 3200 Peptide E | SH6035 | C147H207N41O34S2 | 3156.67 | Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu | ? | ? | ? |
BAM-12P, Bovine Adrenal Medulla Docosapeptide | SH6036 | C62H97N21O16S1 | 1424.66 | Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu | ? | ? | ? |
BAM-12P (7 - 12) | SH6037 | C29H52O9 | 712.81 | Arg-Val-Gly-Arg-Pro-Glu | ? | ? | ? |
BAM - 18P | SH6038 | C107H148N30O26S2 | 2334.69 | Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln | ? | ? | ? |
BAM-22P | SH6039 | C130H184N38O31S2 | 2839.28 | Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly | ? | ? | ? |
Band 3 Protein (547-553) (human) | SH6040 | C41H63N11O11 | 886.02 | His-Pro-Leu-Gln-Lys-Thr-Tyr | ? | ? | ? |
Band 3 Protein (824-829) (human) | SH6041 | C37H65N11O8 | 791.99 | Tyr-Val-Lys-Arg-Val-Lys | ? | ? | ? |
Bax - BH3 | SH6042 | C77H136N22O27S | 1834.13 | Lys-Lys-Leu-Ser-Glu-Cys-Leu-Lys-Arg-Ile-Gly-Asp-Glu-Leu-Asp-Ser | ? | ? | ? |
Bax - BH3L63A | SH6043 | C74H129N22O27S | 1791.05 | Lys-Lys-Leu-Ser-Glu-Cys-Ala-Lys-Arg-Ile-Gly-Asp-Glu-Leu-Asp-Ser | ? | ? | ? |
BDC 2.5(A) | SH6044 | C60H99N19O14S | 1342.64 | Gly-Lys-Lys-Val-Ala-Ala-Pro-Ala-Trp-Ala-Arg-Met-Gly | ? | ? | ? |
bFGF Inhibitory Peptide | SH6045 | C36H53N11O11 | 815.89 | Ala-Pro-Ser-Gly-His-Tyr-Lys-Gly | ? | ? | ? |
bFGF Inhibitory Peptide II | SH6046 | C94H148N30O28S | 2178.48 | Met-Trp-Tyr-Arg-Pro-Asp-Leu-Asp-Glu-Arg-Lys-Gln-Gln-Lys-Arg-Glu | ? | ? | ? |
bFGF (119 - 126), Basic Fibroblast Growth Factor, human, bovine | SH6047 | C44H76N14O12 | 993.18 | Lys-Arg-Thr-Gly-Gln-Tyr-Lys-Leu | ? | ? | ? |
Bid BH3 | SH6048 | C74H127N29O24S | 1839.08 | Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg | ? | ? | ? |
Bid BH3 Peptide | SH6049 | C95H161N33O32S | 2309.61 | Glu-Asp-Ile-Ile-Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg | ? | ? | ? |
Bid BH3 - r8 | SH6050 | C145H260N66O41S | 3616.17 | D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-Gly-Glu-Asp-Ile-Ile-Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg | ? | ? | ? |
Bid BH3 - r9 | SH6051 | C151H272N70O42S | 3772.36 | Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Gly-Glu-Asp-Ile-Ile-Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg | ? | ? | ? |
Big Endothelin-1 Fragment (22-38) (human) | SH6052 | C80H125N23O25 | 1809.03 | Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg-Ser | ? | ? | ? |
Big Endothelin-1 (1-38), human | SH6053 | C189H282N48O56S5 | 4282.96 | Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg-Ser(Disulfide bridge:Cys1-Cys15, Cys3-Cys11) | ? | ? | ? |
Big Endothelin -1 (1-39), porcine | SH6054 | C192H287N49O58S5 | 4370.70 | Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-His-Ile-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Ser-Arg-Ser (Disulfide bridge: Cys1-Cys15, Cys3-Cys11) | ? | ? | ? |
Big Endothelin-1 (22-39), rat | SH6055 | C83H135N25O27 | 1915.20 | Val-Asn-Thr-Pro-Glu-Arg-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Ser-Arg-Ser | ? | ? | ? |
Big Gastrin - 1, human | SH6056 | C176H251N43O53S | 3849.30 | Pyr-Leu-Gly-Pro-Gln-Gly-Pro-Pro-His-Leu-Val-Ala-Asp-Pro-Ser-Lys-Lys-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Biotin-(Arg8)-Vasopressin | SH6057 | C56H79N17O14S2 | 1310.55 | Biotin-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2(Disulfide bridge:Cys1-Cys6) | ? | ? | ? |
Biotin-(Cys1, Lys(biotinyl)18)-Calcitonin (human) | SH6058 | C171H254N4O16 | 3870.52 | Biotin-Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys(bio)-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide bridge: Cys1-Cys6) | ? | ? | ? |
Biotin-[Gln1]-Gastrin I (human) | SH6059 | C107H140N22O34S2 | 2342.60 | Biotin-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Biotin-[Glu1]-Gastrin I (human) (phosphorylated) | SH6060 | C107H141N22O37PS2 | 2422.53 | Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-pTyr-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Biotin-(Leu8, D-Trp22, Tyr25)-Somatostatin-28 | SH6061 | C148H223N43O42S3 | 3372.88 | Biotin-Ser-Ala-Asn-Ser-Asn-Pro-Ala-Leu-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Tyr-Thr-Ser-Cys(Disulfide bridge:Cys17-Cys28) | ? | ? | ? |
Biotin-[Tyr0]-Orexin B, mouse, rat | SH6062 | C145H238N48O38S2 | 3325.90 | Biotin-Tyr-Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | ? | ? | ? |
Biotin-ACTH (1-39), human | SH6063 | C217H322N58O60S | 4767.47 | Biotin-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | ? | ? | ? |
Biotin-Amyloid beta-Protein (1-40) | SH6064 | C204H309N55O60S2 | 4556.20 | Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
Biotin-Amyloid beta-Protein (1-42) | SH6065 | C213H325N57O62S2 | 4740.44 | Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | ? | ? | ? |
Biotin - Angiotensin I, human | SH6066 | C72H103N19O16S | 1522.81 | Biotin-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu | ? | ? | ? |
Biotin-Angiotensin I/II (1-7) | SH6067 | C51H76N14O13S | 1125.33 | Biotin-Asp-Arg-Val-Tyr-Ile-His-Pro | ? | ? | ? |
Biotin-Atrial Natriuretic Peptide (1-28), human, porcine | SH6068 | C137H217N47O41S4 | 3308.80 | Biotin-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge Cys7-Cys23) | ? | ? | ? |
Biotin-Bombesin | SH6069 | C81H126N26O21S2 | 1864.20 | Biotin-Glu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
Biotin-Bradykinin | SH6070 | C60H87N17O13S | 1286.53 | Biotin-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
Biotin-Calcitonin (salmon I) | SH6071 | C155H254N46O50S3 | 3658.22 | Biotin-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2(Disulfide bridge:Cys1-Cys7) | ? | ? | ? |
Biotin-CRF (human, rat) | SH6072 | C218H358N62O65S3 | 4983.85 | Biotin-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2 | ? | ? | ? |
Biotin-Dynorphin A (1-17) | SH6073 | C109H169N33O25S | 2373.83 | Biotin-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | ? | ? | ? |
Biotin - Exendin 4 | SH6074 | C194H296N52O62S2 | 4412.96 | Biotin-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | ? | ? | ? |
Biotin-Galanin, human | SH6075 | C149H224N44O45S | 3383.78 | Biotin-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser | ? | ? | ? |
Biotin - Gastrin (1-17) | SH6076 | C107H140N22O34S2 | 2342.56 | Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Biotin - Gastrin Releasing Peptide, human | SH6077 | C140H218N40O33S3 | 3085.74 | Biotin-Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
Biotin - Glucagon (1 - 29), bovine, human, porcine | SH6078 | C163H239N45O51S2 | 3709.12 | Biotin-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | ? | ? | ? |
Biotin - Glucagon – Like Peptide 1 (7 - 36), amide, human | SH6079 | C159H240N42O47 | 3524.00 | Biotin-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | ? | ? | ? |
Biotin-IkB Inhibitor, amide | SH6080 | C63H101N21O24S | 1600.76 | Biotin-Asp-Arg-His-Asp-Ser-Gly-Leu-Asp-Ser-Met-Lys-Asp-NH2 | ? | ? | ? |
Biotin-Intermedin (human) | SH6081 | C229H353N71O68S4 | 5329.14 | Biotin-Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 | ? | ? | ? |
Biotin-Intermedin (rat) | SH6082 | C236H377N77O66S3 | 5445.29 | Biotin-Pro-His-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Val-Arg-Pro-Ser-Gly-Arg-Arg-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 | ? | ? | ? |
Biotin-Insulin Receptor (1142-1153) | SH6083 | C82H121N21O26 | 1849.07 | Biotin-Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys | ? | ? | ? |
Biotin-Insulin Receptor (1142-1153), amide | SH6084 | C82H122N22O25S | 1848.08 | Biotin-Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys-NH2 | ? | ? | ? |
Biotin-Kemptide | SH6085 | C42H75N15O11S | 998.22 | Biotin-Leu-Arg-Arg-Ala-Ser-Leu-Gly | ? | ? | ? |
Biotin-Kinase Domain of Insulin Receptor (2) | SH6086 | C72H122N21O29S | 1929.07 | Biotin-Thr-Arg-Asp-Ile-pTyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys | ? | ? | ? |
Biotin-Kinase Domain of Insulin Receptor (5) | SH6087 | C82H124N21O35S | 2089.07 | Biotin-Thr-Arg-Asp-Ile-pTyr-Glu-Thr-Asp-pTyr-pTyr-Arg-Lys | ? | ? | ? |
Biotin-LC-Kemptide | SH6088 | C48H86N16O12S | 1111.39 | Biotin-LC-Leu-Arg-Arg-Ala-Ser-Leu-Gly | ? | ? | ? |
Biotin-LC-Neurogranin (28-43) | SH6089 | C94H159N31O20S2 | 2139.48 | Biotin-LC-Ala-Ala-Lys-Ile-Gln-Ala-Ser-Phe-Arg-Gly-His-Met-Ala-Arg-Lys-Lys | ? | ? | ? |
Biotin-LC-Protein Kinase G Substrate; Biotin-LC-G-Subtide | SH6090 | C69H121N25O18S | 1621.00 | Biotin-LC-Gln-Lys-Arg-Pro-Arg-Arg-Lys-Asp-Thr-Pro | ? | ? | ? |
Biotin-MBP Derivatized Peptide | SH6091 | C105H166N28O25 | 2252.73 | Biotin-LC-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly-Lys-NH2 | ? | ? | ? |
Biotin-MBP(94 - 102) | SH6092 | C49H84N20O13S | 1193.41 | Biotin -Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg | ? | ? | ? |
Biotinyl-MCH (salmon) | SH6093 | C99H153N29O26S5 | 2325.82 | Biotin-Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val (Disulfide bridge:Cys5-Cys14) | ? | ? | ? |
Biotin - Neurokinin A | SH6094 | C60H94N16O16S2 | 1359.64 | Biotin -His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
Biotin-Neurokinin B | SH6095 | C67H87N15O14 | 1326.53 | Biotin-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
Biotin-Neuromedin B | SH6096 | C62H87N17O14S2 | 1358.62 | Biotin-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 | ? | ? | ? |
Biotin-Neuromedin S (human) | SH6097 | C67H87N15O14 | 1326.53 | Biotin-Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | ? | ? | ? |
Biotin-Neuromedin S (rat) | SH6098 | C67H87N15O14 | 1326.53 | Biotin-Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | ? | ? | ? |
Biotin-Neuropeptide Y (human, rat) | SH6099 | C199H300N57O60S2 | 4515.10 | Biotin-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
Biotin-Obestatin (human) | SH6100 | C126H190N34O35 | 2773.19 | Biotin-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 | ? | ? | ? |
Biotin-Obestatin (rat) | SH6101 | C124H188N36O33 | 2743.17 | Biotin-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2 | ? | ? | ? |
Biotin-PACAP (1-38), amide, human, ovine, rat | SH6102 | C203H331N63O53S1 | 4534.40 | Biotin-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 | ? | ? | ? |
Biotin-Pancreatic Polypeptide, human | SH6103 | C195H301N55O56S3 | 4409.10 | Biotin-Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | ? | ? | ? |
Biotin-Parathyroid Hormone (1-34), human | SH6104 | C191H305N57O53S3 | 4344.07 | Biotin-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | ? | ? | ? |
Biotin-Phosphorylated MBP (94- 102) | SH6105 | C49H85N20O15S | 1273.41 | Biotin-Ala-Pro-Arg-Thr(po3h2)-Pro-Gly-Gly-Arg-Arg | ? | ? | ? |
Biotin-RR-SRC, Insulin Receptor Tyrosine Kinase Substrate | SH6106 | C74H120N24O23S | 1746.00 | Biotin-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly | ? | ? | ? |
Biotin-Secretin, human | SH6107 | C140H234N46O42S | 5465.80 | Biotin-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2 | ? | ? | ? |
Biotin-Somatostatin-14 | SH6108 | C86H118N20O21S3 | 1864.21 | Biotin-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys(Disulfide bridge:Cys3-Cys14) | ? | ? | ? |
Biotin-Substance P | SH6109 | C73H112N20O15S2 | 1573.96 | Biotin-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
Biotin-Tyrosine Kinase Peptide 1, amide | SH6110 | C87H139N21O24S | 1895.27 | Biotin-Lys-Val-Glu-Lys-Ile-Gly-Glu-Gly-Thr-Tyr-Gly-Val-Val-Tyr-Lys-NH2 | ? | ? | ? |
Biotin-VIP (human, bovine, porcine, rat) | SH6111 | C157H252N46O44S2 | 3552.17 | Biotin-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | ? | ? | ? |
Biotin-a-CGRP (canine, mouse, rat) | SH6112 | C172H276N52O54S3 | 4032.63 | Biotin-Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 (Disulfide bridge:Cys2-Cys6) | ? | ? | ? |
Biotin-a-CGRP (human) | SH6113 | C173H281N53O51S2 | 4015.69 | Biotin-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 (Disulfide bridge:Cys2-Cys6) | ? | ? | ? |
Biotin-beta-Endomorphin, human | SH6114 | C168H265N41O48S | 3691.36 | Biotin-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | ? | ? | ? |
BNP (1-21), Pro (Human) | SH6115 | C89H144N28O35 | 2166.31 | His-Pro-Leu-Gly-Ser-Pro-Gly-Ser-Ala-Ser-Asp-Leu-Glu-Thr-Ser-Gly-Leu-Gln-Glu-Gln-Arg | ? | ? | ? |
BNP-26 (porcine) | SH6116 | C120H198N42O36S2 | 2869.30 | Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr(Disulfide bridge:Cys4-Cys5) | ? | ? | ? |
BNP-32, human | SH6117 | C143H244N50O42S4 | 3464.10 | Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His(Disulfide bridge:Cys10-Cys26) | ? | ? | ? |
BNP-32 , porcine | SH6118 | C149H250N52O44S3 | 3570.17 | Ser-Pro-Lys-Thr-Met-Arg-Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr(Disulfide bridge:Cys10-Cys26) | ? | ? | ? |
BNP-32, rat | SH6119 | C146H239N47O44S3 | 3453.01 | Asn-Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp- Gly-Leu-Arg-Leu-Phe(Disulfide bridge:Cys10-Cys26) | ? | ? | ? |
BNP-45 , rat | SH6120 | C213H349N71O65S3 | 5040.79 | Ser-Gln-Asp-Ser-Ala-Phe-Arg-Ile-Gln-Glu-Arg-Leu-Arg-Asn-Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-Leu-Arg-Leu-Phe(Disulfide bridge:Cys23-Cys39) | ? | ? | ? |
Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human) | SH6121 | C43H551N7O9S | 846.02 | Boc-Gly-Trp-Met-Asp(OBzl)-Phe-NH2 | ? | ? | ? |
Boc-Cholecystokinin Octapeptide (3-8) | SH6122 | C49H62N10O13S2 | 1063.23 | Boc-Met-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Boc-Cholecystokinin Octapeptide (desulfated) | SH6123 | C41H56N8O10S2 | 885.08 | Boc-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Boc-F-L-F-L-F | SH6124 | C44H59N5O8 | 785.99 | Boc-Phe-Leu-Phe-Leu-Phe | ? | ? | ? |
Boc-FAAGRK-AMC | SH6125 | C44H63N11O6 | 906.00 | Boc-Phe-Ala-Ala-Gly-Arg-Lys-AMC | ? | ? | ? |
Boc-GRR-AMC | SH6126 | C29H44N10O7 | 644.70 | Boc-Gly-Arg-Arg-AMC | ? | ? | ? |
Boc-PRR-AMC | SH6127 | C32H48N10O7 | 684.80 | Boc-Pro-Arg-Arg-AMC | ? | ? | ? |
Boc-RRR-AMC | SH6128 | C33H53N13O7 | 743.80 | Boc-Arg-Arg-Arg-AMC | ? | ? | ? |
Bombesin | SH6129 | C71H111N24O18S | 1619.86 | Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
Bombesin (8-14) | SH6130 | C38H57O7S | 812.01 | Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
Bombinin - like Peptide (BLP -1) | SH6131 | C115H194N34O33 | 2581.04 | Gly-Ile-Gly-Ala-Ser-Ile-Leu-Ser-Ala-Gly-Lys-Ser-Ala-Leu-Lys-Gly-Leu-Ala-Lys-Gly-Leu-Ala-Glu-His-Phe-Ala-Asn-NH2 | ? | ? | ? |
Bone Matrix Proteins | SH6132 | C40H67N13O14 | 954.06 | Glu-Ile-Asn-Leu-Ser-His-Asn-Lys | ? | ? | ? |
Bovine Pineal Antireproductive Peptide | SH6133 | C13H26N4O6 | 334.38 | Thr-Ser-Lys | ? | ? | ? |
BPDEtide [RKISASEFDRPLR] | SH6134 | C68H115N23O20 | 1574.82 | Arg-Lys-Ile-Ser-Ala-Ser-Glu-Phe-Asp-Arg-Pro-Leu-Arg | ? | ? | ? |
BPP 5a | SH6135 | C30H41N7O7 | 611.72 | Pyr-Lys-Trp-Ala-Pro | ? | ? | ? |
BPP 9a | SH6136 | C53H76N14O12 | 1101.30 | Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro | ? | ? | ? |
BQ-3020 | SH6137 | C96H139N20O24S | 1989.36 | Ac-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | ? | ? | ? |
Bradykinin | SH6138 | C50H73N15O11 | 1060.22 | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
Bradykinin (1-3) | SH6139 | C16H28N6O4 | 368.40 | Arg-Pro-Pro | ? | ? | ? |
Bradykinin (1-5) | SH6140 | C27H40N8O6 | 572.67 | Arg-Pro-Pro-Gly-Phe | ? | ? | ? |
Bradykinin (1-6) | SH6141 | C30H45N9O8 | 659.75 | Arg-Pro-Pro-Gly-Phe-Ser | ? | ? | ? |
Bradykinin (1-7) | SH6142 | C35H52N10O9 | 756.87 | Arg-Pro-Pro-Gly-Phe-Ser-Pro | ? | ? | ? |
Bradykinin (2-7) | SH6143 | C29H40N6O8 | 600.68 | Pro-Pro-Gly-Phe-Ser-Pro | ? | ? | ? |
Bradykinin [Des-Arg1] | SH6144 | C44H61N11O10 | 904.04 | Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
Bradykinin [Des-Arg9] | SH6145 | C44H61N11O10 | 904.04 | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe | ? | ? | ? |
Bradykinin [Hyp3] | SH6146 | C30H72N15O10 | 1077.23 | Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
Bradykinin Potentiator B; Angiotensin I Converting Enzyme Inhibitor | SH6147 | C56H91N15O13 | 1182.46 | Pyr-Gly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro | ? | ? | ? |
Bradykinin Potentiator C | SH6148 | C51H77N11O13 | 1052.26 | Pyr-Gly-Leu-Pro-Pro-Gly-Pro-Pro-Ile-Pro-Pro | ? | ? | ? |
Bradykinin-Like Neuropeptide (Aplysia californica) | SH6149 | C53H98N24O14S | 1327.59 | Met-Lys-Arg-Ser-Arg-Gly-Pro-Ser-Pro-Arg-Arg | ? | ? | ? |
Bradykinin-Like Neuropeptide (3-11) (Aplysia californica) | SH6150 | C42H77N21O12 | 1068.22 | Arg-Ser-Arg-Gly-Pro-Ser-Pro-Arg-Arg | ? | ? | ? |
Brain Derived Acidic Fibroblast Growth Factor (1-11); FGF acidic (1-11) (bovine brain) | SH6151 | C62H95N15O15 | 1290.53 | Phe-Asn-Leu-Pro-Leu-Gly-Asn-Tyr-Lys-Lys-Pro | ? | ? | ? |
Brain Derived Acidic Fibroblast Growth Factor (102-111); FGF acidic (102-111) (bovine brain) | SH6152 | C59H82N16O13 | 1223.40 | His-Ala-Glu-Lys-His-Trp-Phe-Val-Gly-Leu | ? | ? | ? |
Brain Derived Basic Fibroblast Growth Factor (1-24) | SH6153 | C118H173N31O33 | 2553.86 | Pro-Ala-Leu-Pro-Glu-Asp-Gly-Gly-Ser-Gly-Ala-Phe-Pro-Pro-Gly-His-Phe-Lys-Asp-Pro-Lys-Arg-Leu-Tyr | ? | ? | ? |
Brain Injury Derived Neurotrophic Peptide | SH6154 | C62H102N18O18 | 1387.61 | Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 | ? | ? | ? |
Brain injury Derived Neurotrophic Peptide(3) BINP | SH6155 | C62H101N17O19 | 1388.58 | Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala | ? | ? | ? |
Brevinin–1 | SH6156 | C121H202N28O26S2 | 2529.26 | Phe-Leu-Pro-Val-Leu-Ala-Gly-Ile-Ala-Ala-Lys-Val-Val-Pro-Ala-Leu-Phe-Cys-Lys-Ile-Thr-Lys-Lys-Cys(Disulfide bridge: Cys18-Cys24) | ? | ? | ? |
BTK derived peptide | SH6157 | C72H115N17O18S2 | 1570.95 | Lys-Lys-Val-Val-Ala-Leu-Tyr-Asp-Tyr-Met-Pro-Met-Asn-NH2 | ? | ? | ? |
BTM - P1 | SH6158 | C134H219N33O31 | 2788.44 | Val-Ala-Pro-Ile-Ala-Lys-Tyr-Leu-Ala-Thr-Ala-Leu-Ala-Lys-Trp-Ala-Leu-Lys-Gln-Gly-Phe-Ala-Lys-Leu-Lys-Ser | ? | ? | ? |
Buccalin | SH6159 | C45H72N12O15S | 1053.20 | Gly-Met-Asp-Ser-Leu-Ala-Phe-Ser-Gly-Gly-Leu-NH2 | ? | ? | ? |
Bursin | SH6160 | C14H25N7O3 | 339.40 | Lys-His-Gly-NH2 | ? | ? | ? |
C. difficile Toxin B (192 - 207) | SH6161 | C81H136N22O29 | 1882.12 | Ala-Gln-Arg-Glu-Glu-Asn-Pro-Glu-Leu-Ile-Ile-Asp-Asp-Ile-Val-Lys | ? | ? | ? |
C. difficile Toxin B (232 - 241) | SH6162 | C43H74N16O18 | 1103.17 | Ile-Thr-Gln-Asn-Ser-Gly-Asn-Asp-Val-Arg | ? | ? | ? |
C. difficile Toxin B (248 - 262) | SH6163 | C79H119N21O29 | 1826.95 | Asn-Gly-Glu-Ser-Phe-Asn-Leu-Tyr-Glu-Gln-Glu-Leu-Val-Glu-Arg | ? | ? | ? |
C. difficile Toxin B (392 - 401) | SH6164 | C49H80N12O17S | 1141.31 | Asp-Ser-Tyr-Cys-Ser-Asn-Leu-Ile-Val-Lys | ? | ? | ? |
C. difficile Toxin B (529 - 536) | SH6165 | C48H71N13O15 | 1070.18 | Ala-Gln-Phe-Glu-Glu-Tyr-Lys-Arg | ? | ? | ? |
C. difficile Toxin B (8 - 16) | SH6166 | C45H81N15O14S | 1088.30 | Gln-Leu-Glu-Lys-Met-Ala-Asn-Val-Arg | ? | ? | ? |
C- Myc peptide epitope | SH6167 | C51H86N12O21 | 1203.32 | Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu | ? | ? | ? |
C-Peptide, dogs | SH6168 | C137H225N37O49 | 3174.54 | Glu-Val-Glu-Asp-Leu-Gln-Val-Arg-Asp-Val-Glu-Leu-Ala-Gly-Ala-Pro-Gly-Glu-Gly-Gly-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ala-Leu-Gln | ? | ? | ? |
C-Peptide (57-87), human | SH6169 | C129H211N35O48 | 3020.33 | Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln | ? | ? | ? |
C-Peptide 1 (rat) | SH6170 | C140H228N38O51 | 3259.60 | Glu-Val-Glu-Asp-Pro-Gln-Val-Pro-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Glu-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln | ? | ? | ? |
C-Peptide 2 (rat) | SH6171 | C135H222N38O49 | 3161.50 | Glu-Val-Glu-Asp-Pro-Gln-Val-Ala-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln | ? | ? | ? |
C-Reactive Protein (CRP) (174-185) | SH6172 | C62H93N13O16 | 1276.51 | Ile-Tyr-Leu-Gly-Gly-Pro-Phe-Ser-Pro-Asn-Val-Leu | ? | ? | ? |
C-Reactive Protein (CRP) (201-206) | SH6173 | C38H57N9O8 | 767.93 | Lys-Pro-Gln-Leu-Trp-Pro | ? | ? | ? |
C-Reactive Protein (CRP) (77-82) | SH6174 | C23H40N6O10 | 560.61 | Val-Gly-Gly-Ser-Glu-Ile | ? | ? | ? |
C-telopeptide | SH6175 | C34H56N14O13 | 868.91 | Glu-Lys-Ala-His-Asp-Gly-Gly-Arg | ? | ? | ? |
C-terminal Proghrelin Isoform Peptide, mouse | SH6176 | C50H86N22O17 | 1267.38 | Arg-Arg-Gln-Leu-Thr-Ser-Asn-His-Gly-Gln-Ala | ? | ? | ? |
C-Type Natriuretic Peptide, Chicken | SH6177 | C93H157N29O29S3 | 2241.66 | Gly-Leu-Ser-Arg-Ser-Cys-Phe-Gly-Val-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(Disulfide bridge:Cys6-Cys22) | ? | ? | ? |
C-Type Natriuretic Peptide (1-22), human | SH6178 | C93H157N27O28S3 | 2197.64 | Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(Disulfide bridge:Cys6-Cys22) | ? | ? | ? |
C-Type Natriuretic Peptide (1-53) (human) | SH6179 | C251H417N81O71S3 | 5801.81 | Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(Disulfide bridge:Cys37-Cys54) | ? | ? | ? |
C3 Peptide P16 | SH6180 | C86H131N25O27 | 1947.15 | Lys-Asn-Arg-Trp-Glu-Asp-Pro-Gly-Lys-Gln-Leu-Tyr-Asn-Val-Glu-Ala | ? | ? | ? |
C3a (70 - 77) | SH6181 | C35H61N13O10 | 823.96 | Ala-Ser-His-Leu-Gly-Leu-Ala-Arg | ? | ? | ? |
C3a (72-77) (human) | SH6182 | C29H51N11O7 | 655.80 | His-Leu-Gly-Leu-Ala-Arg | ? | ? | ? |
Cadherin Peptide, avian | SH6183 | C44H75N17O13 | 1050.19 | Leu-Arg-Ala-His-Ala-Val-Asp-Val-Asn-Gly-NH2 | ? | ? | ? |
Caerulein (desulfated) | SH6184 | C58H73N13O19S | 1290.38 | Pyr-Gln-Asp-Tyr-Thr-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Calcineurin Autoinhibitory Fragment | SH6185 | C124H205N39O39S2 | 2930.38 | Ile-Thr-Ser-Phe-Glu-Glu-Ala-Lys-Gly-Leu-Asp-Arg-Ile-Asn-Glu-Arg-Met-Pro-Pro-Arg-Arg-Asp-Ala-Met-Pro | ? | ? | ? |
Calcineurin Substrate | SH6186 | C92H150N28O29 | 2112.40 | Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu | ? | ? | ? |
Calcitonin, chicken | SH6187 | C145H240N42O46S2 | 3371.91 | Cys-Ala-Ser-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2(Disulfide bridge:Cys1-Cys7) | ? | ? | ? |
Calcitonin, eel | SH6188 | C146H241N43O47S2 | 3414.94 | Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2(Disulfide bridge:Cys1-Cys7) | ? | ? | ? |
Calcitonin, human | SH6189 | C151H226N40O45S3 | 3417.87 | Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide bridge: Cys1-Cys7) | ? | ? | ? |
Calcitonin, porcine | SH6190 | C159H232N46O45S3 | 3604.10 | Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Ser-Ala-Tyr-Trp-Arg-Asn-Leu-Asn-Asn-Phe-His-Arg-Phe-Ser-Gly-Met-Gly-Phe-Gly-Pro-Glu-Thr-Pro-NH2 (Disulfide bridge: Cys1-Cys7) | ? | ? | ? |
Calcitonin, rat | SH6191 | C148H228N40O46S3 | 3399.90 | Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Leu-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ser-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide bridge:Cys1-Cys7) | ? | ? | ? |
Calcitonin, salmon | SH6192 | C145H240N44O48S2 | 3417.88 | Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2(Disulfide bridge Cys1-Cys7) | ? | ? | ? |
Calcitonin (8-32) (salmon I) | SH6193 | C119H198N36O37 | 2725.12 | Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2 | ? | ? | ? |
Calcitonin C-terminal Adjacent Peptide, rat | SH6194 | C82H117N23O27S | 1889.05 | Asp-Met-Ala-Lys-Asp-Leu-Glu-Thr-Asn-His-His-Pro-Tyr-Phe-Gly-Asn | ? | ? | ? |
Calcitonin Gene Related Peptide (8-37), human | SH6195 | C139H230N44O38 | 3125.65 | Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | ? | ? | ? |
Calcitonin Gene Related Peptide (8-37), rat | SH6196 | C138H224N42O41 | 3127.58 | Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | ? | ? | ? |
Calcitonin Gene Related Peptide II, human | SH6197 | C162H267N51O48S3 | 3793.38 | Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7) | ? | ? | ? |
Calcitonin Gene Related Peptide II, rat | SH6198 | C163H265N51O50S2 | 3803.39 | Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7) | ? | ? | ? |
Calcitonin Gene Related Peptide, chicken | SH6199 | C165H260N52O50S2 | 3836.37 | Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Asp-Phe-Leu-Ser-Arg-Ser-Gly-Gly-Val-Gly-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7) | ? | ? | ? |
Calcitonin Gene Related Peptide, rat | SH6200 | C162H260N50O52S2 | 3804.33 | Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7) | ? | ? | ? |
Calcitonin N-Terminal Flanking Peptide, human; N –Procalcitonin | SH6201 | C264H426N74O97S | 6220.84 | Ala-Pro-Phe-Arg-Ser-Ala-Leu-Glu-Ser-Ser-Pro-Ala-Asp-Pro-Ala-Thr-Leu-Ser-Glu-Asp-Glu-Ala-Arg-Leu-Leu-Leu-Ala-Ala-Leu-Val-Gln-Asp-Tyr-Val-Gln-Met-Lys-Ala-Ser-Glu-Leu-Glu-Gln-Glu-Gln-Glu-Arg-Glu-Gly-Ser-Ser-Leu-Asp-Ser-Pro-Arg-Ser | ? | ? | ? |
Calcium/Calmodulin Dependent Protein Kinase II - g(345 - 358) | SH6202 | C58H107N21O22 | 1450.63 | Lys-Ser-Asp-Gly-Gly-Val-Lys-Lys-Arg-Lys-Ser-Ser-Ser-Ser | ? | ? | ? |
Calcium-Like Peptide | SH6203 | C40H75N9O10 | 842.10 | Val-Ala-Ile-Thr-Val-Leu-Val-Lys | ? | ? | ? |
Calmodulin-Dependent Protein Kinase II (281 - 289) | SH6204 | C43H71N15O16S2 | 1118.26 | Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys | ? | ? | ? |
Calmodulin-Dependent Protein Kinase II (281-309) | SH6205 | C146H254N46O39S3 | 3374.11 | Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala | ? | ? | ? |
Calmodulin-Dependent Protein Kinase II (290 - 309) | SH6206 | C103H185N31O24S | 2273.88 | Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala | ? | ? | ? |
Caloxin 2A1 | SH6207 | C64H91N19O22 | 1478.55 | Val-Ser-Asn-Ser-Asn-Trp-Pro-Ser-Phe-Pro-Ser-Ser-Gly-Gly-Gly-NH2 | ? | ? | ? |
Calpain Inhibitor Peptide | SH6208 | C140H227N35O44S | 3136.64 | Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala | ? | ? | ? |
cAMP Dependent PK Inhibitor (5-22), amide | SH6209 | C84H137N29O26 | 1969.20 | Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 | ? | ? | ? |
cAMP Dependent PK Inhibitor (5-24) | SH6210 | C94H108N32O31 | 2222.40 | Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-His-Asp | ? | ? | ? |
cAMP Dependent Protein Kinase Substrate | SH6211 | C31H58N14O9 | 770.90 | Arg-Arg-Lys-Ala-Ser-Gly-Pro | ? | ? | ? |
CAP - 18, rabbit | SH6212 | C202H356N64O47 | 4433.49 | Gly-Leu-Arg-Lys-Arg-Leu-Arg-Lys-Phe-Arg-Asn-Lys-Ile-Lys-Glu-Lys-Leu-Lys-Lys-Ile-Gly-Gln-Lys-Ile-Gln-Gly-Leu-Leu-Pro-Lys-Leu-Ala-Pro-Arg-Thr-Asp-Tyr | ? | ? | ? |
Carassin (Carrassius Auratus) | SH6213 | C103H175N35O27S | 2367.83 | Ser-Pro-Ala-Asn-Ala-Gln-Ile-Thr-Arg-Lys-Arg-His-Lys-Ile-Asn-Ser-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
Casein Kinase II Assay Kit | SH6214 | C45H73N19O24 | 1264.20 | Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp | ? | ? | ? |
Casein Kinase II Receptor Peptide | SH6215 | C52H87N19O24 | 1362.30 | Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu | ? | ? | ? |
Casein Kinase II Substrate | SH6216 | C52H87N19O24 | 1362.30 | Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu | ? | ? | ? |
Caspase 1 Substrate 1 (ICE), chromogenic; Ac-YEVD-pNA | SH6217 | C217H322N58O60S | 4767.47 | Ac-Tyr-Glu-Val-Asp-pNA | ? | ? | ? |
Caspase 1 Substrate 1m (ICE), fluorogenic; Ac-YEVD-AMC | SH6218 | C35H41N5O12 | 723.70 | Ac-Tyr-Glu-Val-Asp-AMC | ? | ? | ? |
Caspase 1 Substrate 2m (ICE), fluorogenic; Ac-YVAD-AMC | SH6219 | C33H39N5O10 | 665.70 | Ac-Tyr-Val-Ala-Asp-AMC | ? | ? | ? |
Caspase 2 Substrate 1m (ICH-1), fluorogenic; Ac-VDVAD-AMC | SH6220 | C33H44N6O12 | 716.80 | Ac-Val-Asp-Val-Ala-Asp-AMC | ? | ? | ? |
Caspase 2 Substrate, chromogenic; Ac-VDQQD-pNA | SH6221 | C31H43N9O14 | 765.70 | Ac-Val-Asp-Gln-Gln-Asp-pNA | ? | ? | ? |
Caspase 3 Substrate, Colorimetric | SH6222 | C26H34N6O13 | 638.60 | Ac-Asp-Glu-Val-Asp-pNA | ? | ? | ? |
Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC | SH6223 | C30H37N5O13 | 675.65 | Ac-Asp-Glu-Val-Asp-AMC | ? | ? | ? |
Caspase 3 Substrate, chromogenic; Ac-VQVD-pNA | SH6224 | C27H39N7O10 | 621.66 | Ac-Val-Gln-Val-Asp-Pna | ? | ? | ? |
Catch-Relaxing Peptide (CARP) | SH6225 | C36H67N11O7S2 | 830.13 | Ala-Met-Pro-Met-Leu-Arg-Leu-NH2 | ? | ? | ? |
Cathepsin G (77 - 83) | SH6226 | C40H59N15O12 | 942.01 | His-Pro-Gln-Tyr-Asn-Gln-Arg | ? | ? | ? |
Cathepsin S substrate | SH6227 | C41H66N12O9 | 871.08 | Ac-Lys-Gln-Lys-Leu-Arg-AMC | ? | ? | ? |
CB-TH | SH6228 | C138H230N46O34S4 | 3205.90 | Arg-Trp-Lys-Ile-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Gly-Ser-Tyr-Cys-Asn-Arg-Arg-Thr-Gly-Lys-Cys-Gln-Arg-Met | ? | ? | ? |
CC Chemokine Receptor 3 Fragment I, amide | SH6229 | C142H223N35O53S2 | 3332.68 | Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys-Glu-Lys-Ala-Asp-Thr-Arg-nh2 | ? | ? | ? |
CC Chemokine Receptor 3 Fragment II | SH6230 | C114H174N24O43S2 | 2632.91 | Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys | ? | ? | ? |
CC Chemokine Receptor 3 Fragment II, amide | SH6231 | C114H175N25O42S2 | 2631.93 | Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys-NH2 | ? | ? | ? |
CD36 (93-110)-Cys | SH6232 | C96H151N29O33S | 2271.50 | Tyr-Arg-Val-Arg-Phe-Leu-Ala-Lys-Glu-Asn-Val-Thr-Gln-Asp-Ala-Glu-Asp-Asn-Cys | ? | ? | ? |
CDC25C | SH6233 | C115H198N40O33S | 2701.17 | Lys-Lys-Lys-Val-Ser-Arg-Ser-Gly-Leu-Tyr-Arg-Ser-Pro-Ser-Met-Pro-Glu-Asn-Leu-Asn-Arg-Pro-Arg | ? | ? | ? |
CDPKS, Syntide analog | SH6234 | C47H86N16O13 | 1083.31 | Pro-Leu-Arg-Arg-Thr-Leu-Ser-Val-Ala-Ala | ? | ? | ? |
CDR-H3/C2 | SH6235 | C98H120N16O34S2 | 2130.26 | Cys-Asp-Leu-Ile-Tyr-Tyr-Asp-Tyr-Glu-Glu-Asp-Tyr-Tyr-Phe-Asp-Cys(Disulfide bridge: Cys1-Cys16) | ? | ? | ? |
CEA (605-613) | SH6236 | C43H69N11O14 | 964.09 | Tyr-Leu-Ser-Gly-Ala-Asn-Leu-Asn-Leu | ? | ? | ? |
CEA Related, QYSWFVNGTF | SH6237 | C61H77N13O16 | 1248.37 | Gln-Tyr-Ser-Trp-Phe-Val-Asn-Gly-Thr-Phe | ? | ? | ? |
CEA Related, TYACFVSNL | SH6238 | C46H68N10O14S | 1017.17 | Thr-Tyr-Ala-Cys-Phe-Val-Ser-Asn-Leu | ? | ? | ? |
CEA, CAP-1-6-D, [Asp6] -Carcinoembryonic Antigen | SH6239 | C43H68N10O15 | 965.08 | Tyr-Leu-Ser-Gly-Ala-Asp-Leu-Asn-Leu | ? | ? | ? |
Cecropin A | SH6240 | C184H313N53O46 | 4003.87 | Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Glu-Lys-Val-Gly-Gln-Asn-Ile-Arg-Asp-Gly-Ile-Ile-Lys-Ala-Gly-Pro-Ala-Val-Ala-Val-Val-Gly-Gln-Ala-Thr-Gln-Ile-Ala-Lys-NH2 | ? | ? | ? |
Cecropin A (1-7)-Melittin A (2-9) amide | SH6241 | C89H152N22O15 | 1770.34 | Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-NH2 | ? | ? | ? |
Cecropin A (1-8)-Melittin (1-18) amide | SH6242 | C136H233N33O29 | 2794.58 | Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-NH2 | ? | ? | ? |
Cecropin B | SH6243 | C176H302N52O41S1 | 3834.76 | Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu-NH2 | ? | ? | ? |
Cecropin B, Free Acid | SH6244 | C176H302N52O41S | 3834.73 | Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu | ? | ? | ? |
Cecropin P1 (porcine) | SH6245 | C147H253N46O43 | 3338.93 | Ser-Trp-Leu-Ser-Lys-Thr-Ala-Lys-Lys-Leu-Glu-Asn-Ser-Ala-Lys-Lys-Arg-Ile-Ser-Glu-Gly-Ile-Ala-Ile-Ala-Ile-Gln-Gly-Gly-Pro-Arg | ? | ? | ? |
CEF10 | SH6246 | C39H71N9O11S1 | 906.20 | Cys-Leu-Gly-Gly-Leu-Leu-Thr-Met-Val | ? | ? | ? |
CEF3 | SH6247 | C42H74N10O12 | 911.12 | Ser-Ile-Ile-Pro-Ser-Gly-Pro-Leu-Lys | ? | ? | ? |
CEF4 | SH6248 | C53H93N15O13 | 1148.42 | Arg-Val-Leu-Ser-Phe-Ile-Lys-Gly-Thr-Lys | ? | ? | ? |
CEF6 | SH6249 | C48H78N10O14S1 | 1051.28 | Leu-Pro-Phe-Asp-Lys-Thr-Thr-Val-Met | ? | ? | ? |
Ceratotoxin A | SH6250 | C135H243N35O32 | 2868.66 | Ser-Ile-Gly-Ser-Ala-Leu-Lys-Lys-Ala-Leu-Pro-Val-Ala-Lys-Lys-Ile-Gly-Lys-Ile-Ala-Leu-Pro-Ile-Ala-Lys-Ala-Ala-Leu-Pro | ? | ? | ? |
Ceratotoxin B | SH6251 | C135H235N35O32 | 2860.59 | Ser-Ile-Gly-Ser-Ala-Phe-Lys-Lys-Ala-Leu-Pro-Val-Ala-Lys-Lys-Ile-Gly-Lys-Ala-Ala-Leu-Pro-Ile-Ala-Lys-Ala-Ala-Leu-Pro | ? | ? | ? |
CFP10 (71-85) | SH6252 | C72H120N24O25 | 1721.91 | Glu-Ile-Ser-Thr-Asn-Ile-Arg-Gln-Ala-Gly-Val-Gln-Tyr-Ser-Arg | ? | ? | ? |
CFTR (108-117), Pseudomonas aeruginosa Inhibitor | SH6253 | C51H77N15O22 | 1252.27 | Ser-Tyr-Asp-Pro-Asp-Asn-Lys-Glu-Glu-Arg | ? | ? | ? |
Charybdotoxin | SH6254 | C176H277N57O55S7 | 4296.00 | Glp-Phe-Thr-Asn-Val-Ser-Cys-Thr-Thr-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Gln-Arg-Leu-His-Asn-Thr-Ser-Arg-Gly-Lys-Cys-Met-Asn-Lys-Lys-Cys-Arg-Cys-Tyr-Ser (Disulfide bridges:Cys7-Cys28, Cys13-Cys33, Cys17-Cys35 ) | ? | ? | ? |
Cholecystokinin Octapeptide (1-2) (desulfated) | SH6255 | C13H16N2O6 | 296.28 | Asp-Tyr | ? | ? | ? |
Cholecystokinin Octapeptide (1-3) (desulfated) | SH6256 | C18H25N3O7S | 427.48 | Asp-Tyr-Met | ? | ? | ? |
Cholecystokinin Octapeptide (1-4) (desulfated) | SH6257 | C20H28N4O8S | 484.53 | Asp-Tyr-Met-Gly | ? | ? | ? |
Cholecystokinin Octapeptide (1-5) (desulfated) | SH6258 | C31H38N6O9S | 670.75 | Asp-Tyr-Met-Gly-Trp | ? | ? | ? |
Cholecystokinin Octapeptide (1-6) (desulfated) | SH6259 | C36H47N7O10S2 | 801.94 | Asp-Tyr-Met-Gly-Trp-Met | ? | ? | ? |
Cholecystokinin Octapeptide (2-8) (desulfated) | SH6260 | C45H57N9O10S2 | 948.14 | Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Cholecystokinin Octapeptide (desulfated) | SH6261 | C49H62N10O13S2 | 1063.23 | Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Cholecystokinin Octapeptide free acid (desulfated) | SH6262 | C49H61N9O13S2 | 1064.21 | Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe | ? | ? | ? |
Cholecystokinin Precursor (107-115) (human) (desulfated) | SH6263 | C47H63N9O20 | 1074.07 | Ser-Ala-Glu-Glu-Tyr-Glu-Tyr-Pro-Ser | ? | ? | ? |
Cholecystokinin Precursor (24-32) (rat) | SH6264 | C42H69N9O14S | 956.13 | Val-Pro-Val-Glu-Ala-Val-Asp-Pro-Met | ? | ? | ? |
Cholecystokinin-33 (1-21) (porcine) | SH6265 | C98H169N33O30S | 2321.71 | Lys-Ala-Pro-Ser-Gly-Arg-Val-Ser-Met-Ile-Lys-Asn-Leu-Gln-Ser-Leu-Asp-Pro-Ser-His-Arg | ? | ? | ? |
Cholecystokinin-33 (10-20) (bovine, porcine) | SH6266 | C54H90N16O18 | 1251.42 | Ile-Lys-Asn-Leu-Gln-Ser-Leu-Asp-Pro-Ser-His | ? | ? | ? |
Chorionic Gonadotropin-beta(109-119) amide (human) | SH6267 | C51H76N16O21S | 1269.31 | Thr-Cys-Asp-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-NH2 | ? | ? | ? |
Chorionic Gonadotropin-beta(109-145) (human) | SH6268 | C50H75N16O21S | 1268.31 | Thr-Cys-Asp-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-Ser-Ser-Lys-Ala-Pro-Pro-Pro-Ser-Leu-Pro-Ser-Pro-Ser-Arg-Leu-Pro-Gly-Pro-Ser-Asp-Thr-Pro-Ile-Leu-Pro-Gln | ? | ? | ? |
Chromogranin A (324-337), human | SH6269 | C72H116N18O24S | 1649.90 | Trp-Ser-Lys-Met-Asp-Gln-Leu-Ala-Lys-Glu-Leu-Thr-Ala-Glu | ? | ? | ? |
Chromostatin, bovine | SH6270 | C78H120N24O35 | 1953.97 | Ser-Asp-Glu-Asp-Ser-Asp-Gly-Asp-Arg-Pro-Gln-Ala-Ser-Pro-Gly-Leu-Gly-Pro-Gly-Pro | ? | ? | ? |
CK1tide | SH6271 | C64H96N18O27 | 1549.58 | His-Ala-Ala-Ile-Gly-Asp-Asp-Asp-Asp-Ala-Tyr-Ser-Ile-Thr-Ser-NH2 | ? | ? | ? |
CKS-17 | SH6272 | C87H148N26O24 | 1942.31 | Leu-Gln-Asn-Arg-Arg-Gly-Leu-Asp-Leu-Leu-Phe-Leu-Lys-Glu-Gly-Gly-Leu | ? | ? | ? |
CKS-17 (7-12) | SH6273 | C37H60N6O9 | 732.93 | Leu-Asp-Leu-Leu-Phe-Leu | ? | ? | ? |
CLIP(85–99) | SH6274 | C75H135N23O19S3 | 1759.25 | Lys-Pro-Val-Ser-Gln-Met-Arg-Met-Ala-Thr-Pro-Leu-Leu-Met-Arg | ? | ? | ? |
Collagen Binding Fragment | SH6275 | C52H75N14O20S | 1248.32 | Cys-Gln-Asp-Ser-Glu-Thr-Arg-Thr-Phe-Tyr | ? | ? | ? |
Complement anaphylatoxin C5a (37 - 53), human | SH6276 | C82H140N27O22S | 1888.26 | Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu | ? | ? | ? |
Conantokin G | SH6277 | C88H138N26O44 | 2264.18 | Gly-Glu-Gla-Gla-Leu-Gln-Gla-Asn-Gln-Gla-Leu-Ile-Arg-Gla-Lys-Ser-Asn-NH2 | ? | ? | ? |
Conantokin G (free acid) | SH6278 | C88H137N25O45 | 2265.16 | Gly-Glu-Gla-Gla-Leu-Gln-Gla-Asn-Gln-Gla-Leu-Ile-Arg-Gla-Lys-Ser-Asn | ? | ? | ? |
Conopressin S | SH6279 | C41H73N17O10S2 | 1028.27 | Cys-Ile-Ile-Arg-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge: Cys1-Cys6) | ? | ? | ? |
Conantokin T, Marine snail, Conus tullpa | SH6280 | C110H175N31O45S | 2683.90 | Gly-Glu-Gla-Gla-Tyr-Gln-Lys-Met-Leu-Gla-Asn-Leu-Arg-Gla-Ala-Glu-Val-Lys-Lys-Asn-Ala-NH2 | ? | ? | ? |
Contraceptive Tetrapeptide | SH6281 | C21H40N8O6 | 500.60 | Thr-Pro-Arg-Lys | ? | ? | ? |
Corazonin, American Cockroach, Periplaneta americana | SH6282 | C62H86N18O19 | 1369.49 | Pyr-Thr-Phe-Gln-Tyr-Ser-Arg-Gly-Trp-Thr-Asn-NH2 | ? | ? | ? |
Corticostatin, human | SH6283 | C157H261N49O43S6 | 3715.47 | Val-Cys-Ser-Cys-Arg-Leu-Val-Phe-Cys-Arg-Arg-Thr-Glu-Leu-Arg-Val-Gly-Asn-Cys-Leu-Ile-Gly-Gly-Val-Ser-Phe-Thr-Tyr-Cys-Cys-Thr-Arg-Val | ? | ? | ? |
Corticostatin, rabbit | SH6284 | C163H265N63O44S6 | 4003.66 | Gly-Ile-Cys-Ala-Cys-Arg-Arg-Arg-Phe-Cys-Pro-Asn-Ser-Glu-Arg-Phe-Ser-Gly-Tyr-Cys-Arg-Val-Asn-Gly-Ala-Arg-Tyr-Val-Arg-Cys-Cys-Ser-Arg-Arg | ? | ? | ? |
Corticotropin Releasing Factor, bovine | SH6285 | C206H340N60O63S | 4697.44 | Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Asn-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2 | ? | ? | ? |
Corticotropin Releasing Factor, human, rat | SH6286 | C208H344N60O63S2 | 4575.50 | Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2 | ? | ? | ? |
Corticotropin Releasing Factor, ovine | SH6287 | C205H339N59O63S | 4370.41 | Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2 | ? | ? | ? |
Cortistatin 14 (mouse, rat) | SH6288 | C81H113N19O19S2 | 1721.05 | Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys(Disulfide bridge Cys2-Cys13) | ? | ? | ? |
Cortistatin 17, human | SH6289 | C96H139N27O24S3 | 2151.54 | Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys (Disulfide bridge Cys5-Cys16) | ? | ? | ? |
CREB327 (113 - 126) | SH6290 | C76H131N25O21 | 1731.05 | Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg-Lys-Ile-Leu-Asn-Asp | ? | ? | ? |
CREBtide | SH6291 | C73H127N29O18 | 1699.01 | Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg | ? | ? | ? |
CRF (6-33) (human, rat) | SH6292 | C141H231N41O43S | 3220.73 | Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser | ? | ? | ? |
Cripto-1, CR-1 | SH6293 | C86H129N27O27S2 | 2037.26 | Cys-Pro-Pro-Ser-Phe-Tyr-Gly-Arg-Asn-Cys-Glu-His-Asp-Val-Arg-Lys-Glu | ? | ? | ? |
Crustacean Cardioactive Peptide, CCAP | SH6294 | C42H56N10O12S2 | 957.10 | Pro-Phe-Cys-Asn-Ala-Phe-Thr-Gly-Cys (Disulfide bridge Cys3-Cys9) | ? | ? | ? |
Crustacean Cardioactive Peptide (CCAP), amide | SH6295 | C42H57N11O11S2 | 956.12 | Pro-Phe-Cys-Asn-Ala-Phe-Thr-Gly-Cys-NH2 | ? | ? | ? |
Crustacean Erythrophore Concentrating Hormone | SH6296 | C45H59N11O11 | 930.00 | Pyr-Leu-Asn-Phe-Ser-Pro-Gly-Trp-NH2 | ? | ? | ? |
Crystalline | SH6297 | C13H15N3O3 | 261.20 | Trp-Gly | ? | ? | ? |
CSP | SH6298 | C103H168N30O24S | 2242.74 | Glu-Met-Arg-Leu-Ser-Lys-Phe-Phe-Arg-Asp-Phe-Ile-Leu-Gln-Arg-Lys-Lys | ? | ? | ? |
CTAP | SH6299 | C51H67N13O11S | 1102.33 | D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2(Disulfide bridge Cys2-Pen7) | ? | ? | ? |
CTX IV (6-12) | SH6300 | C48H70N10O7 | 899.14 | Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2 | ? | ? | ? |
Cys-beta- Amyloid (1 - 40) | SH6301 | C197H299N54O59S2 | 4432.03 | Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
Cys-beta- Amyloid (12 - 28) | SH6302 | C92H139N26O26S | 2057.36 | Cys-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | ? | ? | ? |
Cys-CD36 (139-155) | SH6303 | C87H133N25O26S | 1977.24 | Cys-Asn-Leu-Ala-Val-Ala-Ala-Ala-Ser-His-Ile-Tyr-Gln-Asn-Gln-Phe-Val-Gln | ? | ? | ? |
Cys-Gly-His-Gly-Asn-Lys-Ser-Amyloid ß -Protein (33-40) | SH6304 | C58H99N19O18S2 | 1414.67 | Cys-Gly-His-Gly-Asn-Lys-Ser-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
Cys-Gly-Lys-Arg-Amyloid – ß Protein (1-42) | SH6305 | C220H343N63O64S2 | 4958.69 | Cys-Gly-Lys-Arg-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | ? | ? | ? |
Cys-Gly-Lys-Lys-Gly-Amyloid ß -Protein (33-40) | SH6306 | C51H92N15O14S2 | 1203.52 | Cys-Gly-Lys-Lys-Gly-Gly-Leu-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
Cys-Gly-Lys-Lys-Gly-Amyloid ß -Protein (35-40) | SH6307 | C43H79N13O12S2 | 1034.31 | Cys-Gly-Lys-Lys-Gly-Met-Val-Gly-Gly-Val-Val | ? | ? | ? |
Cys-Gly-Lys-Lys-Gly-Amyloid ß -Protein (36-42) | SH6308 | C47H85N14O13S | 1087.35 | Cys-Gly-Lys-Lys-Gly-Val-Gly-Gly-Val-Val-I le-Ala | ? | ? | ? |
Cys-Gly-Lys-Lys-Gly-Amyloid ß -Protein (37-42) | SH6309 | C42H77N13O12S | 988.22 | Cys-Gly-Lys-Lys-Gly-Gly-Gly-Val-Val-Ile-Ala | ? | ? | ? |
Cys-GM-CSF (17-31) | SH6310 | C76H133N28O25S | 1871.14 | Cys-Asn-Ala-Ile-Gln-Glu-Ala-Arg-Arg-Leu-Leu-Asn-Leu-Ser-Arg-Asp | ? | ? | ? |
D-Ala-D-Ala | SH6311 | C6H12N2O3 | 160.17 | D-Ala-D-Ala | ? | ? | ? |
D-Ala-Leu | SH6312 | C9H18N2O3 | 202.26 | D-Ala-Leu | ? | ? | ? |
D-D-D-D-D | SH6313 | C20H27N5O16 | 593.46 | Asp-Asp-Asp-Asp-Asp | ? | ? | ? |
D-D-D-D-D-D | SH6314 | C24H32N6O19 | 708.55 | Asp-Asp-Asp-Asp-Asp-Asp | ? | ? | ? |
D-P | SH6315 | C9H14N2O5 | 230.22 | ASP-PRO | ? | ? | ? |
DAGO | SH6316 | C26H35N5O6 | 513.00 | Tyr-D-Ala-Gly-N-Me-Phe-Gly-OL | ? | ? | ? |
Dansyl-Y-V-G | SH6317 | C28H34N4O7S1 | 571.63 | Dansyl-Tyr-Val-Gly | ? | ? | ? |
DAP10 Signaling Fragment | SH6318 | C74H118N22O24S | 1731.96 | Pro-Ala-Gln-Glu-Asp-Gly-Lys-Val-Tyr-Ile-Asn-Met-Pro-Gly-Arg-Gly | ? | ? | ? |
Decorsin, Leech | SH6319 | C179H277N55O62S6 | 4383.87 | Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu | ? | ? | ? |
Defensin-1 (human) HNP-1 | SH6320 | C150H222N44O38S6 | 3442.10 | Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Disulfide bridges Cys2-Cys30, Cys4-Cys19, and Cys 9-29) | ? | ? | ? |
Defensin (human) HNP-2 | SH6321 | C147H217N43O37S6 | 3371.02 | Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Disulfide bridge: 1-29, 3-18, 8-28) | ? | ? | ? |
Delicious Peptide | SH6322 | C34H57N9O16 | 847.88 | Lys-Gly-Asp-Glu-Glu-Ser-Leu-Ala | ? | ? | ? |
Delta (Phospho) Sleep Inducing Peptide | SH6323 | C35H49N10O18P | 928.83 | Trp-Ala-Gly-Gly-Asp-Ala-Ser(PO3H2)-Gly-Glu | ? | ? | ? |
Delta-MSH | SH6324 | C37H57N11O11S | 863.99 | Ser-Met-Glu-Val-Arg-Gly-Trp | ? | ? | ? |
Delta Sleep Inducing Peptide | SH6325 | C35H48N10O15 | 848.83 | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu | ? | ? | ? |
Dendroaspis Natriuretic Peptide | SH6326 | C180H282N56O56S2 | 4190.72 | Glu-Val-Lys-Tyr-Asp-Pro-Cys-Phe-Gly-His-Lys-Ile-Asp-Arg-Ile-Asn-His-Val-Ser-Asn-Leu-Gly-Cys-Pro-Ser-Leu-Arg-Asp-Pro-Arg-Pro-Asn-Ala-Pro-Ser-Thr-Ser-Ala(Disulfide bridge Cys7-Cys23) | ? | ? | ? |
Dermenkephalin | SH6327 | C44H62N10O10S2 | 955.17 | Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2 | ? | ? | ? |
Dermorphin | SH6328 | C40H50N8O10 | 802.88 | Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 | ? | ? | ? |
Dermorphin Analog | SH6329 | C44H59NllO10 | 902.03 | Tyr-D-Arg-Phe-Sar-Tyr-Pro-Ser-NH2 | ? | ? | ? |
Desmopressin | SH6330 | C46H64N14O12S2 | 1069.10 | Map-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2 (Disulfide bridge, Map1-Cys6) | ? | ? | ? |
Diazepam-Binding Inhibitor Fragment, human | SH6331 | C91H148N26O32S | 2150.41 | Gln-Ala-Thr-Val-Gly-Asp-Ile-Asn-Thr-Glu-Arg-Pro-Gly-Met-Leu-Asp-Phe-Thr-Gly-Lys | ? | ? | ? |
Doc- 6 (130 - 145) | SH6332 | C86H134N26O26S | 1980.25 | Gly-Val-Gln-Arg-Glu-Gln-Asn-Glu-Arg-Phe-Asn-Val-Tyr-Leu-Met-Pro | ? | ? | ? |
Dok-4 (130 - 145) | SH6333 | C83H128N22O25S | 1866.10 | Gly-Val-Gln-Cys-Glu-Gln-Thr-Asp-Arg-Phe-Asn-Val-Phe-Leu-Leu-Pro | ? | ? | ? |
Dok-4 (263 - 275) | SH6334 | C70H101N21O18 | 1524.72 | Leu-Pro-Arg-Ser-Ala-Tyr-Trp-His-His-Ile-Thr-Gly-Ser | ? | ? | ? |
Dok- 5 (263 - 275) | SH6335 | C75H114N24O19 | 1655.89 | Leu-Pro-Arg-Ser-Ala-Tyr-Trp-Gln-His-Ile-Thr-Arg-Gln | ? | ? | ? |
Dok-6 (263 - 275) | SH6336 | C76H113N25O18 | 1664.90 | Leu-Pro-Arg-Ser-Ala-Tyr-Trp-His-His-Ile-Thr-Arg-Gln | ? | ? | ? |
DTrp-Gamma MSH | SH6337 | C74H99N21O16S | 1570.81 | Tyr-Val-Met-Gly-His-Phe-Arg-D-Trp-Asp-Arg-Phe-Gly | ? | ? | ? |
dY-V-G | SH6338 | C16H23N3O5 | 337.38 | D-Tyr-Val-Gly | ? | ? | ? |
DYKDDDDK | SH6339 | C41H60N10O20 | 1012.99 | Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys | ? | ? | ? |
Dynorphin A (1-8), porcine | SH6340 | C46H72N14O10 | 981.17 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile | ? | ? | ? |
Dynorphin A (1-9), porcine | SH6341 | C52H84N18O11 | 1137.36 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg | ? | ? | ? |
Dynorphin A (1-6), porcine | SH6342 | C34H49N9O8 | 711.83 | Tyr-Gly-Gly-Phe-Leu-Arg | ? | ? | ? |
Dynorphin A (1-7), porcine | SH6343 | C40H61N13O9 | 868.01 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg | ? | ? | ? |
Dynorphin A (1-10), amide, porcine | SH6344 | C57H92N20O11 | 1233.50 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-NH2 | ? | ? | ? |
Dynorphin A (1-10), porcine | SH6345 | C57H91N19O12 | 1234.48 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro | ? | ? | ? |
Dynorphin A (1-11), porcine | SH6346 | C63H103N21O13 | 1362.66 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys | ? | ? | ? |
Dynorphin A (1-12), porcine | SH6347 | C69H114N22O14 | 1475.82 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu | ? | ? | ? |
Dynorphin A (1-13), amide, porcine | SH6348 | C75H127N25O14 | 1603.01 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-NH2 | ? | ? | ? |
Dynorphin A (1-13), porcine | SH6349 | C75H126N24O15 | 1603.99 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | ? | ? | ? |
Dynorphin A (1-17), (Prodynorphin 209-225), Porcine | SH6350 | C99H155N31O23 | 2147.53 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | ? | ? | ? |
Dynorphin A (13-17), porcine | SH6351 | C30H43N9O10 | 689.73 | Lys-Trp-Asp-Asn-Gln | ? | ? | ? |
Dynorphin A (2-12), porcine | SH6352 | C60H105N21O12 | 1312.64 | Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu | ? | ? | ? |
Dynorphin A (2 - 13), porcine | SH6353 | C66H117N23O13 | 1440.81 | Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | ? | ? | ? |
Dynorphin (2-17), amide, porcine | SH6354 | C90H147N31O20 | 1983.37 | Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2 | ? | ? | ? |
Dynorphin A (2-17), porcine | SH6355 | C90H146N30O21 | 1984.36 | Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | ? | ? | ? |
Dynorphin A (3-8), porcine | SH6356 | C35H60N12O7 | 760.94 | Gly-Phe-Leu-Arg-Arg-Ile | ? | ? | ? |
Dynorphin A (3-13), porcine | SH6357 | C64H114N22O12 | 1383.76 | Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | ? | ? | ? |
Dynorphin A (6-17), porcine | SH6358 | C71H120N26O17 | 1609.91 | Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | ? | ? | ? |
Dynorphin A (7-17), porcine | SH6359 | C65H108N22O16 | 1453.72 | Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | ? | ? | ? |
Dynorphin A (8-17), porcine | SH6360 | C59H96N18O15 | 1297.53 | Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | ? | ? | ? |
Dynorphin A (9-17), porcine | SH6361 | C53H85N17O14 | 1184.37 | Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | ? | ? | ? |
Dynorphin A amide, porcine | SH6362 | C99H156N32O22 | 2146.55 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2 | ? | ? | ? |
Dynorphin B (1-9) | SH6363 | C54H78N16O12 | 1143.32 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe | ? | ? | ? |
E-I-L-D-V, human, bovine, rat | SH6364 | C26H45N5O10 | 587.68 | Glu-Ile-Leu-Asp-Val | ? | ? | ? |
E-I-L-E-V-P-S-T | SH6365 | C39H66N8O15 | 887.01 | Glu-Ile-Leu-Glu-Val-Pro-Ser-Thr | ? | ? | ? |
E75, Her - 2/neu (369 - 377) | SH6366 | C50H78N10O11 | 995.24 | Lys-Ile-Phe-Gly-Ser-Leu-Ala-Phe-Leu | ? | ? | ? |
Ecdysis-Triggering Hormone (Manduca sexta) ; Mas-ETH | SH6367 | C127H206N36O38S3 | 2941.45 | Ser-Asn-Glu-Ala-Ile-Ser-Pro-Phe-Asp-Gln-Gly-Met-Met-Gly-Tyr-Val-Ile-Lys-Thr-Asn-Lys-Asn-Ile-Pro-Arg-Met-NH2 | ? | ? | ? |
EGF Receptor (988-993) (phosphorylated) (human) | SH6368 | C31H46N7O16P | 804.70 | Asp-Ala-Asp-Glu-pTyr-Leu-NH2 | ? | ? | ? |
EGF Receptor Substrate 1 | SH6369 | C72H100N15O26P | 1622.68 | Asp-Ala-Asp-Glu-pTyr-Leu-Ile-Pro-Gln-Gln-Gly-Phe-Phe | ? | ? | ? |
EGF Receptor Substrate 2 | SH6370 | C54H82N13O24P | 1328.32 | Asp-Ala-Asp-Glu-pTyr-Leu-Ile-Pro-Gln-Gln-Gly | ? | ? | ? |
EGFR-derived peptide | SH6371 | C69H114N18O24 | 1579.78 | Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Lys | ? | ? | ? |
Egg Laying Hormone of Aplysia | SH6372 | C190H329N59O57S1 | 4384.17 | Ile-Ser-Ile-Asn-Gln-Asp-Leu-Lys-Ala-Ile-Thr-Asp-Met-Leu-Leu-Thr-Glu-Gln-Ile-Arg-Glu-Arg-Gln-Arg-Tyr-Leu-Ala-Asp-Leu-Arg-Gln-Arg-Leu-Leu-Glu-Lys-NH2 | ? | ? | ? |
Eglin c (41-49) | SH6373 | C48H78N12O15 | 1063.23 | Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr | ? | ? | ? |
Eglin c (60-63)-methyl ester | SH6374 | C19H35N5O7 | 445.49 | Thr-Asn-Val-Val-Ome | ? | ? | ? |
Elcatonin Acetate | SH6375 | C148H244N42O47 | M.W.3363.8 | Ser-Asn-Leu-Ser-Thr-Asu-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro (Ser----Asu) | ? | ? | ? |
Eledoisin | SH6376 | C54H85N13O15S1 | 1188.44 | Pyr-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2 | ? | ? | ? |
Eledoisin Related Peptide | SH6377 | C34H58N8O6S1 | 706.96 | Lys-Phe-Ile-Gly-Leu-Met-NH2 | ? | ? | ? |
EMP-1 (Epithelial Membrane Protein) | SH6378 | C94H133N25O26S2 | 2093.39 | Gly-Gly-Thr-Tyr-Ser-Cys-His-Phe-Gly-Pro-Leu-Thr-Trp-Val-Cys-Lys-Pro-Gln-Gly-Gly | ? | ? | ? |
Endokinin A/B | SH6379 | C50H77N13O12S | 1084.32 | Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
Endokinin C (Human) | SH6380 | C78H123N21O20 | 1674.98 | Lys-Lys-Ala-Tyr-Gln-Leu-Glu-His-Thr-Phe-Gln-Gly-Leu-Leu-NH2 | ? | ? | ? |
Endokinin D (Human) | SH6381 | C73H111N19O20 | 1574.81 | Val-Gly-Ala-Tyr-Gln-Leu-Glu-His-Thr-Phe-Gln-Gly-Leu-Leu-NH2 | ? | ? | ? |
Endomorphin-1 | SH6382 | C34H38N6O5 | 610.72 | Tyr-Pro-Trp-Phe-NH2 | ? | ? | ? |
Endomorphin-2 | SH6383 | C32H37N5O5 | 571.68 | Tyr-Pro-Phe-Phe-NH2 | ? | ? | ? |
Endonuclease Antigenic Site | SH6384 | C108H167N27O29 | 2307.67 | Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-Leu-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro-Val-Lys | ? | ? | ? |
Endothelin (16-21) | SH6385 | C39H57N9O9 | 795.94 | His-Leu-Asp-Ile-Ile-Trp | ? | ? | ? |
Endothelin 2 (human, canine) | SH6386 | C115H160N26O32S4 | 2546.97 | Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge Cys1-Cys15, Cys3-Cys11) | ? | ? | ? |
Endothelin 3, human, rat | SH6387 | C121H168N26O33S4 | 2643.10 | Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge Cys1-Cys15, Cys3-Cys11) | ? | ? | ? |
Endothelin-1 (11-21) | SH6388 | C68H92N14O15S2 | 1409.70 | Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge Cys1-Cys5) | ? | ? | ? |
Endothelin-1 (1-15), amide, human | SH6389 | C70H109N17O23S5 | 1717.04 | Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-NH2 | ? | ? | ? |
Endothelin-1 (1-15), human | SH6390 | C70H108N16O24S5 | 1718.02 | Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys | ? | ? | ? |
Endothelin-1, human | SH6391 | C109H159N25O32S5 | 2491.95 | Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr- Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge Cys1-Cys15, Cys3-Cys11) | ? | ? | ? |
Endotoxin Inhibitor | SH6392 | C55H97N15O12S2 | 1224.60 | Lys-Thr-Lys-Cys-Lys-Phe-Leu-Lys-Lys-Cys(Disulfide bridge Cys4-Cys10 ) | ? | ? | ? |
Enfuvirtide(T-20) | SH6393 | C204H301N51O64 | 4462.00 | CH3CO-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2 | ? | ? | ? |
ent-Amyloid b-Protein (1-42) | SH6394 | C203H311N55O60S | 4514.14 | D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-D-Ile-D-Ala | ? | ? | ? |
Entero-Hylambatin | SH6395 | C63H91N17O18S2 | 1438.66 | Asp-Pro-Pro-Asn-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 | ? | ? | ? |
Enterostatin, human | SH6396 | C27H36N6O6S1 | 572.69 | Ala-Pro-Gly-Pro-Arg | ? | ? | ? |
Enterostatin (pig, rat) | SH6397 | C25H42N8O8 | 582.66 | Val-Pro-Asp-Pro-Arg | ? | ? | ? |
Eosinophilotactic Peptide | SH6398 | C15H26N4O8 | 390.40 | Val-Gly-Ser-Glu | ? | ? | ? |
Eosinophilotactic Tetrapeptides | SH6399 | C13H22N4O8 | 362.34 | Ala-Gly-Ser-Glu | ? | ? | ? |
Ep-CAM (263 - 271) | SH6400 | C38H70N10O10 | 827.04 | Gly-Leu-Lys-Ala-Gly-Val-Ile-Ala-Val | ? | ? | ? |
Epidermal Growth Factor Receptor Peptide (985-996) | SH6401 | C61H93N13O23 | 1376.49 | Asp-Val-Val-Asp-Ala-Asp-Glu-Tyr-Leu-Ile-Pro-Gln | ? | ? | ? |
Epidermal Mitosis Inhibiting Pentapeptide | SH6402 | C19H27N5O12 | 517.45 | Pyr-Glu-Asp-Ser-Gly | ? | ? | ? |
Eptifibatide | SH6403 | C35H49N11O9S2 | 832.40 | Map-Har-Gly-Asp-Trp-Pro-Cys-NH2(Disulfide bridge, Map1-Cys6) | ? | ? | ? |
ERKtide | SH6404 | C58H93N19O16 | 1312.51 | Ala-Thr-Gly-Pro-Leu-Ser-Pro-Gly-Pro-Phe-Gly-Arg-Arg | ? | ? | ? |
Erythromycin resistance peptide | SH6405 | C31H52N8O6S | 664.86 | Met-Arg-Leu-Phe-Val | ? | ? | ? |
Exendin 3 | SH6406 | C184H282N50O61S1 | 4202.66 | His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | ? | ? | ? |
Exendin 4 | SH6407 | C184H282N50O60S1 | 4186.03 | His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | ? | ? | ? |
Exendin 4 (1-8) | SH6408 | C35H51N11O13 | 833.86 | His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-NH2 | ? | ? | ? |
Exendin 4 (3-39) | SH6409 | C176H272N46O58S | 3992.47 | Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | ? | ? | ? |
Exendin 4 (3-39) | SH6410 | C176H271N46O58S1 | 3991.50 | Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | ? | ? | ? |
Exendin (9-39) | SH6411 | C149H234N40O47S1 | 3369.83 | Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | ? | ? | ? |
Experimental Allergic Encephalitogenic Peptide (human) | SH6412 | C46H64N14O14 | 1037.11 | Phe-Ser-Trp-Gly-Ala-Glu-Gly-Gln-Arg | ? | ? | ? |
Experimental Autoimmune Encephalomyelitis Complementary Peptide | SH6413 | C59H100N14O12 | 1197.54 | Val-Phe-Ile-Leu-Gly-Pro-Leu-Arg-Leu-Leu-Gly | ? | ? | ? |
Ealfa (52–68) | SH6414 | C73H118N20O25 | 1675.87 | Ala-Ser-Phe-Glu-Ala-Gln-Gly-Ala-Leu-Ala-Asn-Ile-Ala-Val-Asp-Lys-Ala | ? | ? | ? |
F-L-E-E-V | SH6415 | C30H45N5O10 | 635.72 | Phe-Leu-Glu-Glu-Val | ? | ? | ? |
F-M-R-F | SH6416 | C29H41N7O5S | 599.76 | Phe-Met-Arg-Phe | ? | ? | ? |
F1 Peptide, lobster | SH6417 | C48H75N17O11 | 1066.24 | Thr-Asn-Arg-Asn-Phe-Leu-Arg-Phe-NH2 | ? | ? | ? |
Fas C-Terminal Tripeptide | SH6418 | C16H29N3O6 | 359.43 | Ac-Ser-Leu-Val | ? | ? | ? |
FDC - SP (30 - 85), human | SH6419 | C314H447N71O78 | 6464.49 | Ser-Ile-Ser-Asp-Ser-Asp-Glu-Leu-Ala-Ser-Gly-Phe-Phe-Val-Phe-Pro-Tyr-Pro-Tyr-Pro-Phe-Arg-Pro-Leu-Pro-Pro-Ile-Pro-Phe-Pro-Arg-Phe-Pro-Trp-Phe-Arg-Arg-Asn-Phe-Pro-Ile-Pro-Ile-Pro-Glu-Ser-Ala-Pro-Thr-Thr-Pro-Leu-Pro-Ser-Glu-Lys | ? | ? | ? |
FDC - SP (61 - 85), human | SH6420 | C140H206N34O35 | 2925.41 | Phe-Pro-Trp-Phe-Arg-Arg-Asn-Phe-Pro-Ile-Pro-Ile-Pro-Glu-Ser-Ala-Pro-Thr-Thr-Pro-Leu-Pro-Ser-Glu-Lys | ? | ? | ? |
FGF basic (119-126) (human, bovine, ovine, rabbit) | SH6421 | C44H76N14O12 | 993.18 | Arg-Thr-Gly-Gln-Tyr-Lys-Leu | ? | ? | ? |
Fibrinogen Binding Inhibitory Peptide | SH6422 | C50H80N18O16 | 1189.29 | His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val | ? | ? | ? |
Fibrinogen-binding Peptide | SH6423 | C25H39N7O8 | 565.63 | Glu-His-Ile-Pro-Ala | ? | ? | ? |
Fibrinogen Related Peptide | SH6424 | C62H99N23O21 | 1502.62 | Gly-Gln-Gln-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val | ? | ? | ? |
Fibrinogen beta-Chain (24-42) | SH6425 | C86H135N25O27 | 1951.19 | Glu-Glu-Ala-Pro-Ser-Leu-Arg-Pro-Ala-Pro-Pro-Pro-Ile-Ser-Gly-Gly-Gly-Tyr-Arg | ? | ? | ? |
Fibrinogen ? - Chain (117 - 133) | SH6426 | C84H147N25O27 | 1939.26 | Asn-Asn-Gln-Lys-Ile-Val-Asn-Leu-Lys-Glu-Lys-Val-Ala-Gln-Leu-Glu-Ala | ? | ? | ? |
Fibrinolysis Inhibitng Factor | SH6427 | C18H31N7O5 | 425.49 | Gly-Pro-Arg-Pro | ? | ? | ? |
Fibrinopeptide A, human | SH6428 | C63H97N19O26 | 1536.59 | Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg | ? | ? | ? |
Fibrinopeptide B | SH6429 | C66H93N19O25 | 1552.60 | Pyr-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg | ? | ? | ? |
Fibrinopeptide B, Bovine | SH6430 | C101H154N30O36 | 2364.53 | Gln-Phe-Pro-Thr-Asp-Tyr-Asp-Glu-Gly-Gln-Asp-Asp-Arg-Pro-Lys-Val-Gly-Leu-Gly-Ala-Arg | ? | ? | ? |
Fibrinopeptide B, human | SH6431 | C66H93N19O25 | 1552.60 | Glp-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg | ? | ? | ? |
Fibrinopeptide B, human | SH6432 | C66H93N19O25 | 1552.59 | Pyr-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg | ? | ? | ? |
Fibronectin Adhesion-Promoting Peptide | SH6433 | C47H74N16O10 | 1023.22 | Trp-Gln-Pro-Pro-Arg-Ala-Arg-Ile | ? | ? | ? |
Fibronectin Analog | SH6434 | C29H51N11O11 | 729.80 | Gly-Arg-Ala-Asp-Ser-Pro-Lys | ? | ? | ? |
Fibronectin-Binding Protein | SH6435 | C190H283N49O66 | 4309.66 | Phe-Asn-Lys-His-Thr-Glu-Ile-Ile-Glu-Glu-Asp-Thr-Asn-Lys-Asp-Lys-Pro-Ser-Tyr-Gln-Phe-Gly-Gly-His-Asn-Ser-Val-Asp-Phe-Glu-Glu-Asp-Thr-Leu-Pro-Lys-Val | ? | ? | ? |
Fibronectin CS-1 Peptide | SH6436 | C38H64N8O15 | 872.97 | Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr | ? | ? | ? |
Fibronectin Type III Connecting Segment (1-25) | SH6437 | C123H195N31O39 | 2732.11 | Asp-Glu-Leu-Pro-Gln-Leu-Val-Thr-Leu-Pro-His-Pro-Asn-Leu-His-Gly-Pro-Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr | ? | ? | ? |
FITC-LC-Myelin Basic Protein Peptide Substrate | SH6438 | C66H92N20O17S | 1325.40 | FITC-LC-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg | ? | ? | ? |
FluM1 A2 (58-66) | SH6439 | C49H75N9O11 | 966.20 | Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu | ? | ? | ? |
Fmoc-Lys(Boc)-Leu-Lys(Boc) | SH6440 | C26H35N8O7S | 809.90 | Fmoc-Lys(boc)-Leu-Lys(Boc) | ? | ? | ? |
Fmoc-Mating Factor a | SH6441 | C97H125N20O19S | 1907.26 | Fmoc-Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-Met-Tyr | ? | ? | ? |
FMRF amide Molluscan Cardioexcitatory Peptide | SH6442 | C29H42N8O4S | 598.76 | Phe-Met-Arg-Phe-NH2 | ? | ? | ? |
FMRF-like Neuropeptide; SchistoFLRFamide | SH6443 | C59H86N16O14 | 1243.44 | Pro-Asp-Val-Asp-His-Val-Phe-Leu-Arg-Phe-NH2 | ? | ? | ? |
FMRF - related peptide, Lymnaea heptapeptide | SH6444 | C41H59N11O9 | 850.00 | Gly-Asp-Pro-Phe-Leu-Arg-Phe-NH2 | ? | ? | ? |
FMRF - related peptide, Pyr -DPFLRFM - NH2 | SH6445 | C44H62N11O10 | 904.03 | Pyr-Asp-Pro-Phe-Leu-Arg-Phe-NH2 | ? | ? | ? |
FMRF - related peptide, SDPFLRF - NH2 | SH6446 | C42H61N11O10 | 880.02 | Ser-Asp-Pro-Phe-Leu-Arg-Phe-NH2 | ? | ? | ? |
Forkhead derived peptide, Woodtide | SH6447 | C68H123N21O20S | 1586.93 | Lys-Lys-Ile-Ser-Gly-Arg-Leu-Ser-Pro-Ile-Met-Thr-Glu-Gln-NH2 | ? | ? | ? |
Formyl-LHRH (2-10) | SH6448 | C51H70N16O12 | 1099.22 | For-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 | ? | ? | ? |
G-a-Y | SH6449 | C14H19N3O5 | 309.18 | Gly-Ala-Tyr | ? | ? | ? |
G-F-R | SH6450 | C17H26N6O4 | 378.40 | Gly-Phe-Arg | ? | ? | ? |
G-P-R | SH6451 | C13H24N6O4 | 328.18 | Gly-Pro-Arg | ? | ? | ? |
G-Q | SH6452 | C7H13N3O4 | 203.20 | Gly-Gln | ? | ? | ? |
G-R-G-D-S-P | SH6453 | C22H37N9O10 | 587.59 | Gly-Arg-Gly-Asp-Ser-Pro | ? | ? | ? |
G-R-G-D-T-P | SH6454 | C23H39N9O10 | 601.60 | Gly-Arg-Gly-Asp-Thr-Pro | ? | ? | ? |
G-R-G-E-S-P (Inactive control) | SH6455 | C23H39N9O10 | 601.60 | Gly-Arg-Gly-Glu-Ser-Pro | ? | ? | ? |
G-R-G-E-T-P | SH6456 | C24H41N9O10 | 615.70 | Gly-Arg-Gly-Glu-Thr-Pro | ? | ? | ? |
G154; gp100 (154-162) | SH6457 | C58H78N14O14 | 1195.35 | Lys-Thr-Trp-Gly-Gln-Tyr-Trp-Gln-Val | ? | ? | ? |
G209-2M; gp100 (209-217) | SH6458 | C47H74N10O14S | 1035.24 | Ile-Met-Asp-Gln-Val-Pro-Phe-Ser-Val | ? | ? | ? |
G250.A2 | SH6459 | C45H72N14O12 | 1001.16 | His-Leu-Ser-Thr-Ala-Phe-Ala-Arg-Val | ? | ? | ? |
GAD65 (206 - 220) | SH6460 | C86H129N15O24 | 1757.07 | Thr-Tyr-Glu-Ile-Ala-Pro-Val-Phe-Val-Leu-Leu-Glu-Tyr-Val-Thr | ? | ? | ? |
GAD65 (78–97) | SH6461 | C97H148N26O29S2 | 2206.53 | Lys-Pro-Cys-Asn-Cys-Pro-Lys-Gly-Asp-Val-Asn-Tyr-Ala-Phe-Leu-His-Ala-Thr-Asp-Leu | ? | ? | ? |
Galanin, human | SH6462 | C139H210N42O43 | 3157.44 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser | ? | ? | ? |
Galanin, porcine | SH6463 | C146H213N43O40 | 3210.55 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala-NH2 | ? | ? | ? |
Galanin, rat | SH6464 | C141H211N43O41 | 3164.48 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr-NH2 | ? | ? | ? |
Galanin-Lys(Biotin), human | SH6465 | C155H237N46O46S1 | 3512.00 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser-Lys(Biotin) | ? | ? | ? |
Galanin (1-13)-Neuropeptide Y (25-36), amide (M32) | SH6466 | C136H209N41O34 | 2962.40 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
Galanin (1-13)-Spantide I | SH6467 | C138H199N35O30 | 2828.34 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | ? | ? | ? |
Galanin (1-16), porcine, rat | SH6468 | C78H116N20O21 | 1669.92 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile | ? | ? | ? |
Galanin (2-11) | SH6469 | C54H81N13O14 | 1136.33 | Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-NH2 | ? | ? | ? |
Galanin Message Associated Peptide (1-41), amide; GMAP (1-41), amide; Preprogalanin (65-105), amide | SH6470 | C206H326N56O64S | 4643.30 | Glu-Leu-Glu-Pro-Glu-Asp-Glu-Ala-Arg-Pro-Gly-Gly-Phe-Asp-Arg-Leu-Gln-Ser-Glu-Asp-Lys-Ala-Ile-Arg-Thr-Ile-Met-Glu-Phe-Leu-Ala-Phe-Leu-His-Leu-Lys-Glu-Ala-Gly-Ala-Leu-NH2 | ? | ? | ? |
Galanin Message Associated Peptide (44-59) amide | SH6471 | C61H100N18O25 | 1485.58 | Leu-Pro-Gly-Leu-Pro-Ser-Ala-Ala-Ser-Ser-Glu-Asp-Ala-Gly-Gln-Ser-NH2 | ? | ? | ? |
Galantide | SH6472 | C104H151N25O26S1 | 2199.58 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
Gastric Inhibitory Peptide (GIP), human | SH6473 | C226H338N60O66S1 | 4983.64 | Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | ? | ? | ? |
Gastric Inhibitory Polypeptide (1-30) (porcine) | SH6474 | C162H244N40O48S | 3552.10 | Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys | ? | ? | ? |
Gastric Inhibitory Polypeptide (6-30) amide (human) | SH6475 | C139H209N35O38S | 3010.49 | Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-NH2 | ? | ? | ? |
Gastric Juice Peptide Fragmentc | SH6476 | C62H98N16O22 | 1419.56 | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | ? | ? | ? |
Gastrin I (1-14) (human) | SH6477 | C79H100N16O27 | 1705.76 | Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp | ? | ? | ? |
Gastrin I (rat) | SH6478 | C94H128N22O31S2 | 2126.30 | Pyr-Arg-Pro-Pro-Met-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Gastrin, chicken | SH6479 | C190H265N47O51S1 | 4055.58 | Phe-Leu-Pro-His-Val-Phe-Ala-Glu-Leu-Ser-Asp-Arg-Lys-Gly-Phe-Val-Gln-Gly-Asn-Gly-Ala-Val-Glu-Ala-Leu-His-Asp-Phe-Tyr-Pro-Asp-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Gastrin-1, human | SH6480 | C97H125N20O31S | 2098.22 | Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Gastrin-1, rat | SH6481 | C94H128N22O31S2 | 2126.32 | Pyr-Arg-Pro-Pro-Met-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Gastrin Releasing Peptide, human | SH6482 | C130H204N38O31S2 | 2859.40 | Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
Gastrin Releasing Peptide, procine | SH6483 | C126H198N38O31S2 | 2805.40 | Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
Gastrin Releasing Peptide-Lys(Biotin), human | SH6484 | C130H204N38O31S2 | 2859.30 | Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-Lys(Biotin) | ? | ? | ? |
Gastrin Releasing Peptide (1-16), human | SH6485 | C74H121N17O20S1 | 1600.90 | Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro | ? | ? | ? |
Gastrin Tetrapeptide | SH6486 | C29H36N6O6S | 596.71 | Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Ghrelin (human) | SH6487 | C149H249N47O42 | 3370.90 | Gly-Ser-Ser(n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg | ? | ? | ? |
Ghrelin (Rat) | SH6488 | C147H245N45O42 | 3314.80 | Gly-Ser-Ser(n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro- Arg | ? | ? | ? |
GHRF, mouse | SH6489 | C220H365N69O64S1 | 5032.85 | His-Val-Asp-Ala-Ile-Phe-Thr-Thr-Asn-Tyr-Arg-Lys-Leu-Leu-Ser-Gln-Leu-Tyr-Ala-Arg-Lys-Val-Ile-Gln-Asp-Ile-Met-Asn-Lys-Gln-Gly-Glu-Arg-Ile-Gln-Glu-Gln-Arg-Ala-Arg-Leu-Ser | ? | ? | ? |
GHRF, ovine | SH6490 | C221H368N72O66S1 | 5121.90 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Ile-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Asn-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Gly-Ala-Lys-Val-Arg-Leu-NH2 | ? | ? | ? |
GHRF, rat | SH6491 | C225H361N77O66S1 | 5232.93 | His-Ala-Asp-Ala-Ile-Phe-Thr-Ser-Ser-Tyr-Arg-Arg-Ile-Leu-Gly-Gln-Leu-Tyr-Ala-Arg-Lys-Leu-Leu-His-Glu-Ile-Met-Asn-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Arg-Ser-Arg-Phe-Asn | ? | ? | ? |
GHRF (1-44), human | SH6492 | C215H358N72O66S1 | 5039.70 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 | ? | ? | ? |
GHRP-2 | SH6493 | C45H54O6N9 | 818.00 | D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 | ? | ? | ? |
GIP, mouse, rat | SH6494 | C226H343N61O66S | 5002.69 | Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | ? | ? | ? |
GIP, porcine | SH6495 | C225H342N60O66S | 4975.66 | Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Ser-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | ? | ? | ? |
GIP (1 - 30), porcine, amide | SH6496 | C162H245N41O47S | 3551.07 | Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-NH2 | ? | ? | ? |
GIP (3 - 42), human | SH6497 | C214H324N58O63S | 4749.38 | Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | ? | ? | ? |
Gliadin (43-49)(Gliadorphin) Alpha | SH6498 | C43H57N9O11 | 875.99 | Tyr-Pro-Gln-Pro-Gln-Pro-Phe | ? | ? | ? |
GLP-1 (1-37) (human, bovine, guinea pig, mouse, rat) | SH6499 | C186H275N51O59 | 4169.57 | His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly | ? | ? | ? |
GLP-1 (7-36) amide (chicken, common turkey) | SH6500 | C149H224N40O47 | 3327.69 | His-Ala-Glu-Gly-Thr-Tyr-Thr-Ser-Asp-Ile-Thr-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Asn-Gly-Arg-NH2 | ? | ? | ? |
GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat) | SH6501 | C165H252N44O48S | 3652.18 | His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Lys(bio) -NH2 | ? | ? | ? |
GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat) | SH6502 | C140H214N36O43 | 3089.48 | Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | ? | ? | ? |
GLP-2 (1-34) (human) | SH6503 | C171H266N48O56S1 | 3922.38 | His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-Arg | ? | ? | ? |
GLP-2 (1-33) (human) | SH6504 | C165H254N44O55S1 | 3766.20 | His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp | ? | ? | ? |
GLP-2 (rat) | SH6505 | C166H256N44O56S1 | 3796.22 | His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Thr-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp | ? | ? | ? |
Glucagon (1 - 29), bovine, human, porcine | SH6506 | C153H225N43O49S | 3482.78 | His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | ? | ? | ? |
Glucagon (1 - 37), porcine;Oxyntomodulin, porcine | SH6507 | C192H295N59O60S | 4421.92 | His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-Lys-Arg-Asn-Lys-Asn-Asn-Ile-Ala | ? | ? | ? |
Glucagon (19 - 29), bovine, human, porcine | SH6508 | C61H89N15O18S1 | 1352.54 | Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | ? | ? | ? |
Glucagon - Like Peptide 1, (GLP - 1) amide, human | SH6509 | C184H273N51O57 | 4111.53 | His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | ? | ? | ? |
Glucagon - Like Peptide 1 (7 -17) - Cys, GLP - 1 (7 - 17) – Cys | SH6510 | C192H295N59O60S | 4421.92 | His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Cys | ? | ? | ? |
Glucagon-Like Peptide I (7-36), amide, human | SH6511 | C149H229N40O45 | 3297.70 | His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | ? | ? | ? |
Glucagon - Like Peptide 1 (7 -37) | SH6512 | C151H226N40O46 | 3337.73 | His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly | ? | ? | ? |
Gluten Exorphin A5 | SH6513 | C29H37N5O9 | 599.65 | Gly-Tyr-Tyr-Pro-Thr | ? | ? | ? |
Gluten Exorphin B5 | SH6514 | C30H38N6O7 | 594.67 | Tyr-Gly-Gly-Trp-Leu | ? | ? | ? |
Gluten Exorphin C | SH6515 | C29H45N5O8 | 591.71 | Tyr-Pro-Ile-Ser-Leu | ? | ? | ? |
Glycogen Synthase – derived peptide | SH6516 | C49H92N16O14 | 1129.38 | Lys-Lys-Leu-Asn-Arg-Thr-Leu-Ser-Val-Ala | ? | ? | ? |
Glycoprotein Hormone a (32-46) amide | SH6517 | C78H128N24O20S | 1754.09 | Cys-Phe-Ser-Arg-Ala-Tyr-Pro-Thr-Pro-Leu-Arg-Ser-Lys-Lys-Thr-NH2 | ? | ? | ? |
Glycoprotein IIb Fragment (300-312) | SH6518 | C57H94N18O18 | 1319.49 | Gly-Asp-Gly-Arg-His-Asp-Leu-Leu-Val-Gly-Ala-Pro-Leu | ? | ? | ? |
Glycoprotein IIb Fragment (656-667) | SH6519 | C57H90N18O18S | 1347.53 | Gly-Ala-His-Tyr-Met-Arg-Ala-Leu-Ser-Asn-Val-Glu | ? | ? | ? |
GM-CSF (17-31) | SH6520 | C73H129N27O24 | 1769.01 | Asn-Ala-Ile-Gln-Glu-Ala-Arg-Arg-Leu-Leu-Asn-Leu-Ser-Arg-Asp | ? | ? | ? |
GM-CSF (96-112) | SH6521 | C88H139N21O29S | 1986.27 | Cys-Ala-Thr-Gln-Ile-Ile-Thr-Phe-Glu-Ser-Phe-Lys-Glu-Asn-Leu-Lys-Asp | ? | ? | ? |
GMAP (16-41), amide | SH6522 | C134H219N35O37S | 2944.52 | Leu-Gln-Ser-Glu-Asp-Lys-Ala-Ile-Arg-Thr-Ile-Met-Glu-Phe-Leu-Ala-Phe-Leu-His-Leu-Lys-Glu-Ala-Gly-Ala-Leu-NH2 | ? | ? | ? |
GMAP (25-41), amide | SH6523 | C90H143N21O22S | 1903.33 | Thr-Ile-Met-Glu-Phe-Leu-Ala-Phe-Leu-His-Leu-Lys-Glu-Ala-Gly-Ala-Leu-NH2 | ? | ? | ? |
Gn-RH Associated Peptide (GAP) (1-13), human | SH6524 | C65H101N15O25 | 1492.60 | Asp-Ala-Glu-Asn-Leu-Ile-Asp-Ser-Phe-Gln-Glu-Ile-Val | ? | ? | ? |
GnT-V (nt38 - 67) | SH6525 | C54H89N13O13S | 1159.45 | Val-Leu-Pro-Asp-Val-Phe-Ile-Arg-Cys-Val | ? | ? | ? |
gp38 | SH6526 | C133H209N41O38S2 | 3056.50 | Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys(Disulfide bridge:Cys20-Cys26) | ? | ? | ? |
gp100 (177–186) | SH6527 | C45H76N12O15S2 | 1089.31 | Ala-Met-Leu-Gly-Thr-His-Thr-Met-Glu-Val | ? | ? | ? |
gp100 (178 - 187) | SH6528 | C42H71N11O14S2 | 1018.23 | Met-Leu-Gly-Thr-His-Thr-Met-Glu-Val | ? | ? | ? |
gp100 (457 - 466) | SH6529 | C47H85N13O15 | 1072.28 | Leu-Leu-Asp-Gly-Thr-Ala-Thr-Leu-Arg-Leu | ? | ? | ? |
gp100 (476 - 485) | SH6530 | C57H83N13O15 | 1190.38 | Val-Leu-Tyr-Arg-Tyr-Gly-Ser-Phe-Ser-Val | ? | ? | ? |
gp100 (570–579) | SH6531 | C41H71N11O17 | 990.09 | Ser-Leu-Ala-Asp-Thr-Asn-Ser-Leu-Ala-Val | ? | ? | ? |
gp100 (614–622) | SH6532 | C56H101N19O11S | 1248.61 | Leu-Ile-Tyr-Arg-Arg-Arg-Leu-Met-Lys | ? | ? | ? |
gp100 (619–627) | SH6533 | C49H82N14O14S | 1123.35 | Arg-Leu-Met-Lys-Gln-Asp-Phe-Ser-Val | ? | ? | ? |
gp100 (639–647) | SH6534 | C47H79N15O11S2 | 1094.36 | Arg-Leu-Pro-Arg-Ile-Phe-Cys-Ser-Cys | ? | ? | ? |
gp120, HIV-1 MN | SH6535 | C135H221N45O33 | 3002.55 | Tyr-Asn-Ala-Lys-Arg-Lys-Arg-Ile-His-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Tyr-Thr-Thr-Lys-Asn-Ile-Ile | ? | ? | ? |
GPC3 (144 - 152) | SH6536 | C52H69N9O15 | 1060.18 | Phe-Val-Gly-Glu-Phe-Phe-Thr-Asp-Val | ? | ? | ? |
GPC3 (298 - 306), mouse | SH6537 | C51H81N9O18 | 1108.26 | Glu-Tyr-Ile-Leu-Ser-Leu-Glu-Glu-Leu | ? | ? | ? |
Granuliberin R | SH6538 | C69H103N19O14 | 1422.71 | Phe-Gly-Phe-Leu-Pro-Ile-Tyr-Arg-Arg-Pro-Ala-Ser-NH2 | ? | ? | ? |
Grb2 SH2 Domain Ligand | SH6539 | C23H361N5O10P | 573.56 | Tyr(PO3H2)-Val-Asn-Val | ? | ? | ? |
GRF, porcine | SH6540 | C219H365N73O66S | 5108.86 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Gly-Ala-Arg-Val-Arg-Leu-NH2 | ? | ? | ? |
GRF (1-29) amide (rat) | SH6541 | C155H251N49O40S | 3473.10 | His-Ala-Asp-Ala-Ile-Phe-Thr-Ser-Ser-Tyr-Arg-Arg-Ile-Leu-Gly-Gln-Leu-Tyr-Ala-Arg-Lys-Leu-Leu-His-Glu-Ile-Met-Asn-Arg-NH2 | ? | ? | ? |
GRF (free acid) (human) | SH6542 | C215H357N71O67S | 5040.74 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu | ? | ? | ? |
GRPP (human) | SH6543 | C136H215N41O58S | 3384.53 | Arg-Ser-Leu-Gln-Asp-Thr-Glu-Glu-Lys-Ser-Arg-Ser-Phe-Ser-Ala-Ser-Gln-Ala-Asp-Pro-Leu-Ser-Asp-Pro-Asp-Gln-Met-Asn-Glu-Asp | ? | ? | ? |
Growth Hormone Releasing Factor, GRF (1 - 29), amide, human | SH6544 | C149H246N44O42S | 3357.96 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | ? | ? | ? |
Growth Hormone Releasing Factor, GRF (1 - 40), amide, human | SH6545 | C194H318N62O62S | 4543.14 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-NH2 | ? | ? | ? |
Growth Hormone Releasing Factor, GRF, (1 - 40), human | SH6546 | C194H317N61O63S | 4544.12 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala | ? | ? | ? |
Growth Hormone Releasing Factor, GRF (1 - 44), amide, bovine | SH6547 | C220H366N72O66S | 5107.88 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Asn-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Gly-Ala-Lys-Val-Arg-Leu-NH2 | ? | ? | ? |
GRP (1-16) (porcine) | SH6548 | C70H115N17O20S1 | 1546.90 | Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro | ? | ? | ? |
GRP (14-27) (human, porcine, canine) | SH6549 | C75H110N24O16S2 | 1668.00 | Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
GSK3 Peptide Substrate | SH6550 | C470H76N16O16 | 1121.23 | Gly-Arg-Pro-Arg-Thr-Thr-Ser-Phe-Ala-Glu | ? | ? | ? |
Guanylin, human | SH6551 | C58H87N15O21S4 | 1458.68 | Pro-Gly-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys(Disulfide bridge: Cys4-Cys12, Cys7-Cys15) | ? | ? | ? |
Guanylin, rat, mouse | SH6552 | C60H90N16O22S4 | 1515.74 | Pro-Asn-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys(Disulfide bridge: Cys4-Cys12, Cys7-Cys15) | ? | ? | ? |
HA Peptide | SH6553 | C53H67N9O17 | 1102.18 | Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala | ? | ? | ? |
HBcAg (HBV) (18 - 27) | SH6554 | C580H78N10O15 | 1155.33 | Phe-Leu-Pro-Ser-Asp-Phe-Phe-Pro-Ser-Val | ? | ? | ? |
HBV core (107 - 115) | SH6555 | C44H72N12O14S | 1025.19 | Cys-Leu-Thr-Phe-Gly-Arg-Glu-Thr-Val | ? | ? | ? |
HBV core14, (HBA31) | SH6556 | C53H95N17O18 | 1258.45 | Ser-Thr-Leu-Pro-Glu-Thr-Thr-Val-Val-Arg-Arg | ? | ? | ? |
HBV core protein (128-140) | SH6557 | C66H103N17O17 | 1406.64 | Thr-Pro-Pro-Ala-Tyr-Arg-Pro-Pro-Asn-Ala-Pro-Ile-Leu | ? | ? | ? |
HBV env (183–191) | SH6558 | C53H92N12O12 | 1089.40 | Phe-Leu-Leu-Thr-Arg-Ile-Leu-Thr-Ile | ? | ? | ? |
HBV env (335 - 343) | SH6559 | C56H84N10O11 | 1073.35 | Trp-Leu-Ser-Leu-Leu-Val-Pro-Phe-Val | ? | ? | ? |
HBV polymerase (455 - 463) | SH6560 | C46H79N15O12 | 1034.24 | Gly-Leu-Ser-Arg-Tyr-Val-Ala-Arg-Leu | ? | ? | ? |
HBVpol502, HBV polymerase (502 - 510) | SH6561 | C53H82N14O12 | 1107.33 | Lys-Leu-His-Leu-Tyr-Ser-His-Pro-Ile | ? | ? | ? |
HBVpol655, HBV polymerase (655 - 663) | SH6562 | C46H75N9O11S2 | 994.28 | Ala-Leu-Met-Pro-Leu-Tyr-Ala-Cys-Ile | ? | ? | ? |
HCV Core Protein (19-25) | SH6563 | C39H59N9O11 | 829.96 | Pro-Gln-Asp-Val-Lys-Phe-Pro | ? | ? | ? |
HCV Core Protein (59-68) | SH6564 | C50H91N21O12 | 1178.42 | Arg-Gly-Arg-Arg-Gln-Pro-Ile-Pro-Lys-Ala | ? | ? | ? |
HCV Core Protein (107-114) | SH6565 | C43H64N16O12 | 997.09 | Trp-Gly-Pro-Asn-Asp-Pro-Arg-Arg | ? | ? | ? |
HCV NS4A Protein (21-34) (JT strain) | SH6566 | C63H116N20O17 | 1425.75 | Gly-Ser-Val-Val-I le-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg | ? | ? | ? |
HCV NS4A Protein (22-33) (FDA strain) | SH6567 | C54H98N15O14S | 1213.54 | Cys-Val-Val-I le-Val-Gly-Arg-I le-Val-Leu-Ser-Gly | ? | ? | ? |
HCV NS4A Protein (22-34) (H strain) | SH6568 | C59H108N17O15S | 1327.69 | Cys-Val-Val-I le-Val-Gly-Arg-Val-Val-Leu-Ser-Gly-Lys | ? | ? | ? |
HCV Nucleoprotein (88-96) | SH6569 | C46H60N12O13 | 989.06 | Asn-Glu-Gly-Leu-Gly-Trp-Ala-Gly-Trp | ? | ? | ? |
HCV-1 e2 Protein (484 - 499) | SH6570 | C88H122N20O19S2 | 1828.19 | Pro-Tyr-Cys-Trp-His-Tyr-Pro-Pro-Lys-Pro-Cys-Gly-Ile-Val-Pro-Ala | ? | ? | ? |
HCV-1 e2 Protein (554 - 569) | SH6571 | C74H111N19O21S3 | 1699.00 | Trp-Met-Asn-Ser-Thr-Gly-Phe-Thr-Lys-Val-Cys-Gly-Ala-Pro-Pro-Cys | ? | ? | ? |
He-LWamide II | SH6572 | C35H53N9O6 | 695.86 | Lys-Pro-Pro-Gly-Leu-Trp-NH2 | ? | ? | ? |
Head activator | SH6573 | C54H84N12O14 | 1125.36 | Pyr-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe | ? | ? | ? |
Head activator (7-11) | SH6574 | C32H54N6O6 | 618.82 | Lys-Val-Ile-Leu-Phe | ? | ? | ? |
Helodormin | SH6575 | C176H285N47O49 | 3843.47 | His-Ser-Asp-Ala-Ile-Phe-Thr-Gln-Gln-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala-Leu-Gln-Lys-Tyr-Leu-Ala-Ser-Ile-Leu-Gly-Ser-Arg-Thr-Ser-Pro-Pro-Pro-NH2 | ? | ? | ? |
Helospectin I | SH6576 | C183H293N47O59 | 4095.66 | His-Ser-Asp-Ala-Thr-Phe-Thr-Ala-Glu-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala-Leu-Gln-Lys-Tyr-Leu-Glu-Ser-Ile-Leu-Gly-Ser-Ser-Thr-Ser-Pro-Arg-Pro-Pro-Ser-Ser | ? | ? | ? |
Helospectin II | SH6577 | C180H288N46O57 | 4008.58 | His-Ser-Asp-Ala-Thr-Phe-Thr-Ala-Glu-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala-Leu-Gln-Lys-Tyr-Leu-Glu-Ser-Ile-Leu-Gly-Ser-Ser-Thr-Ser-Pro-Arg-Pro-Pro-Ser | ? | ? | ? |
Hemagglutinin (48-68) /Influenza virus | SH6578 | C97H163N29O32S2 | 2311.67 | Thr-Gly-Lys-Ile-Cys-Asn-Asn-Pro-His-Arg-Ile-Leu-Asp-Gly-Ile-Asp-Cys-Thr-Leu-Ile-Asp | ? | ? | ? |
Hemoglobin (Hb) (64 - 76) | SH6579 | C64H109N17O18 | 1404.69 | Gly-Lys-Lys-Val-Ile-Thr-Ala-Phe-Asn-Glu-Gly-Leu-Lys | ? | ? | ? |
Hemokinin 1 (human) | SH6580 | C54H84N14O14S | 1185.42 | Thr-Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2 | ? | ? | ? |
Hemokinin 1 (mouse, rat) | SH6581 | C61H100N22O15S | 1413.68 | Arg-Ser-Arg-Thr-Arg-Gln-Phe-Tyr-Gly-Leu-Met-NH2 | ? | ? | ? |
Hemorphin-7 | SH6582 | C49H64N12O11 | 997.12 | Tyr-Pro-Trp-Thr-Gln-Arg-Phe | ? | ? | ? |
Hepatitis B Virus Receptor Binding Fragment | SH6583 | C140H185N35O42 | 3030.20 | Pro-Leu-Gly-Phe-Phe-Pro-Asp-His-Gln-Leu-Asp-Pro-Ala-Phe-Gly-Ala-Asn-Ser-Asn-Asn-Pro-Asp-Trp-Asp-Phe-Asn-Pro | ? | ? | ? |
Hepatitis Virus C NS3 Protease Inhibitor 1 | SH6584 | C29H45N6O16S2 | 796.80 | Ac-Asp-Glu-Met-Glu-Glu-Cys | ? | ? | ? |
Hepatitus B Virus Pre-S Region (120-145) | SH6585 | C135H199N39O38S1 | 3008.40 | Met-Gln-Trp-Asn-Ser-Thr-Thr-Phe-His-Gln-Thr-Leu-Gln-Asp-Pro-Arg-Val-Arg-Gly-Leu-Tyr-Phe-Pro-Ala-Gly-Gly | ? | ? | ? |
HER2/neu(654-662) GP2 | SH6586 | C42H77N9O11 | 884.12 | Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu | ? | ? | ? |
HER2/neu (869-877) | SH6587 | C49H75N9O20 | 1110.19 | Leu-Leu-Asp-Ile-Asp-Glu-Thr-Glu-Tyr | ? | ? | ? |
Herpes Virus Inhibitor 1 | SH6588 | C41H64N10O14 | 920.46 | Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu | ? | ? | ? |
Hexa His | SH6589 | C36H42N18O6 | 822.85 | His-His-His-His-His-His | ? | ? | ? |
Hexa -Tyrosine | SH6590 | C54H56N6O13 | 997.08 | Tyr-Tyr-Tyr-Tyr-Tyr-Tyr | ? | ? | ? |
Hexarelin | SH6591 | C47H58N12O6 | 887.00 | His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2 | ? | ? | ? |
Hirudin (54-65) (desulfated) | SH6592 | C66H93N13O25 | 1468.55 | Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln | ? | ? | ? |
Histatin 3 (H3) | SH6593 | C178H258N64O48 | 4062.44 | Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr-Arg-Ser-Asn-Tyr-Leu-Tyr-Asp-Asn | ? | ? | ? |
Histatin 5 | SH6594 | C133H195N51O33 | 3036.36 | Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr | ? | ? | ? |
Histatin-8 [Hemagglutination -Inhibiting Peptide (HIP)] | SH6595 | C70H99N25O17 | 1562.73 | Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr | ? | ? | ? |
Histone H1 - derived peptide | SH6596 | C56H101N17O15 | 1252.53 | Gly-Gly-Gly-Pro-Ala-Thr-Pro-Lys-Lys-Ala-Lys-Lys-Leu | ? | ? | ? |
Histone H3 (1 - 25), amide | SH6597 | C110H202N42O32 | 2625.10 | Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Thr-Lys-Ala-Ala--NH2 | ? | ? | ? |
Histone H3 (116–136), C116–136 | SH6598 | C107H195N39O28S | 2508.06 | Lys-Arg-Val-Thr-Ile-Met-Pro-Lys-Asp-Ile-Gln-Leu-Ala-Arg-Arg-Ile-Arg-Gly-Glu-Arg-Ala | ? | ? | ? |
Histone H3 (116–136), N15–39 | SH6599 | C112H197N39O30 | 2570.06 | Ala-Pro-Arg-Lys-Gln-Leu-Ala-Thr-Lys-Ala-Ala-Arg-Lys-Ser-Ala-Pro-Ala-Thr-Gly-Gly-Val-Lys-Lys-Pro-His | ? | ? | ? |
HIV-1, HIV-2 Protease Substrate | SH6600 | C56H80N12O14 | 1145.30 | Ala-Thr-Leu-Asn-Phe-Pro-Ile-Ser-Pro-Trp | ? | ? | ? |
HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) | SH6601 | C95H155N27O26S | 2123.52 | Ala-Val-Gly-Ile-Gly-Ala-Leu-Phe-Leu-Gly-Phe-Leu-Gly-Ala-Ala-Gly-Ser-Thr-Met-Gly-Ala-Arg-Ser-NH2 | ? | ? | ? |
HIV-1 env Protein gp120 (278-292) (strains BH10, BH8, HXB2, HXB3, PV22) | SH6602 | C73H126N26O18 | 1655.98 | Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys | ? | ? | ? |
HIV-1 gag Protein p24 (137-154) | SH6603 | C92H158N26O26S | 2076.51 | Gly-Leu-Asn-Lys-Ile-Val-Arg-Met-Tyr-Ser-Pro-Thr-Ser-Ile-Leu-Asp-Ile-Arg | ? | ? | ? |
HIV-1 gag Protein p24 (194-210) | SH6604 | C73H125N20O23S | 1682.99 | Ala-Asn-Pro-Asp-Cys-Lys-Thr-Ile-Leu-Lys-Ala-Leu-Gly-Pro-Ala-Ala-Thr | ? | ? | ? |
HIV-1 gag Protein p24 (65-73) (isolates MAL/U455) | SH6605 | C44H79N11O14S2 | 1050.31 | Ala-Met-Gln-Met-Leu-Lys-Asp-Thr-Ile | ? | ? | ? |
HIV-1 rev Protein (34-50) | SH6606 | C97H173N51O24 | 2437.79 | Thr-Arg-Gln-Ala-Arg-Arg-Asn-Arg-Arg-Arg-Arg-Trp-Arg-Glu-Arg-Gln-Arg | ? | ? | ? |
HIV-1 tat Protein (1-9) | SH6607 | C43H168N10O17S | 1029.14 | Met-Asp-Pro-Val-Asp-Pro-Asn-Ile-Glu | ? | ? | ? |
HIV-1 tat Protein (47-57) | SH6608 | C64H118N32O14 | 1559.86 | Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg | ? | ? | ? |
HIV-1 tat Protein (49-57) | SH6609 | C53H106N30O11 | 1339.63 | Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg | ? | ? | ? |
HIV-gp120-41-C | SH6610 | C116H164N32O31S | 2534.86 | Val-Pro-Trp-Asn-Ser-Ser-Trp-Ser-Asn-Lys-Leu-Asp-Arg-Ile-Trp-Asn-Asn-Met-Thr-Trp | ? | ? | ? |
HIV-gp120-41-N-A | SH6611 | C99H146N20O20 | 1936.39 | Leu-Trp-Val-Thr-Val-Tyr-Tyr-Gly-Val-Pro-Val-Trp-Lys-Lys-Val-Val | ? | ? | ? |
HIV-gp120-41-N-B | SH6612 | C107H193N37O28 | 2445.96 | Ile-Glu-Pro-Leu-Gly-Ile-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg | ? | ? | ? |
HIV -gp120- Antigenic Peptide | SH6613 | C117H211N41O31S | 2720.30 | Cys-Gly-Lys-Ile-Glu-Pro-Leu-Gly-Val-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg | ? | ? | ? |
HIV -gp120- Fragment (254-274) | SH6614 | C95H162N28O30S | 2208.58 | Cys-Thr-His-Gly-Ile-Arg-Pro-Val-Val-Ser-Thr-Gln-Leu-Leu-Leu-Asn-Gly-Ser-Leu-Ala-Glu | ? | ? | ? |
HIV-gp120- Fragment (308-331) | SH6615 | C114H199N41O31 | 2640.11 | Asn-Asn-Thr-Arg-Lys-Ser-Ile-Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys-Ile-Gly | ? | ? | ? |
HIV-gp120-Fragment (318-327) | SH6616 | C48H80N16O12 | 1073.27 | Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-I le | ? | ? | ? |
HIV -gp120- Fragment (421-438) | SH6617 | C99H148N24O25S2 | 2138.56 | Lys-Gln-Phe-Ile-Asn-Met-Trp-Gln-Glu-Val-Gly-Lys-Ala-Met-Tyr-Ala-Pro-Pro | ? | ? | ? |
HIV-gp41-Antigenic Peptide 5 | SH6618 | C184H282N56O53S2 | 4190.77 | Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys-His-Thr-Thr-Val-Pro-Trp-Val-Asn-Asp-Ser-NH2(Disulfide bridge: Cys20-Cys26) | ? | ? | ? |
HIV-gp41-Fragment | SH6619 | C21H38N6O7 | 486.57 | Ala-Val-Gly-Ile-Gly-Ala | ? | ? | ? |
HIV Integrase Protein Inhibitor(1) | SH6620 | C46H55N11O7S | 906.10 | His-Cys-Lys-Phe-Trp-Trp | ? | ? | ? |
HIV Nef(90 - 100) | SH6621 | C55H91N13O16 | 1190.42 | Phe-Leu-Lys-Glu-Lys-Gly-Gly-Leu-Glu-Gly-Leu | ? | ? | ? |
HIV Protease Substrate | SH6622 | C33H59N11O10 | 769.90 | Ac-Ala-Arg-Val-Leu-Ala-Glu-Ala-NH2 | ? | ? | ? |
HIV QK10 | SH6623 | C51H86N14O13S | 1135.40 | Gln-Val-Pro-Leu-Arg-Met-Thr-Tyr-Lys | ? | ? | ? |
HJ Inhibitor Peptide 2 | SH6624 | C48H61N13O7S | 964.16 | Lys-Trp-Trp-Cys-Arg-Trp | ? | ? | ? |
HPV-E6-C | SH6625 | C110H178N36O30S | 2516.92 | Pro-Leu-Cys-Pro-Glu-Glu-Lys-Gln-Arg-His-Leu-Asp-Lys-Lys-Gln-Arg-Phe-His-Asn-Ile | ? | ? | ? |
HPV-E6-M | SH6626 | C111H151N25O37S | 2459.64 | Ser-Glu-Tyr-Pro-His-Tyr-Cys-Tyr-Ser-Leu-Tyr-Gly-Thr-Thr-Leu-Glu-Gln-Gln-Tyr-Asn | ? | ? | ? |
HPV-E6-N | SH6627 | C76H128N24O25S | 1810.07 | Asp-Pro-Gln-Glu-Arg-Pro-Arg-Lys-Leu-Pro-Gln-Leu-Cys-Thr-Glu | ? | ? | ? |
HPV-E7-C | SH6628 | C83H128N24O40 | 2102.08 | Ser-Ser-Glu-Glu-Glu-Asp-Glu-Ile-Asp-Gly-Pro-Ala-Gly-Gln-Ala-Glu-Pro-Asp-Arg-Ala | ? | ? | ? |
HPV-E7-N | SH6629 | C108H159N23O39S2 | 2467.72 | Tyr-Met-Leu-Asp-Leu-Gln-Pro-Glu-Thr-Thr-Asp-Leu-Tyr-Cys-Tyr-Glu-Gln-Leu-Asn-Asp | ? | ? | ? |
Hsp Heat shock protein (3–13) | SH6630 | C57H94N18O20 | 1351.49 | Lys-Thr-Ile-Ala-Tyr-Asp-Glu-Glu-Ala-Arg-Arg | ? | ? | ? |
HSV-1 Glycoprotein (gB) (497-507) | SH6631 | C59H91N15O18 | 1298.47 | Thr-Ser-Ser-Ile-Glu-Phe-Ala-Arg-Leu-Gln-Phe | ? | ? | ? |
HSV-1-amide UL 26 Open Reading Frame (242-255) | SH6632 | C80H117N21O20S | 1725.02 | His-Thr-Tyr-Leu-Gln-Ala-Ser-Glu-Lys-Phe-Lys-Met-Trp-Gly-NH2 | ? | ? | ? |
HSV-gB2 (498 - 505) | SH6633 | C41H67N11O13 | 922.06 | Ser-Ser-Ile-Glu-Phe-Ala-Arg-Leu | ? | ? | ? |
Human CMV Assemblin Protease Substrate (M-site) | SH6634 | C52H96N20O16 | 1257.47 | Arg-Gly-Val-Val-Asn-Ala-Ser-Ser-Arg-Leu-Ala-Lys | ? | ? | ? |
Human CMV pp65 (495-503) | SH6635 | C42H74N10O12S | 943.18 | Asn-Leu-Val-Pro-Met-Val-Ala-Thr-Val | ? | ? | ? |
Human Follicular Conadotropin Releasing Peptide (Hf-GRP) | SH6636 | C68H94N22O27 | 1651.60 | Thr-Asp-Thr-Ser-His-His-Asp-Gln-Asp-His-Pro-Thr-Phe-Asn | ? | ? | ? |
Human Growth Hormone (1-43) | SH6637 | C240H358N62O67S | 5215.97 | Phe-Pro-Thr-Ile-Pro-Leu-Ser-Arg-Leu-Phe-Asp-Asn-Ala-Met-Leu-Arg-Ala-His-Arg-Leu-His-Gln-Leu-Ala-Phe-Asp-Thr-Tyr-Gln-Glu-Phe-Glu-Glu-Ala-Tyr-Ile-Pro-Lys-Glu-Gln-Lys-Tyr-Ser | ? | ? | ? |
Human IgE Pentapeptide HEPP | SH6638 | C22H36N8O11 | 588.58 | Asp-Ser-Asp-Pro-Arg | ? | ? | ? |
Human Papillomavirus E7 protein (49 - 57) | SH6639 | C52H77N15O13 | 1120.29 | Arg-Ala-His-Tyr-Asn-Ile-Val-Thr-Phe | ? | ? | ? |
Humanin (human) | SH6640 | C119H204N34O32S2 | 2687.28 | Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala | ? | ? | ? |
Hydrin 1 | SH6641 | C57H93N21O16S2 | 1392.64 | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-Lys-Arg (Disulfide bridge: Cys1-Cys6) | ? | ? | ? |
Hydrin 1 | SH6642 | C51H81N17O15S2 | 1236.45 | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-Lys (Disulfide bridge: Cys1-Cys6) | ? | ? | ? |
Hydrin 2 | SH6643 | C45H69N15O14S2 | 1108.27 | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly(Disulfide bridge:C1-C6) | ? | ? | ? |
Hylambatin | SH6644 | C63H90N16O19S2 | 1439.64 | Asp-Pro-Pro-Asp-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 | ? | ? | ? |
Hypercalcemia Malignancy Factor (1-34), amide, human | SH6645 | C180H288N58O47 | 4016.60 | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 | ? | ? | ? |
Hypercalcemia Malignancy Factor (1-34), human | SH6646 | C180H287N57O48 | 4017.65 | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala | ? | ? | ? |
Hypercalcemia Malignancy Factor (1-40) | SH6647 | C180H287N57O48 | 4017.70 | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser | ? | ? | ? |
Hypercalcemia Malignancy Factor (7-34), amide, human | SH6648 | C153H247N49O37 | 3365.00 | Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 | ? | ? | ? |
Hypertrehalosaemic Neuropeptide, Heliothis zea | SH6649 | C49H67N13O15 | 1078.17 | Pyr-Leu-Thr-Phe-Ser-Ser-Gly-Trp-Gly-Asn-NH2 | ? | ? | ? |
Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea | SH6650 | C50H67N13O14 | 1074.19 | Pyr-Val-Asn-Phe-Ser-Pro-Gly-Trp-Gly-Thr-NH2 | ? | ? | ? |
Hypocretin (70-98) (human) | SH6651 | C125H214N44O37S1 | 2957.40 | Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-Gly | ? | ? | ? |
I-309 (human) | SH6652 | C370H604N114O99S8 | 8490.11 | Lys-Ser-Met-Gln-Val-Pro-Phe-Ser-Arg-Cys-Cys-Phe-Ser-Phe-Ala-Glu-Gln-Glu-Ile-Pro-Leu-Arg-Ala-Ile-Leu-Cys-Tyr-Arg-Asn-Thr-Ser-Ser-Ile-Cys-Ser-Asn-Glu-Gly-Leu-Ile-Phe-Lys-Leu-Lys-Arg-Gly-Lys-Glu-Ala-Cys-Ala-Leu-Asp-Thr-Val-Gly-Trp-Val-Gln-Arg-His-Arg-Lys-Met | ? | ? | ? |
IELLQAR Selectin Binding Peptide | SH6653 | C37H67N11O11 | 842.01 | Ile-Glu-Leu-Leu-Gln-Ala-Arg | ? | ? | ? |
IGF-I (1-3) | SH6654 | C12H19N3O6 | 301.30 | Gly-Pro-Glu | ? | ? | ? |
IGF-I (24-41) | SH6655 | C88H133N27O28 | 2017.21 | Tyr-Phe-Asn-Lys-Pro-Thr-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr | ? | ? | ? |
IGF-I (30-41) | SH6656 | C51H83N19O19 | 1266.35 | Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr | ? | ? | ? |
IGF-I Analog | SH6657 | C55H90N14O15S2 | 1251.53 | Cys-Tyr-Ala-Ala-Pro-Leu-Lys-Pro-Ala-Lys-Ser-Cys | ? | ? | ? |
IGF-II (33-40) | SH6658 | C38H74N20O12 | 1003.14 | Ser-Arg-Val-Ser-Arg-Arg-Ser-Arg | ? | ? | ? |
IL-1 Receptor Peptide (human) | SH6659 | C47H88N14O12S | 1073.37 | Lys-Ile-Cys-Ile-Arg-Ile-Gln-Ile-Ser | ? | ? | ? |
IL-1a (223-250) (human) | SH6660 | C158H219N37O44 | 3340.73 | Phe-Phe-Tyr-Glu-Thr-His-Gly-Thr-Lys-Asn-Tyr-Phe-Thr-Ser-Val-Ala-His-Pro-Asn-Leu-Phe-Ile-Ala-Thr-Lys-Gln-Asp-Tyr | ? | ? | ? |
IL-1b (178-207) (human) | SH6661 | C157H256N38O49S | 3492.07 | Leu-Lys-Glu-Lys-Asn-Leu-Tyr-Leu-Ser-Cys-Val-Leu-Lys-Asp-Asp-Lys-Pro-Thr-Leu-Gln-Leu-Glu-Ser-Val-Asp-Pro-Lys-Asn-Tyr-Pro | ? | ? | ? |
IL-1b (208-240) (human) | SH6662 | C191H292N48O51S | 4108.81 | Lys-Lys-Lys-Met-Glu-Lys-Arg-Phe-Val-Phe-Asn-Lys-Ile-Glu-Ile-Asn-Asn-Lys-Leu-Glu-Phe-Glu-Ser-Ala-Gln-Phe-Pro-Asn-Trp-Tyr-Ile-Ser-Thr | ? | ? | ? |
IL-6 (88-121) (human) | SH6663 | C179H281N45O58S | 4023.57 | Ile-Ile-Thr-Gly-Leu-Leu-Glu-Phe-Glu-Val-Tyr-Leu-Glu-Tyr-Leu-Gln-Asn-Arg-Phe-Glu-Ser-Ser-Glu-Glu-Gln-Ala-Arg-Ala-Val-Gln-Met-Ser-Thr-Lys | ? | ? | ? |
IL-8 (-5 to +5) | SH6664 | C48H86N14O14 | 1083.31 | Ala-Val-Leu-Pro-Arg-Ser-Ala-Lys-Glu-Leu | ? | ? | ? |
IL-8 Inhibitor | SH6665 | C45H66N18O7S | 1003.20 | Ac-Arg-Arg-Trp-Trp-Cys-Arg-NH2 | ? | ? | ? |
IL-8ra (9-29) | SH6666 | C112H150N24O38S2 | 2504.71 | Ac-Met-Trp-Asp-Phe-Asp-Asp-Leu-Asn-Phe-Thr-Gly-Met-Pro-Pro-Ala-Asp-Glu-Asp-Tyr-Ser-Pro-NH2 | ? | ? | ? |
Indolicidin | SH6667 | C100H132N26O13 | 1906.33 | Ile-Leu-Pro-Trp-Lys-Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-NH2 | ? | ? | ? |
Influenza A M2 coat protein (22- 46) | SH6668 | C129H215N31O33 | 2728.34 | Ser-Ser-Asp-Pro-Leu-Val-Val-Ala-Ala-Ser-Ile-Ile-Gly-Ile-Leu-His-Leu-Ile-Leu-Trp-Ile-Leu-Asp-Arg-Leu | ? | ? | ? |
Influenza A NP (366 - 374) | SH6669 | C36H59N11O17S2 | 982.06 | Ala-Ser-Asn-Glu-Met-Asn-Asp-Ala-Met | ? | ? | ? |
Influenza A NP (366 - 374) Strain A/NT/60/68 | SH6670 | C36H59N11O17S2 | 982.06 | Ala-Ser-Asn-Glu-Asn-Met-Asp-Ala-Met | ? | ? | ? |
Influenza A NP(366 - 374) Strain A/PR/8/35 | SH6671 | C38H63N11O18S2 | 1026.12 | Ala-Ser-Asn-Glu-Asn-Met-Glu-Thr-Met | ? | ? | ? |
Influenza HA (110 - 119) | SH6672 | C63H90N14O16 | 1299.50 | Ser-Phe-Glu-Arg-Phe-Glu-Ile-Phe-Pro-Lys | ? | ? | ? |
Influenza HA (110 - 120) | SH6673 | C68H97N15O19 | 1428.62 | Ser-Phe-Glu-Arg-Phe-Glu-Ile-Phe-Pro-Lys-Glu | ? | ? | ? |
Influenza HA (204 - 212) | SH6674 | C49H73N11O15 | 1056.19 | Leu-Tyr-Gln-Asn-Val-Gly-Thr-Tyr-Val | ? | ? | ? |
Influenza HA (210 - 219) | SH6675 | C45H74N10O17 | 1027.15 | Thr-Tyr-Val-Ser-Val-Gly-Thr-Ser-Thr-Leu | ? | ? | ? |
Influenza HA (307 - 319) | SH6676 | C69H118N18O19 | 1503.82 | Pro-Lys-Tyr-Val-Lys-Gln-Asn-Thr-Leu-Lys-Leu-Ala-Thr | ? | ? | ? |
Influenza HA (518 - 526) | SH6677 | C42H69N9O15 | 940.07 | Ile-Tyr-Ser-Thr-Val-Ala-Ser-Ser-Leu | ? | ? | ? |
Influenza HA (529 - 537) | SH6678 | C41H67N9O13 | 894.04 | Ile-Tyr-Ala-Thr-Val-Ala-Gly-Ser-Leu | ? | ? | ? |
Influenza NP (50 - 57) | SH6679 | C41H65N11O15 | 952.04 | Ser-Asp-Tyr-Glu-Gly-Arg-Leu-Ile | ? | ? | ? |
Influenza NP (147 - 155) | SH6680 | C48H82N16O14 | 1107.29 | Thr-Tyr-Gln-Arg-Thr-Arg-Ala-Leu-Val | ? | ? | ? |
Influenza NP (482 - 489) | SH6681 | C44H55N9O15 | 949.98 | Ser-Asn-Glu-Gly-Ser-Tyr-Phe-Phe | ? | ? | ? |
Insulin B (9-23) | SH6682 | C72H116N20O22S | 1645.90 | Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly | ? | ? | ? |
Insulin Receptor (1142-1153) | SH6683 | C72H107N19O24 | 1622.77 | Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys | ? | ? | ? |
Insulin Receptor (1142 - 1153), Amide | SH6684 | C72H108N20O23 | 1621.78 | Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys-NH2 | ? | ? | ? |
Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated | SH6685 | C82H122N22O25S | 1848.08 | Biotin-Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-pTyr-Tyr-Arg-Lys | ? | ? | ? |
Insulin-like Growth Factor I (57-70) | SH6686 | C65H104N15O23S1 | 1495.70 | Ala-Leu-Leu-Glu-Thr-Tyr-Cys-Ala-Thr-Pro-Ala-Lys-Ser-Glu | ? | ? | ? |
Insulin-Like Growth Factor II (69-84) | SH6687 | C83H124N20O26 | 1817.90 | Asp-Val-Ser-Thr-Pro-Pro-Thr-Val-Leu-Pro-Asp-Asn-Phe-Pro-Arg-Tyr | ? | ? | ? |
Interleukin II (60-70) | SH6688 | C68H104N14O14S | 1373.74 | Leu-Thr-Phe-Lys-Phe-Tyr-Met-Pro-Lys-Lys-Ala | ? | ? | ? |
Interleukin-1beta Convertase Substrate | SH6689 | C68H105N21O23 | 1584.71 | Asn-Glu-Ala-Tyr-Val-His-Asp-Ala-Pro-Val-Arg-Ser-Leu-Asn | ? | ? | ? |
Interleukin-6 Receptor (partial) | SH6690 | C51H85N13O21 | 1216.32 | Thr-Ser-Leu-Pro-Val-Gln-Asp-Ser-Ser-Ser-Val-Pro | ? | ? | ? |
Intermedin (human) | SH6691 | C219H351N69O66S3 | 5102.84 | Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 | ? | ? | ? |
Intermedin (rat) | SH6692 | C226H361N75O64S2 | 5216.99 | Pro-His-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Val-Arg-Pro-Ser-Gly-Arg-Arg-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 | ? | ? | ? |
Intermedin-53 (human) | SH6693 | C247H397N83O73S3 | 5793.61 | His-Ser-Gly-Pro-Arg-Arg-Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 | ? | ? | ? |
Invertebrate Tachykinin - I, OctTK – I | SH6694 | C58H94N14O17S | 1291.54 | Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Ile-Gly-Leu-Met-NH2 | ? | ? | ? |
IP3R - derived Peptide | SH6695 | C46H77N17O15 | 1108.23 | Gly-Arg-Arg-Glu-Ser-Leu-Thr-Ser-Phe-Gly-NH2 | ? | ? | ? |
IRL-1038 | SH6696 | C68H94N14O15S2 | 1411.70 | Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp | ? | ? | ? |
IRL-1720 | SH6697 | C85H120N18O23 | 1762.01 | Ac-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | ? | ? | ? |
IRS1 - derived peptide | SH6698 | C63H108N20O19S2 | 1513.81 | Lys-Lys-Ser-Arg-Gly-Asp-Tyr-Met-Thr-Met-Gln-Ile-Gly-NH2 | ? | ? | ? |
IV9 (476 - 484), HIV - 1 RT Epitope | SH6699 | C46H78N12O12 | 991.21 | Ile-Leu-Lys-Glu-Pro-Val-His-Gly-Val | ? | ? | ? |
JAG - 1 (188 - 204), Jagged – 1 (188 - 204), Notch Ligand | SH6700 | C93H127N25O26S3 | 2107.37 | Cys-Asp-Asp-Tyr-Tyr-Tyr-Gly-Phe-Gly-Cys-Asn-Lys-Phe-Cys-Arg-Pro-Arg | ? | ? | ? |
K-G-D-S | SH6701 | C15H27N5O8 | 405.41 | Lys-Gly-Asp-Ser | ? | ? | ? |
K-R-Q-H-P-G | SH6702 | C30H51N13O8 | 721.82 | Lys-Arg-Gln-His-Pro-Gly | ? | ? | ? |
Kallikrein Inhibitor | SH6703 | C35H55N11O9 | 773.90 | Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2 | ? | ? | ? |
Kassinin | SH6704 | C59H95N15O18S1 | 1334.57 | Asp-Val-Pro-Lys-Ser-Asp-Gln-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
Katacalcin | SH6705 | C97H154N34O36S2 | 2436.64 | Asp-Met-Ser-Ser-Asp-Leu-Glu-Arg-Asp-His-Arg-Pro-His-Val-Ser-Met-Pro-Gln-Asn-Ala-Asn | ? | ? | ? |
KEEAE | SH6706 | C24H40N6O12 | 604.62 | Lys-Glu-Glu-Ala-Glu | ? | ? | ? |
Kemptamide | SH6707 | C65H112N24018 | 1517.76 | Lys-Lys-Arg-Pro-Gln-Arg-Ala-Thr-Ser-Asn-Val-Phe-Ser-NH2 | ? | ? | ? |
Kemptide | SH6708 | C32H61N13O9 | 771.92 | Leu-Arg-Arg-Ala-Ser-Leu-Gly | ? | ? | ? |
Kemptide Negative Control | SH6709 | C32H61N13O8 | 755.93 | Leu-Arg-Arg-Ala-Ala-Leu-Gly | ? | ? | ? |
Ketolide resistance Peptide MRFFV | SH6710 | C34H50N8O6S | 698.90 | Met-Arg-Phe-Phe-Val | ? | ? | ? |
KGF Receptor Peptide | SH6711 | C114H174N30O42S | 2668.90 | His-Ser-Gly-Ile-Asn-Ser-Ser-Asn-Ala-Glu-Val-Leu-Ala-Leu-Phe-Asn-Val-Thr-Glu-Met-Asp-Ala-Gly-Glu-Tyr | ? | ? | ? |
Kinase Domain of Insulin Receptor (1) | SH6712 | C70H105N18O25P | 1629.72 | Tyr-Glu-Thr-Asp-pTyr-Tyr-Arg-Lys-Gly-Gly-Lys-Gly-Leu | ? | ? | ? |
Kinase Domain of Insulin Receptor (2) | SH6713 | C72H108N19O27P | 1702.77 | Thr-Arg-Asp-Ile-pTyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys | ? | ? | ? |
Kinase Domain of Insulin Receptor (3) | SH6714 | C72H108N19O27 | 1702.77 | Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-pTyr-Tyr-Arg-Lys | ? | ? | ? |
Kinase Domain of Insulin Receptor (4) | SH6715 | C72H108N19O27 | 1702.77 | Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-pTyr-Arg-Lys | ? | ? | ? |
Kinase Domain of Insulin Receptor (5) | SH6716 | C72H110N19O33 | 1862.77 | Thr-Arg-Asp-Ile-pTyr-Glu-Thr-Asp-pTyr-pTyr-Arg-Lys | ? | ? | ? |
Kinase Domain of Pyruvate Kinase, porcine liver | SH6717 | C32H62N12O13P | 853.88 | Leu-Arg-Arg-Ala-pSer-Leu-Gly | ? | ? | ? |
Kinetensin | SH6718 | C56H85N17O11 | 1172.40 | Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu | ? | ? | ? |
Kisspeptin-13 (human) | SH6719 | C78H107N21O18 | 1626.85 | Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 | ? | ? | ? |
Kisspeptin-13 (4-13) (human) | SH6720 | C63H83N17O14 | 1302.47 | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 | ? | ? | ? |
Kisspeptin-54 (27-54) (human) | SH6721 | C149H226N42O39 | 3229.72 | Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 | ? | ? | ? |
KK4A | SH6722 | C74H138N22O19 | 1640.06 | Lys-Lys-Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Val-Leu-Ser-Gly-Lys | ? | ? | ? |
KL-1 | SH6723 | C53H90N16O18 | 1239.40 | Leu-Pro-Pro-Val-Ala-Ala-Ser-Ser-Leu-Arg-Asn-Asp | ? | ? | ? |
Kyotorphin | SH6724 | C15H23N5O4 | 337.40 | Tyr-Arg | ? | ? | ? |
Laminin (925-933) | SH6725 | C40H62N12O14S1 | 967.10 | Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg | ? | ? | ? |
Laminin (929-933) | SH6726 | C26H42N8O8 | 594.70 | Tyr-Ile-Gly-Ser-Arg | ? | ? | ? |
Laminin A Chain (2091-2108) | SH6727 | C82H148N31O26S1 | 2016.30 | Cys-Ser-Arg-Ala-Arg-Lys-Gln-Ala-Ala-Ser-Ile-Lys-Val-Ala-Val-Ser-Ala-Asp-Arg | ? | ? | ? |
Laminin Nonapeptide, Amide | SH6728 | C40H63N13O13S | 966.09 | Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 | ? | ? | ? |
Laminin Penta Peptide, amide | SH6729 | C26H43N9O7 | 593.70 | Tyr-Ile-Gly-Ser-Arg-NH2 | ? | ? | ? |
Lamprey PQRFamide | SH6730 | C102H147N29O22S2 | 2195.62 | Ser-Trp-Gly-Ala-Pro-Ala-Glu-Lys-Phe-Trp-Met-Arg-Ala-Met-Pro-Gln-Arg-Phe-NH2 | ? | ? | ? |
LEAP-2 (38 - 77) (Human) | SH6731 | C191H320N64O57S5 | 4585.36 | Met-Thr-Pro-Phe-Trp-Arg-Gly-Val-Ser-Leu-Arg-Pro-Ile-Gly-Ala-Ser-Cys-Arg-Asp-Asp-Ser-Glu-Cys-Ile-Thr-Arg-Leu-Cys-Arg-Lys-Arg-Arg-Cys-Ser-Leu-Ser-Val-Ala-Gln-Glu | ? | ? | ? |
Leptin Receptor Precursor | SH6732 | C60H94N13O19P | 1332.49 | Pro-Phe-Val-Lys-pTyr-Ala-Thr-Leu-Ile-Ser-Asn | ? | ? | ? |
Leptin (116-130), mouse | SH6733 | C64H107N18O25S1 | 1560.74 | Ser-Cys-Ser-Leu-Pro-Gln-Thr-Ser-Gly-Leu-Gln-Lys-Pro-Glu-Ser | ? | ? | ? |
Leptin (22-56), human; OBGRP(22-56), human | SH6734 | C171H298N50O56 | 3950.60 | Val-Pro-Ile-Gln-Lys-Val-Gln-Asp-Asp-Thr-Lys-Thr-Leu-Ile-Lys-Thr-Ile-Val-Thr-Arg-Ile-Asn-Asp-Ile-Ser-His-Thr-Gln-Ser-Val-Ser-Ser-Lys-Gln-Lys | ? | ? | ? |
Leptin (93-105) (human) | SH6735 | C64H110N20O23 | 1527.70 | Asn-Val-Ile-Gln-Ile-Ser-Asn-Asp-Leu-Glu-Asn-Leu-Arg | ? | ? | ? |
Leu-Enkephalin | SH6736 | C28H38N6O6 | 554.65 | Tyr-Gly-Gly-Phe-Leu | ? | ? | ? |
Leu-Enkephalin, amide | SH6737 | C28H38N6O6 | 554.65 | Tyr-Gly-Gly-Phe-Leu-NH2 | ? | ? | ? |
Leu-Valorphin-Arg | SH6738 | C56H84N14O13 | 1161.38 | Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg | ? | ? | ? |
Leucokinin I | SH6739 | C41H52N11O12 | 891.93 | Asp-Pro-Ala-Phe-Asn-Ser-Trp-Gly-NH2 | ? | ? | ? |
Leucokinin II | SH6740 | C39H50N10O12 | 850.90 | Asp-Pro-Gly-Phe-Ser-Ser-Trp-Gly-NH2 | ? | ? | ? |
Leucokinin III | SH6741 | C40H52N12O13 | 908.90 | Asp-Gln-Gly-Phe-Asn-Ser-Trp-Gly-NH2 | ? | ? | ? |
Leucokinin IV | SH6742 | C41H52N12O12 | 904.90 | Asp-Ala-Ser-Phe-His-Ser-Trp-Gly-NH2 | ? | ? | ? |
Leucokinin V | SH6743 | C35H46N10O11 | 782.80 | Gly-Ser-Gly-Phe-Ser-Ser-Trp-Gly-NH2 | ? | ? | ? |
Leucokinin VII | SH6744 | C40H52N10O12 | 864.90 | Asp-Pro-Ala-Phe-Ser-Ser-Trp-Gly-NH2 | ? | ? | ? |
Leucokinin VIII | SH6745 | C42H52N10O11 | 872.94 | Gly-Ala-Ser-Phe-Tyr-Ser-Trp-Gly-NH2 | ? | ? | ? |
Leucomyosuppressin (lms) | SH6746 | C59H84N16O15 | 1257.44 | Pyr-Asp-Val-Asp-His-Val-Phe-Leu-Arg-Phe-NH2 | ? | ? | ? |
Leucopyrokinin (4-8); Pheromonotropic Pentapeptide | SH6747 | C30H49N9O6 | 631.78 | Phe-Thr-Pro-Arg-Leu-NH2 | ? | ? | ? |
Leucopyrokinin (LPK) | SH6748 | C42H66N12O12 | 931.06 | PYR-Thr-Ser-Phe-Thr-Pro-Arg-Leu-NH2 | ? | ? | ? |
Levitide | SH6749 | C66H119N21O19S | 1542.88 | Pyr-Gly-Met-Ile-Gly-Thr-Leu-Thr-Ser-Lys-Arg-Ile-Lys-Gln-NH2 | ? | ? | ? |
LF 20 Consensus Peptide. Anthrax Related Lethal Factor | SH6750 | C106H173N29O27S2 | 2349.87 | Met-Leu-Ala-Arg-Arg-Lys-Lys-Val-Tyr-Pro-Tyr-Pro-Met-Glu-Pro-Thr-Ile-Ala-Glu-Gly-NH2 | ? | ? | ? |
LHRH, salmon | SH6751 | C60H73N15O13 | 1212.36 | Pyr-His-Trp-Ser-Tyr-Gly-Trp-Leu-Pro-Gly-NH2 | ? | ? | ? |
LHRH (4-10) | SH6752 | C33H53N11O9 | 747.85 | Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 | ? | ? | ? |
LHRH-?, lamprey | SH6753 | C59H75N18O14 | 1259.40 | Pyr-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2 | ? | ? | ? |
Litorin | SH6754 | C51H68N14O11S1 | 1085.28 | Pyr-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2 | ? | ? | ? |
LKRApYLG-NH2 | SH6755 | C38H67N12O11P | 899.03 | Leu-Lys-Arg-Ala-pTyr-Leu-Gly-NH2 | ? | ? | ? |
LL - 37, Antimicrobial Peptide, human | SH6756 | C205H340N60O53 | 4493.37 | Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser | ? | ? | ? |
LL - 37 pentamide | SH6757 | C208H343N65O48 | 4522.46 | Leu-Leu-Gly-Asn-Phe-Phe-Arg-Lys-Ser-Lys-Gln-Lys-Ile-Gly-Lys-Gln-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asn-Phe-Phe-Arg-Asn-Leu-Val-Pro-Arg-Thr-Gln-Ser | ? | ? | ? |
LL - 37, reverse sequence | SH6758 | C205H340N60O53 | 4493.37 | Ser-Glu-Thr-Arg-Pro-Val-Leu-Asn-Arg-Leu-Phe-Asp-Lys-Ile-Arg-Gln-Val-Ile-Arg-Lys-Phe-Glu-Lys-Gly-Ile-Lys-Glu-Lys-Ser-Lys-Arg-Phe-Phe-Asp-Gly-Leu-Leu | ? | ? | ? |
LMP1, TDD | SH6759 | C68H102N26O35 | 1843.72 | Thr-Asp-Asp-Ser-Gly-His-Glu-Ser-Asp-Ser-Asn-Ser-Asn-Glu-Gly-Arg-His | ? | ? | ? |
LMP1 (156 - 164), IAL | SH6760 | C55H81N13O14 | 1148.34 | Ile-Ala-Leu-Tyr-Leu-Gln-Gln-Asn-Trp | ? | ? | ? |
LMP2 (236 - 244) , RRR | SH6761 | C56H99N25O11 | 1298.50 | Arg-Arg-Arg-Trp-Arg-Arg-Leu-Thr-Val | ? | ? | ? |
LMP2 (419 - 427), TYG | SH6762 | C48H71N9O12S2 | 1030.27 | Thr-Tyr-Gly-Pro-Val-Phe-Met-Cys-Leu | ? | ? | ? |
Locustachykinin I | SH6763 | C43H63N13O11 | 938.00 | Gly-Pro-Ser-Gly-Phe-Tyr-Gly-Val-Arg-NH2 | ? | ? | ? |
Locustachykinin II | SH6764 | C50H76N14O12 | 1065.40 | Ala-Pro-Leu-Ser-Gly-Phe-Tyr-Gly-Val-Arg-NH2 | ? | ? | ? |
Luteinizing Hormone Releasing Hormone LH-RH | SH6765 | C55H75N17O13 | 1182.40 | Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 | ? | ? | ? |
Luteinizing Hormone-Releasing Hormone, free acid, human; LH-RH, free acid, human | SH6766 | C58H81N17O16S | 1304.45 | Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-Cys | ? | ? | ? |
Lymphocyte Activating Pentapeptide | SH6767 | C25H44N8O7 | 568.67 | Leu-Pro-Pro-Ser-Arg | ? | ? | ? |
Lys-(Ala3)-Bradykinin | SH6768 | C54H83N17O12 | 1162.37 | Lys-Arg-Pro-Ala-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
Lys-(Des-Arg9)-Bradykinin | SH6769 | C50H73N13O11 | 1032.22 | Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe | ? | ? | ? |
Lys-(Des-Arg9, Leu8)-Bradykinin | SH6770 | C47H75N13O11 | 998.20 | Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu | ? | ? | ? |
Lys-(Hyp3)-Bradykinin | SH6771 | C56H85N17O13 | 1204.41 | Lys-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
Lys-(Tyr8)-Bradykinin | SH6772 | C56H85N17O13 | 1204.41 | Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg | ? | ? | ? |
Lys-Bradykinin-Ser-Val-Gln-Val-Ser | SH6773 | C77H121N23O20 | 1688.96 | Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-Ser-Val-Gln-Val-Ser | ? | ? | ? |
Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human) | SH6774 | C73H114N18O22 | 1595.83 | Lys-Lys-Lys-Ser-Pro-Gly-Glu-Tyr-Val-Asn-Ile-Glu-Phe-Gly | ? | ? | ? |
Lys(Boc)-Leu-Lys(Boc)-Obzl | SH6775 | C35H59N5O8 | 667.90 | Lys(Boc)-Leu-Lys(Boc)-Obzl | ? | ? | ? |
Lytic Peptide, SB – 37 | SH6776 | C188H320N54O45S | 4089.05 | Met-Pro-Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Val-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu-Gly | ? | ? | ? |
Lytic Peptide, Shiva-1 | SH6777 | C155H269N53O39S | 3531.27 | Met-Pro-Arg-Leu-Phe-Arg-Arg-Ile-Asp-Arg-Val-Gly-Lys-Gln-Gly-Ile-Leu-Arg-Ala-Gly-Pro-Ala-Ile-Ala-Leu-Val-Gly-Asp-Ala-Arg-Ala-Val-Gly | ? | ? | ? |
M35 | SH6778 | C107H153N27O26 | 2233.58 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-NH2 | ? | ? | ? |
M40 | SH6779 | C94H145N23O24 | 1981.34 | Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Pro-Pro-Ala-Leu-Ala-Leu-Ala-NH2 | ? | ? | ? |
Macrophage Inhibitory Peptide | SH6780 | C15H28N4O5 | 344.41 | Thr-Lys-Pro | ? | ? | ? |
Magainin 1 | SH6781 | C112H177N29O28S | 2409.90 | Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Gly-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Lys-Ser | ? | ? | ? |
Magainin 2 | SH6782 | C114H180N30O29S | 2466.95 | Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Asn-Ser | ? | ? | ? |
Magainin Spacer Peptide | SH6783 | C97H150N28O39 | 2332.30 | Asp-Ala-Glu-Ala-Val-Gly-Pro-Glu-Ala-Phe-Ala-Asp-Gln-Asp-Leu-Asp-Glu-Arg-Glu-Val-Arg | ? | ? | ? |
Mage-1 Antigen (161-169), human | SH6784 | C41H57N11O17 | 975.97 | Glu-Ala-Asp-Pro-Thr-Gly-His-Ser-Tyr | ? | ? | ? |
MAGE-3 Antigen (167-176), human | SH6785 | C53H80N12O16S | 1173.36 | Met-Glu-Val-Asp-Pro-Ile-Gly-His-Leu-Tyr | ? | ? | ? |
MAGE-3 Antigen (271-279), human | SH6786 | C53H79N13O10 | 1058.30 | Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val | ? | ? | ? |
Malantide | SH6787 | C72H124N22O21 | 1633.93 | Arg-Thr-Lys-Arg-Ser-Gly-Ser-Val-Tyr-Glu-Pro-Leu-Lys-Ile | ? | ? | ? |
MAP Kinase Substrate; EGF-R (661-681) | SH6788 | C101H172N30O32 | 2318.66 | Lys-Arg-Glu-Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Ala-Leu-Leu-Arg | ? | ? | ? |
MARCKS Protein (151-175) | SH6789 | C147H243N41O31 | 3080.83 | Lys-Lys-Lys-Lys-Lys-Arg-Phe-Ser-Phe-Lys-Lys-Ser-Phe-Lys-Leu-Ser-Gly-Phe-Ser-Phe-Lys-Lys-Asn-Lys-Lys | ? | ? | ? |
MARCKS Protein (159-165) | SH6790 | C45H72N10O9 | 897.14 | Phe-Lys-Lys-Ser-Phe-Lys-Leu | ? | ? | ? |
MARCKS PSD-Derived Peptide, PKC Substrate | SH6791 | C75H122N20O15 | 1543.93 | Lys-Lys-Arg-Phe-Ser-Phe-Lys-Lys-Ser-Phe-Lys-Leu | ? | ? | ? |
MARCKS Substrate (151-175) | SH6792 | C147H246N41O40P3 | 3320.78 | Lys-Lys-Lys-Lys-Lys-Arg-Phe-pSer-Phe-Lys-Lys-pSer-Phe-Lys-Leu-Ser-Gly-Phe-pSer-Phe-Lys-Lys-Asn-Lys-Lys | ? | ? | ? |
MART-1 (26-35) (human) | SH6793 | C42H74N10O14 | 943.12 | Glu-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val | ? | ? | ? |
MART-1 (27-35) (human) | SH6794 | C37H67N9O11 | 814.00 | Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val | ? | ? | ? |
Mas17 | SH6795 | C70H132N20O15 | 1493.96 | Ile-Asn-Leu-Lys-Ala-Lys-Ala-Ala-Leu-Ala-Lys-Lys-Leu-Leu-NH2 | ? | ? | ? |
Mas8 | SH6796 | C70H131N21O15 | 1506.96 | Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Arg-Leu-Leu-NH2 | ? | ? | ? |
Mast Cell Degranulating (MCD) Peptide | SH6797 | C110H188N40O24S4 | 2583.27 | Ile-Lys-Cys-Asn-Cys-Lys-Arg-His-Val-Ile-Lys-Pro-His-Ile-Cys-Arg-Lys-Ile-Cys-Gly-Lys-Asn-NH2(Disulfide bridge Cys3-Cys15, Cys5-Cys19) | ? | ? | ? |
Mast Cell Degranulating (MCD) Peptide HR-1 | SH6798 | C71H133N19O15 | 1492.97 | Ile-Asn-Leu-Lys-Ala-Ile-Ala-Ala-Leu-Val-Lys-Lys-Val-Leu-NH2 | ? | ? | ? |
Mast Cell Degranulating (MCD) Peptide HR-2 | SH6799 | C77H135N17O14 | 1523.04 | Phe-Leu-Pro-Leu-Ile-Leu-Gly-Lys-Leu-Val-Lys-Gly-Leu-Leu-NH2 | ? | ? | ? |
Mastoparan | SH6800 | C70H131N19O15 | 1478.90 | Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2 | ? | ? | ? |
Mastoparan 7 | SH6801 | C67H124N18O15 | 1421.85 | Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Ala-Leu-Leu-NH2 | ? | ? | ? |
Mastoparan X | SH6802 | C73H126N20O15S | 1556.01 | Ile-Asn-Trp-Lys-Gly-Ile-Ala-Ala-Met-Ala-Lys-Lys-Leu-Leu-NH2 | ? | ? | ? |
Mating Factor aSK2 | SH6803 | C81H106N18O19S | 1667.92 | Trp-His-Trp-Leu-Ser-Phe-Ser-Lys-Gly-Glu-Pro-Met-Tyr | ? | ? | ? |
MBP MAPK Substrate | SH6804 | C39H70N18O11 | 967.11 | Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg | ? | ? | ? |
MBP (1-11), human | SH6805 | C52H88N22O17 | 1293.42 | Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His-Gly | ? | ? | ? |
MBP (1 - 11), mouse | SH6806 | C53H95N21O18 | 1314.48 | Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys | ? | ? | ? |
MBP (1 - 17) | SH6807 | C79H135N27O26 | 1879.12 | Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu-Ala-Thr-Ala-Ser | ? | ? | ? |
MBP (68-82), gulinea pig; Myelin Basic Protein(68-82), guinea pig | SH6808 | C71H113N23O28 | 1736.80 | Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn | ? | ? | ? |
MBP (74 - 85), guinea pig | SH6809 | C56H94N20O23 | 1415.49 | Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn-Pro-Val | ? | ? | ? |
MBP (87-99), human; Myelin Basic Protein (87-99), guinea pig, human | SH6810 | C74H114N20O17 | 1555.86 | Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro | ? | ? | ? |
MBP (90-106) | SH6811 | C91H143N25O23 | 1955.31 | AC-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly-Lys-NH2 | ? | ? | ? |
MBP (90-106), phosphorylated | SH6812 | C89H141N25O22 | 1913.27 | Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr(PO3H2)-Pro-Pro-Pro-Ser-Gln-Gly-Lys-NH2 | ? | ? | ? |
MCH-Gene-Overprinted-Polypeptide-14 (rat) | SH6813 | C80H131N22O18S3 | 1785.26 | Thr-Ile-His-Cys-Lys-Trp-Arg-Glu-Lys-Pro-Leu-Met-Leu-Met | ? | ? | ? |
MCH-Gene-Overprinted-Polypeptide-27 (rat) | SH6814 | C145H227N39O40S4 | 3284.92 | Ser-Asp-Thr-Cys-Trp-Ser-Thr-Thr-Ser-Phe-Gln-Lys-Lys-Thr-Ile-His-Cys-Lys-Trp-Arg-Glu-Lys-Pro-Leu-Met-Leu-Met(Disulfide bridge: Cys4-Cys17) | ? | ? | ? |
mCRAMP, mouse | SH6815 | C178H302N50O46 | 3878.70 | Gly-Leu-Leu-Arg-Lys-Gly-Gly-Glu-Lys-Ile-Gly-Glu-Lys-Leu-Lys-Lys-Ile-Gly-Gln-Lys-Ile-Lys-Asn-Phe-Phe-Gln-Lys-Leu-Val-Pro-Gln-Pro-Glu-Gln | ? | ? | ? |
Melanin Concentrating Hormone, human, mouse, rat MCH, human, mouse, rat | SH6816 | C105H160N30O26S4 | 2386.80 | Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val(Disulfide bridge Cys7-Cys16) | ? | ? | ? |
Melanin Concentrating Hormone, salmon MCH, salmon | SH6817 | C89H137N27O24S4 | 2097.90 | Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val(Disulfide bridge Cys5-Cys14) | ? | ? | ? |
Melanocyte Associated Antigen gp100 | SH6818 | C43H68N12O13 | 961.09 | Ala-Leu-Asn-Phe-Pro-Gly-Ser-Gln-Lys | ? | ? | ? |
Melanocyte Associated Antigen gp 100 (17 - 25) | SH6819 | C38H70N10O11 | 843.04 | Ala-Leu-Leu-Ala-Val-Gly-Ala-Thr-Lys | ? | ? | ? |
Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | SH6820 | C46H72N10O15 | 1005.14 | Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val | ? | ? | ? |
Melanocyte Protein PMEL 17 (256-264) (human, bovine, mouse) | SH6821 | C44H67N9O14 | 946.08 | Tyr-Leu-Glu-Pro-Gly-Pro-Val-Thr-Ala | ? | ? | ? |
Melanocyte Protein PMEL 17 (44-59) (human, bovine, mouse) | SH6822 | C95H137N27O29 | 2105.32 | Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp | ? | ? | ? |
Melanoma-associated antigen peptide; MART-1(27-35), human | SH6823 | C37H67N9O11 | 814.00 | Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val | ? | ? | ? |
Melanotan II, MT-? | SH6824 | C50H69N15O9 | 1024.20 | Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2 (Lactam bridge Asp2-Lys7) | ? | ? | ? |
Melanostatin, frog | SH6825 | C189H285N53O57S1 | 4243.76 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Lys-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
Melittin(Mellitin) | SH6826 | C131H229N39O31 | 2846.50 | Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 | ? | ? | ? |
Men 10376 | SH6827 | C57H68N12O10 | 1081.25 | Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2 | ? | ? | ? |
Met-Enkephalin | SH6828 | C27H35N5O7S | 573.67 | Tyr-Gly-Gly-Phe-Met | ? | ? | ? |
Met-Enkephalin, amide | SH6829 | C27H36N6O6S | 572.69 | Tyr-Gly-Gly-Phe-Met-NH2 | ? | ? | ? |
Met-Lys-Bradykinin | SH6830 | C61H94N18O13S | 1319.61 | Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | ? | ? | ? |
Metamorphosin A | SH6831 | C34H47N9O8 | 709.80 | Pyr-Gln-Pro-Gly-Leu-Trp-NH2 | ? | ? | ? |
MGP-pNA | SH6832 | C18H25N5O5S | 423.40 | Met-Gly-Pro-pNA | ? | ? | ? |
MIF-1 Tyr | SH6833 | C22H33N5O5 | 447.54 | Tyr-Pro-Leu-Gly-NH2 | ? | ? | ? |
mini-ANP | SH6834 | C75H117N27O19S4 | 1829.19 | Met-Cys-His-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Ser-Cys-Tyr-Arg-NH2 (Disulfide bond) | ? | ? | ? |
Minigastrin I (human) | SH6835 | C74H99N15O26S | 1645.66 | Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | ? | ? | ? |
Miraculin (1-20) | SH6836 | C18H33N5O4 | 383.49 | Asp-Ser-Ala-Pro-Asn-Pro-Val-Leu-Asp-Ile-Asp-Gly-Glu-Lys-Leu-Arg-Thr-Gly-Thr-Asn | ? | ? | ? |
MKKp2 | SH6837 | C85H158N31O26S1 | 2063.50 | Ser-Lys-Gly-Lys-Ser-Lys-Arg-Lys-Lys-Asp-Leu-Arg-Ile-Ser-Cys-Asn-Ser-Lys | ? | ? | ? |
MLC-derived peptide | SH6838 | C70H115N25O17 | 1578.85 | Lys-Lys-Arg-Pro-Gln-Arg-Arg-Tyr-Ser-Asn-Val-Phe | ? | ? | ? |
MMP Biotinylated Substrate I | SH6839 | C53H86N14O11 | 1127.43 | Biotin-LC-Pro-Leu-Gly-Leu-Arg-Ala-Tyr-NH2 | ? | ? | ? |
MMP Substrate I, fluorogenic | SH6840 | C45H64N14O11 | 977.10 | Dnp-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-NH2 | ? | ? | ? |
MMP-1 Substrate I, fluorogenic | SH6841 | C46H65N13O12 | ? | Dnp-Pro-Leu-Ala-Leu-Trp-Ala-Arg | ? | ? | ? |
MMP-2/MMP-9 Substrate I, fluorogenic | SH6842 | C44H61N13O13S | ? | Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg | ? | ? | ? |
MMP-2/MMP-9 Inhibitor III | SH6843 | C52H73N13O14S2 | 1168.35 | Cys-Thr-Thr-His-Trp-Gly-Phe-Thr-Leu-Cys | ? | ? | ? |
MMP-3 Inhibitor I | SH6844 | C27H46N10O9S | 686.80 | Ac-Arg-Cys-Gly-Val-Pro-Asp-NH2 | ? | ? | ? |
MMP-3 Substrate I, fluorogenic | SH6845 | C44H61N13O13S | 1012.13 | Dnp-Pro-Tyr-Ala-Tyr-Trp-Met-Arg | ? | ? | ? |
MMP-7 Substrate I, fluorogenic | SH6846 | C52H77N17O14 | 1164.31 | Dnp-Arg-Pro-Leu-Ala-Leu-Trp-Arg-Ser | ? | ? | ? |
MMP-8 Substrate, fluorogenic | SH6847 | C49H63N13O13 | 1042.14 | Dnp-Pro-Leu-Ala-Tyr-Trp-Ala-Arg | ? | ? | ? |
Morphine Modulating Peptide, C-Terminal Fragment | SH6848 | C25H39N9O5 | 545.65 | Pro-Gln-Arg-Phe-NH2 | ? | ? | ? |
Motilin, canine | SH6849 | C120H194N36O34 | 2685.10 | Phe-Val-Pro-Ile-Phe-Thr-His-Ser-Glu-Leu-Gln-Lys-Ile-Arg-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | ? | ? | ? |
Motilin, porcine | SH6850 | C120H188N34O35S | 2699.10 | Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | ? | ? | ? |
MSH Release Inhibiting Factor, amide | SH6851 | C13H24N4O3 | 284.36 | Pro-Leu-Gly-NH2 | ? | ? | ? |
MSP-1 P2, Malaria Merozoite Surface Peptide – 1 | SH6852 | C116H190N32O35S | 2625.07 | Gly-Tyr-Arg-Lys-Pro-Leu-Asp-Asn-Ile-Lys-Asp-Asn-Val-Gly-Lys-Met-Glu-Asp-Tyr-Ile-Lys-Lys | ? | ? | ? |
MSP-1 (20 - 39), Merozoite Surface Peptide 1 | SH6853 | C102H165N25O35 | 2301.60 | Val-Thr-His-Glu-Ser-Tyr-Gln-Glu-Leu-Val-Lys-Lys-Leu-Glu-Ala-Leu-Glu-Asp-Ala-Val | ? | ? | ? |
Murine CMV pp 89 (168-176) | SH6854 | C53H74N12O13S | 1119.32 | Tyr-Pro-His-Phe-Met-Pro-Thr-Asn-Leu | ? | ? | ? |
Murine CMV pp 89 (170-174) | SH6855 | C29H41N7O7S | 631.76 | His-Phe-Met-Pro-Thr | ? | ? | ? |
Myelin Oligodendrocyte Glycoprotein(35-55), rat MOG(35-55) | SH6856 | C118H177N35O29S | 2582.00 | Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys | ? | ? | ? |
Myelopeptide-2 (MP-2) | SH6857 | C41H57N7O8 | 776.00 | Leu-Val-Val-Tyr-Pro-Trp | ? | ? | ? |
Myomodulin | SH6858 | C36H67N11O8S2 | 846.13 | Pro-Met-Ser-Met-Leu-Arg-Leu-NH2 | ? | ? | ? |
Myosin Kinase Inhibiting Peptide | SH6859 | C40H78N18O11 | 987.20 | Lys-Lys-Arg-Ala-Ala-Arg-Ala-Thr-Ser-NH2 | ? | ? | ? |
Myristoylated ADP -Ribosylation Factor 1, myr -ARF1 (2 - 17) | SH6860 | C99H157N21O22 | 1993.49 | myr-Gly-Asn-Ile-Phe-Ala-Asn-Leu-Phe-Lys-Gly-Leu-Phe-Gly-Lys-Lys-Glu | ? | ? | ? |
Myristoylated ADP -Ribosylation Factor 6, myr -ARF6 (2 - 13) | SH6861 | C74H128N16O18 | 1529.95 | myr-Gly-Lys-Val-Leu-Ser-Lys-Ile-Phe-Gly-Asn-Lys-Glu | ? | ? | ? |
Myristoylated Protein Kinase C (19-31) | SH6862 | C81H144N26O26 | 1754.23 | Myristoyl-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val | ? | ? | ? |
N-10 Region of TRAP | SH6863 | C51H78N11O21S | 1213.32 | Asp-Glu-Ile-Lys-Tyr-Ser-Glu-Glu-Val-Cys | ? | ? | ? |
N-Formyl -Met-Ala-Ser | SH6864 | C12H21N3O6S | 335.38 | For-Met-Ala-Ser | ? | ? | ? |
N-Formyl-Met-Leu-Phe | SH6865 | C21H31N3O5S | 437.60 | For-Met-Leu-Phe | ? | ? | ? |
N-Formyl-Met-Leu-Phe-Lys | SH6866 | C27H43N3O6S | 565.74 | For-Met-Leu-Phe-Lys | ? | ? | ? |
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys | SH6867 | C43H65O7N9 | 824.04 | For-Nle-Leu-Phe-Nle-Tyr-Lys | ? | ? | ? |
N(p-Tosyl)-GPR-pNA | SH6868 | C26H34N8O7S | 602.00 | N(p-Tosyl)-Gly-Pro-Arg-pNA | ? | ? | ? |
NAP | SH6869 | C36H60N10O12 | 824.94 | Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln | ? | ? | ? |
Ne-Trifluoroacetyl-L-lysine | SH6870 | C17H22N3O5F3 | 405.37 | LYS(TFA)-TYR | ? | ? | ? |
Necrofibrin, human | SH6871 | C67H112N16O25 | 1541.73 | Gly-Ala-Val-Ser-Thr-Ala | ? | ? | ? |
Necrofibrin, rat | SH6872 | C32H47N7O9 | 673.77 | Trp-Thr-Val-Pro-Thr-Ala | ? | ? | ? |
Neo-Kyotorphin | SH6873 | C28H47N9O9 | 653.74 | Thr-Ser-Lys-Tyr-Arg | ? | ? | ? |
NES Topoisomerase II alpha (1017 - 1028) | SH6874 | C73H117N19O19 | 1564.86 | Asp-Ile-Leu-Arg-Asp-Phe-Phe-Glu-Leu-Arg-Leu-Lys | ? | ? | ? |
Nesfatin-1 (human) | SH6875 | C427H691N113O134 | 9551.87 | Val-Pro-Ile-Asp-Ile-Asp-Lys-Thr-Lys-Val-Gln-Asn-Ile-His-Pro-Val-Glu-Ser-Ala-Lys-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Asp-Val-Leu-Glu-Thr-Asp-Lys-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Lys-Ser-Gly-Arg-Leu | ? | ? | ? |
Nesfatin-1 (mouse) | SH6876 | C424H683N117O137 | 9611.87 | Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Thr-Glu-Pro-Val-Glu-Asn-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu | ? | ? | ? |
Nesfatin-1 (rat) | SH6877 | C424H684N116O136 | 9582.80 | Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu | ? | ? | ? |
Neurogranin (28-43) | SH6878 | C78H134N28O19S | 1800.18 | Ala-Ala-Lys-Ile-Gln-Ala-Ser-Phe-Arg-Gly-His-Met-Ala-Arg-Lys-Lys | ? | ? | ? |
Neurokinin A; Substance K; Neuromedin L; NKA | SH6879 | C50H80N14O14S | 1133.34 | His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
Neurokinin A (4-10) | SH6880 | C34H54N8O10S1 | 766.92 | Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
Neurokinin B | SH6881 | C55H79N13O14S2 | 1210.45 | Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
Neurokinin Receptor (393 -407), rat | SH6882 | C67H87N15O14 | 1326.53 | Lys-Thr-Met-Thr-Glu-Ser-Ser-Phe-Tyr-Ser-Asn-Met-Leu-Ala | ? | ? | ? |
Neuromedin (B-30) | SH6883 | C157H243N51O38S | 3485.07 | Leu-Ser-Trp-Asp-Leu-Pro-Glu-Pro-Arg-Ser-Arg-Ala-Gly-Lys-Ile-Arg-Val-His-Pro-Arg-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 | ? | ? | ? |
Neuromedin (U25), human | SH6884 | C141H203N41O38 | 3080.44 | Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | ? | ? | ? |
Neuromedin (U25), porcine | SH6885 | C144H217N43O37 | 3142.60 | Phe-Lys-Val-Asp-Glu-Glu-Phe-Gln-Gly-Pro-Ile-Val-Ser-Gln-Asn-Arg-Arg-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | ? | ? | ? |
Neuromedin (U8), porcine | SH6886 | C54H78N16O10 | 1111.32 | Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | ? | ? | ? |
Neuromedin B, porcine | SH6887 | C52H73N15O12S | 1132.30 | Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 | ? | ? | ? |
Neuromedin C, porcine GRP(18-27) | SH6888 | C50H73N17O11S | 1120.30 | Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | ? | ? | ? |
Neuromedin N | SH6889 | C38H63N7O8 | 745.97 | Lys-Ile-Pro-Tyr-Ile-Leu | ? | ? | ? |
Neuromedin S (human) | SH6890 | C67H87N15O14 | 1326.53 | Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | ? | ? | ? |
Neuromedin S (rat) | SH6891 | C67H87N15O14 | 1326.53 | Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | ? | ? | ? |
Neuromedin U, rat | SH6892 | C124H180N34O31 | 2643.03 | Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | ? | ? | ? |
Neuron Specific Peptide | SH6893 | C161H262N52O51S4 | 3870.44 | Asp-Val-Ser-Asp-Gly-Ser-Ala-Glu-Arg-Arg-Pro-Tyr-Thr-Arg-Met-Gly-Ser-Gly-Gly-Leu-Lys-Leu-His-Cys-Val-His-Pro-Ala-Asn-Cys-Pro-Gly-Gly-Leu-Met-Val-Thr | ? | ? | ? |
Neuropeptide AF (hNPAF), Human | SH6894 | C90H132N26O25 | 1978.21 | Ala-Gly-Glu-Gly-Leu-Asn-Ser-Gln-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2 | ? | ? | ? |
Neuropeptide EI-Gly-Arg-Arg-MCH (human, mouse, rat) | SH6895 | C182H282N54O52S4 | 4186.86 | Glu-Ile-Gly-Asp-Glu-Glu-Asn-Ser-Ala-Lys-Phe-Pro-Ile-Gly-Arg-Arg-Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val(Disulfide bridge:C23-C32) | ? | ? | ? |
Neuropeptide EI (human, mouse, rat) | SH6896 | C63H98N16O23 | 1447.58 | Glu-Ile-Gly-Asp-Glu-Glu-Asn-Ser-Ala-Lys-Phe-Pro-Ile-NH2 | ? | ? | ? |
Neuropeptide F | SH6897 | C210H328N58O58 | 4593.27 | Pro-Asp-Lys-Asp-Phe-Ile-Val-Asn-Pro-Ser-Asp-Leu-Val-Leu-Asp-Asn-Lys-Ala-Ala-Leu-Arg-Asp-Tyr-Leu-Arg-Gln-Ile-Asn-Glu-Tyr-Phe-Ala-Ile-Ile-Gly-Arg-Pro-Arg-Phe-NH2 | ? | ? | ? |
Neuropeptide FF Morphine Modulating Neuropeptide F-8-F-NH2 | SH6898 | C54H76N14O10 | 1081.30 | Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 | ? | ? | ? |
Neuropeptide W-30 (human) | SH6899 | C165H249N49O37S | 3543.17 | Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp | ? | ? | ? |
Neuropeptide W-30 (rat) | SH6900 | C165H249N49O38S | 3559.17 | Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp | ? | ? | ? |
Neuropeptide Y, human, rat | SH6901 | C189H285N55O57S | 4271.70 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
Neuropeptide Y (free acid) (human) | SH6902 | C189H284N54O58S1 | 4272.80 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr | ? | ? | ? |
Neuropeptide Y (porcine) | SH6903 | C190H287N55O57 | 4253.70 | Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | ? | ? | ? |
Neuropeptide Y-Lys(Biotin), human, rat; NPY-Lys(Biotin), human, rat | SH6904 | C199H300N57O60S2 | 4515.10 | Biotin-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-Lys | ? | ? | ? |
Neurotensin | SH6905 | C78H121N21O20 | 1672.96 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu | ? | ? | ? |
Neurotensin (1-8) | SH6906 | C46H71N13O14 | 1030.15 | Pyr--Leu-Tyr-Glu-Asn-Lys-Pro-Arg | ? | ? | ? |
Neurotensin (1-11) | SH6907 | C66H99N19O18 | 1446.66 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr | ? | ? | ? |
Neurotensin (8-13) | SH6908 | C38H64N12O8 | 817.01 | Arg-Arg-Pro-Tyr-Ile-Leu | ? | ? | ? |
Neurotensin (8-13), N-Acetyl | SH6909 | C40H66N12O9 | 859.05 | Ac-Arg-Arg-Pro-Tyr-Ile-Leu | ? | ? | ? |
Neurotensin (9-13) | SH6910 | C 32H52N8O7 | 660.82 | Arg-Pro-Tyr-Ile-Leu | ? | ? | ? |
Neurotensin (Frog) | SH6911 | C70H115N23O17 | 1550.84 | Pyr-Ser-His-Ile-Ser-Lys-Ala-Arg-Arg-Pro-Tyr-Ile-Leu-NH2 | ? | ? | ? |
Neurotensin, guinea pig | SH6912 | C76H119N21O21 | 1662.92 | Pyr-Leu-Tyr-Glu-Asn-Lys-Ser-Arg-Arg-Pro-Tyr-Ile-Leu | ? | ? | ? |
Neuropeptide K, porcine | SH6913 | C175H284N52O52S1 | 5980.60 | Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | ? | ? | ? |
|